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Abstract 
Calcium is an important secondary messenger and plays a major role in 
cell function, including proliferation, cell growth, secretion and death .It 
also plays a critical role in uterine smooth muscle contraction and 
embryo implantation. This thesis is concerned with calcium homeostasis 
in epithelial tissue lining the oviduct and uterus which are key players in 
early reproductive events, being involved in gamete transport, sperm 
capacitation and providing the micro-environment for the gametes and 
early embryo. Calcium transport across epithelial cells is either via tight 
junctions or calcium channels, specifically, members of the transient 
receptor potential (TRP) channel superfamily and the Na+/Ca2+ 
exchanger. TRP channels are an important class of calcium channels 
with more than 28 identified members and their potential involvement in 
calcium transport in uterus and oviduct epithelia has yet to be 
determined. The aim of this study was to discover which TRPC isoforms 
are expressed in epithelial cells lining the female reproductive tract in the 
bovine and human. Gene expression of TRPC channels changes was 
measured throughout the estrous cycle in bovine oviduct and uterine 
epithelial cells using Real-Time PCR, while immunohistochemistry, 
immunocytochemistry and western blotting were used to discover the 
localization of TRPC channels in oviduct/uterine epithelium and changes 
in protein expression of TRPC isoforms induced by sex hormones. . to 
The physiological role of TRPC isofoms in regulating intracellular calcium 
concentration in bovine oviduct epithelial cells was determined using a 
calcium assay approach and finally. the potential clinical relevance of a 
possible role of TRP channels in female reproduction was investigated.  
OF 7 members of TRPC family, TRPC1, 2, 3, 4 and 6 were expressed in 
bovine oviduct and uterine epithelia. In human endometrium, TRPC1, 6 
and 7 genes were detected. Expression levels of all TRPC isoforms 
present in both bovine oviduct and uterine epithelia changed throughout 
the estrous cycle. 17β-estradiol, FSH and LH individually and in 
combination up-regulated gene expression of TRPC isoforms in bovine 
oviduct epithelial cells. However, progesterone inhibited the up-
regulatory effect of 17β-estradiol, FSH and LH on TRPCs gene 
  
expression.  TRPC1 and TRPC6 which are the common TRPC isoforms 
in bovine oviduct/uterine epithelium and human endometrium were 
localized on the apical, basal and lateral membranes of the epithelial 
tissue in bovine oviduct/uterus and human endometrium. TRPC isoforms 
were physiologically active in bovine oviduct epithelial cells (BOEC). 
SKF96365 which is a general TRP channel blocker inhibited the calcium 
influx into BOEC. Furthermore, Hyperforin which is a TRPC6 channel 
activator increased the intracellular calcium concentration in BOEC. 
TRPC1, 6 and 7 expression in endometrium of patients being treated for 
infertility by IVF illustrated that gene expression of TRTPC1 and 6 were 
up regulated in the endometrium of the IVF patients compared to 
controls. However, gene expression of TRPC7 in IVF patients was down-
regulated compared to that of the endometrium of the control group. 
Gene expression of TRPC6 and 7 in endometrium of women with Poly 
Cystic Ovarian Syndrome (PCOS) who have higher level of LH and 
normal FSH level, alongside the absence of the post-ovulatory increase 
in progesterone secretion, were up -regulated compared to that of the 
control group. However, the expression level of TRPC1 in endometrium 
of PCOS patients was not significantly different compared to the control 
group. 
Gene expression of TRPC isoforms in the epithelia lining the female 
reproductive tract is possibly regulated by sex hormones via nuclear 
factor-kappa B (NF-КB) signalling pathway. However, further 
investigation is required to determine the mechanisms underlying the 
endocrine regulation of TRPC channels.  
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1. Reproduction 
The reproductive system describes the aspect of physiology involved in the 
survival and propagation of the species. The reproductive systems of both 
males and females have broadly similar components that comprise the gonads, 
a ‘reproductive tract’ and accessory sex glands.  However, unlike other body 
systems that are largely identical between male and female individuals, the 
anatomy of the reproductive system is unique to each of the sexes.  The female 
reproductive tract is a complex system which, in eutherian mammals, 
undergoes periodic physiological changes which relate to functional 
requirements.  The detail of these cyclical changes in female reproductive 
physiology differs between species of eutherian mammals, and can be 
categorised as menstrual (in humans and higher primates such as gorillas 
(Nadler et al., 1979) and chimpanzees (Graham et al., 1972) or  estrous (in 
other placental mammalian species). 
1.1 The oviduct 
The anatomy of the oviduct is highly variable among the different species. In 
general terms, the oviduct is a tube consisting of an internal mucosa, 
specifically termed the endosalpinx, especially in women, an intermediate 
muscular layer, also known as the myosalpinx, and an outer serosa. The 
endosalpinx is lined by three types of cells; ciliated, secretory and peg cells.  It 
is divided into three sections; the infundibulum, the ampulla and the isthmus 
(Menezo & Guerin, 1997). The infundibulum is the part of the oviduct that is 
nearest to the ovary and is associated with the fimbriae, a bordering fringe at 
the ovarian end of the oviduct. The infundibulum is mainly lined with a ciliated 
simple columnar epithelium that facilitates the movement of the oocyte toward 
the uterus (Yániz et al., 2000).  
The ampulla is a thin-walled part of oviduct and forms more than half of the 
length of the tube. In woman, the outer diameter of the ampulla is 1-2 cm and 
the inner diameter is 1-2 mm (Pauerstein & Eddy, 1979). It is in the ampulla that 
fertilization occurs (Shalgi & Phillips, 1988).  The epithelial cells in the ampulla 
are largely secretory and contain a granular cytoplasm and their endoplasmic 
reticulum is spread out irregularly. However, ciliated epithelial cells are still 
apparent (Pauerstein & Eddy, 1979). These secretory cells release secretory 
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material into the lumen for nourishment of the oocyte and embryo providing an 
optimal environment for fertilization (Ledger, 2010).  
The isthmus is the narrow, proximal portion of the oviduct which connects to the 
ampulla and terminates in the uterus at the uterotubal junction. The isthmus is 
2-3 cm in length and 0.1-1.0 mm in diameter (Pauerstein & Eddy, 1979). There 
are fewer ciliated cells in the isthmus compared to the infundibulum and 
ampulla. The increase in the percentage of ciliated cells from the isthmus to the 
fimbriae is dramatic (Shalgi & Phillips, 1988). 
First described by Novak and Everett (1928), the histological appearance of the 
oviductal epithelium undergoes cyclic changes (Novak & Everett, 1928) that are 
regulated by the level of estrogens and progesterone during the 
menstrual/estrous cycle. At the late follicular phase, the height and degree of 
ciliation of the epithelial cells reach a maximum level in the ampulla and 
infundibulum.   Atrophy and deciliation occurs in the late luteal phase. In the 
early follicular phase the epithelial cells undergo hypertrophy and re-ciliation. 
Further atrophy and deciliation occur during pregnancy and the postpartum 
period (Verhage et al., 1979). 
1.2 The uterus 
The uterus in women is a pear-shaped organ, made up of the fundus, body and 
cervix. In the bovine, there are two uterine horns. The endometrium lines the 
uterus and comprises a single layer of columnar luminal epithelium with 
glandular epithelial cells which penetrate into the stroma. This epithelial layer is 
supported by a base of stromal connective tissue (Lawn, 1973). 
17-β estradiol and progesterone, two of the major ovarian steroids, regulate the 
function of the uterus. For instance, a balance of 17-β estradiol and 
progesterone controls proliferation of the uterine epithelial cells by regulating 
DNA synthesis, mitogenesis and expression of cell cycle markers such as Ki67 
(Martin, 1980; Clarke & Sutherland, 1990). Progesterone inhibits the 17-β 
estradiol-induced epithelial proliferation (Martin et al., 1973) . 
During the follicular phase of the menstrual/estrous cycle, a rise in 17-β 
estradiol level leads to an increase in both myometrial contractility and 
excitability to facilitate spermatozoa movement towards the site of fertilization in 
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the ampulla (Mesiano & Welsh, 2007). Also, in the endometrium, proliferation of 
the stromal cells contributes to overall stromal thickening. An increase occurs in 
the surface area and metabolic activity of the surface epithelium which involves 
an increase in the number and size of the glandular epithelial cells.  
Estrogens bind to estrogen receptors ERα, ERβ which are abundant in the 
uterine tissue. Estrogens induce the synthesis of intracellular progesterone 
receptor at the proliferation phase ready for ovulation and the transition to the 
subsequent proliferative phase. In the rat, estradiol increases the mRNA level of 
ERα in glandular and luminal epithelia, however, the protein level of ERα 
decreases in glandular epithelium under the influence of estradiol (Sharma & 
Rao, 1992). 
1.3 Menstrual and estrous cycles 
The menstrual (human) and estrous (bovine) cycles commence with puberty. 
The ovaries begin their endocrine activity with the secretion of two key steroid 
hormones; oestrogen and progesterone. Both menstrual and estrous cycle 
involve changes in the ovary and uterus. The bovine cycle, summarised in Fig 
1, is considered first. 
1.3.1 Bovine estrous cycle 
The bovine estrous cycle (Fig 1.1) begins with ovulation, when the oocyte(s) is 
released from the dominant follicle on the ovary as a result of the preovulatory 
Luteinizing hormone (LH) surge which in turn triggers nuclear and cytoplasmic 
maturation of the oocyte (Gordon, 2003). After ovulation, the tissue of the 
recently ovulated follicle consists of theca interna cells, which have LH 
receptors, and granulosa cells which have both FSH and LH receptors (Boron & 
Emile, 2005). Under the influence of these hormones, the tissue undergoes 
transformation under the effect of follicle stimulating hormone (FSH) and 
Luteinizing hormone (LH) produced in gonadotrophs of the anterior pituitary 
gland (Channing et al., 1980), and differentiates to form small and large luteal 
cells respectively. Both small and large luteal cells secrete progesterone. 
Secretion of LH is regulated by 17-β estradiol concentration (Gordon, 2003) 
whereas, secretion of FSH is regulated by inhibin in association with 17-β 
estradiol (Kaneko et al., 1995). Large luteal cells secrete oxytocin and are 
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responsive to prostaglandin E whereas, small luteal cells are responsive to LH. 
Formation of a functional CL requires LH. However, the CL maintains its 
function without LH (Peters et al., 1994). Progesterone, which is secreted from 
the CL, is the dominant hormone for the major part of the bovine's estrous 
cycle. The concentration l of progesterone increases from day 3-4 of the estrous 
cycle, and then,  dramatically until day 8 of the estrous cycle when a plateau is 
reached (Gordon, 2003). A decrease in progesterone concentration, the result 
of rapid regression of the CL induced by PGF2α secreted by the endometrium 
(Schramm et al., 1983) is the key event in the estrous cycle. Regression of the 
CL begins 1-4 days before estrous and is completed within 2 days (Gordon, 
2003). Apoptosis is responsible for CL regression (Zheng et al., 1994). PGF2α is 
secreted from the endometrium as a result of interaction with  oxytocin secreted 
from the CL with its specific receptor on the endometrial cells. The formation of 
oxytocin is dependent on the 17-β estradiol secreted by the granulosa cells of 
the follicle using the androstenedione produced in theca cells (Gordon, 2003). 
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Fig 1.1 Hormonal changes throughout the bovine estrous cycle. Taken from 
http://www.google.co.uk/imgres?q=hormonal+changes+in+estrous+cycle&um=1&hl=en&sa=N&
rlz=1T4GGHP_en-GBGB438GB438&biw=1366&bih=583&tbm=isch&tbnid=B9rlHU3_-
jxUBM:&imgrefurl=http://www.fao.org/Wairdocs/ILRI/x5442E/x5442e04.htm&docid=AtGarE7y08
4EQM&imgurl=http://www.fao.org/Wairdocs/ILRI/x5442E/x5442e09.gif&w=599&h=486&ei=waS
yTvWVHcnFtAbM-6ypBA&zoom=1.  Accessed on 31/10/2011 
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1.3.2 The menstrual cycle 
The menstrual cycle (Fig 1.2), which usually takes 28 days, is controlled by 
interaction between the hypothalamus, pituitary gland and ovaries similar to that 
of the estrous cycle. Gonadotropin-releasing hormone (GnRH) is synthesized, 
stored and released by neurons in the hypothalamus. GnRH is then carried to 
the anterior pituitary where it binds to its specific receptors on gonadotrophs 
(Boron & Emile, 2005) and induces the synthesis and secretion of FSH and LH. 
FSH and LH in turn induce the synthesis and release of estrogens and 
progesterone from the ovaries. Furthermore, the ovaries secrete two peptides 
called inhibins and activins which are also involved in regulation of the 
menstrual cycle (Boron & Emile, 2005).  
The follicular phase, which is the first phase of the ovarian cycle, begins  with 
menstruation. The FSH surge in the late luteal phase of the preceding cycle 
results in the development of follicles in the ovary. Upon initiation of follicle 
development, granulosa cells of the follicle start the secretion of 17-β estradiol 
which is turn triggers continue growth and maturation of endometrium, known 
as the proliferative phase of the endometrial cycle. Increased levels of 17-β 
estradiol lead to an LH surge just before ovulation via a positive feedback on 
the anterior pituitary. An increase in progesterone and activin concentrations 
then leads to the FSH surge prior to ovulation (Boron & Emile, 2005). 
The second phase of the ovarian cycle is known as the luteal phase and begins 
after ovulation with the formation of the corpus luteum. Luteal cells secrete 
significant amount of progesterone, and at lower concentrations, 17-β estradiol 
and inhibin. Progesterone and 17-β estradiol trigger further growth and 
development of endometrium (Boron & Emile, 2005). This is known as the 
secretory phase of the endometrial cycle. Increase in estrogen and 
progesterone leads to a fall in FSH and LH levels via a negative feedback on 
the hypothalamic-pituitary system. The decrease in FSH and LH levels results 
in the regression of the corpus luteum which in turn leads to menstrual bleeding 
known as the menstrual phase of the endometrial cycle and initiation of the next 
cycle (Boron & Emile, 2005). 
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Fig 1.2 Physiological and hormonal changes in endometrium and ovary throughout the 
menstrual cycle. Taken from  
http://www.google.co.uk/imgres?q=hormonal+changes+in+menstrual+cycle&um=1&hl=en&rlz=
1T4GGHP_enBGB438GB438&biw=1366&bih=544&tbm=isch&tbnid=6XUkkqokSxQt1M:&imgref
url=http://www.medscape.com/viewarticle/719473_2&docid=I75DhXyo3QjAmM&imgurl=http://i
mg.medscape.com/article/719/473/719473-
fig1.jpg&w=800&h=515&ei=JaayTvquGcv0sgai6u23BA&zoom=1. Accessed on 31/10/2011 
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1.4 Endocrine control of calcium homeostasis 
About 99% of total calcium in the body is stored in crystalline form within the 
skeleton and teeth. About one tenth of the remaining 1% resides within cells in 
the soft tissue. Less than 0.1% of the total calcium in the body is found in the 
extracellular fluid. Approximately half of this extracellular fluid calcium is 
restricted to the plasma, bound to the plasma proteins or involved in formation 
of complexes with PO4
-3. Consequently only approximately 0.05% of total body 
calcium is biologically active and involved in essential physiological activities 
(Aurbach et al., 1992).  
Regulation of Ca2+ homeostasis is hormone dependent. Parathyroid hormone 
(PTH), vitamin D and calcitonin are the three key hormones that regulate Ca2+ 
homeostasis and balance in the body (Mundy & Guise, 1999).  
1.4.1 Parathyroid Hormone 
PTH is a 84-amino acid peptide hormone  secreted from the parathyroid glands. 
The key function of PTH is to prevent hypocalcemia by increasing Ca2+ 
concentration of plasma by acting on bone, kidneys and intestine. It also 
reduces plasma PO4
-3  concentration, thus raising unbound Ca2+ levels (Mundy 
& Guise, 1999).  
PTH secretion from the parathyroid gland is initiated when hypocalcaemia 
occurs, as the secretory cells of the parathyroid are directly responsive to 
changes in free plasma Ca2+ concentration.  PTH can promote either a fast Ca2+ 
efflux into the plasma from bone fluid or a slow increase by triggering bone 
dissolution and transferring Ca2+ and PO4
-3 from bone minerals. In the case of 
rapid Ca2+  efflux, PTH first activates a membrane Ca2+ pump in osteocytes and 
osteoblasts. This Ca2+ pump in turn promotes Ca2+  movement from bone fluid 
into the cytosol of these cells without movement of PO4
-3 (Sherwood, 2008). 
Osteocytes and osteoblast then release the Ca2+ into the plasma. The entire 
process is dependent on cAMP (Dietrich et al., 1976). The slow PTH-induced 
transfer of Ca2+ from bone to the extracellular fluid occurs through stimulation of 
osteoblasts to secrete the receptor activator of NF-ᵏß ligand (RANKL), which 
induces macrophages to differentiate into osteoclasts (Fu et al., 2002). This 
results in stimulation of osteoclasts to metabolise the bone and further increase 
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the formation of osteoclasts.  In parallel, bone formation by osteoblasts is 
transiently inhibited. Released PO4
-3 during bone dissolution is eliminated by the 
kidney under the influence of PTH. However, PTH induces reabsorption of 
filtered Ca2+ by the kidneys which leads to an increase in the plasma Ca2+ 
concentration. Furthermore, PTH enhances the activation of vitamin D 
(cholecalciferol) by the kidney which in turn increases Ca2+ and PO4
-3 
absorption in the intestine. The relationship between PTH secretion and free 
plasma Ca2+ concentration forms a negative-feedback loop similar to that of 
calcitonin (Mundy & Guise, 1999). 
1.4.2 Vitamin D 
Vitamin D is a steroid-like compound produced in the skin from 7-
dehydrocholestrol when exposed to sunlight (Webb & Holick, 1988). Vitamin D 
is then released into the blood stream and after conversion to its active 
metabolite (see below) acts on intestine and bone. In countries close to the 
poles, with seasonal short periods of sunlight, essential vitamin D should be 
obtained from dietary sources. Vitamin D produced in the skin or from a dietary 
source is biologically inactive and must undergo biochemical alteration by 
addition of two hydroxyl (-OH) groups to become activated. The first 
hydroxylation step occurs in liver and the second in the kidney (Kawashima et 
al., 1982). Hydroxylated vitamin D is known as 1,25-(OH)2-vitamin D3 or 
calcitriol. The enzymes that catalyse the second hydrolxylation of vitamin D in 
kidney are regulated by PTH (Barbour et al., 1981; Gkonos et al., 1984; 
Zerwekh & Breslau, 1986).  
Most of the dietary Ca2+ is lost in the faeces. However, when plasma Ca2+ level 
is low, the active form of vitamin D, Calcitriol, increases the absorption of dietary 
Ca2+ as well as PO4
-3 into the plasma (Norman et al., 1982). Vitamin D also 
enhances the effect of PTH on bone. Vitamin D induces its effect by binding to a 
nuclear vitamin D receptor and regulating gene expression (Takahashi et al., 
1988; Suda et al., 1992). 
1.4.3 Calcitonin 
Calcitonin is a 32-amino acid peptide which is secreted by the C cells of the 
thyroid gland and acts in contrast to PTH and vitamin D to decrease plasma 
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Ca2+ levels. Calcitonin induces short-term and a long-term effects on plasma 
Ca2+ concentration in a similar but reciprocal manner to that of PTH. The short-
term action of calcitonin decreases Ca2+ transport from bone fluid into the 
plasma (Friedman et al., 1968). The long-term effect reduces bone resorption 
via inhibition of cAMP activity in osteoclasts (Heersche et al., 1974). Inhibition of 
bone resorption results in hypocalcemia and hyposphatemia. Calcitonin inhibits 
Ca2+ and PO4
-3 reabsorption from the nephron (Quamme, 1980). However, Ca2+ 
and PO4
-3 absorption in intestine is not affected by calcitonin.  
 
 
 
 
 
 
  
  
  
 
  
  
  
  
 Fig 1.3 Endocrine regulation of calcium homeostasis. Taken form 
http://mycozynook.com/102RGCh25OH.htm  
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1.5 Calcium homeostasis in the oviduct and uterus 
Calcium acts as an intracellular second messenger and plays a major role in a 
variety of cell functions, including proliferation, growth, secretion and death 
(Berridge et al., 1998a). As regards the female reproductive tract, it is useful to 
distinguish between the role of calcium ions in the outer muscle coats 
(myometrium of the uterus and myosalpinx in the oviduct) and the mucosal 
lining (endometrium and endosalpinx respectively). While calcium ions are 
obviously closely linked with contraction of the myometrium and myosalpinx 
(Wray et al., 2003),  their role in these processes is not considered in this thesis 
where the focus is on calcium regulation of events in the endosalpinx and 
endometrium. Here the main emphasis is on the epithelial cells lining the 
oviduct and uterus, rather than the stroma, though in some cases, localisation 
of calcium transporters in stroma has been examined. The epithelial cells are 
ultimately responsible for regulating the passage of calcium ions into the lumen 
compartment where they are required by the gametes and cleavage stages of 
the preimplantation embryo and by the blastocyst during implantation (Sanborn, 
2000). The movement of calcium from the blood across the epithelial cells is 
therefore vital for gamete and embryo survival and requires calcium 
transporters but this process has been little studied in female tract epithelia. 
Similarly, intracellular calcium homeostasis is obviously essential for the 
survival of the endosalpinx and endometrium but the mechanisms involved 
have yet to be determined.  
In general, calcium movement across epithelia has to be considered alongside 
calcium exchange between epithelial cells, which  is either via tight junctions or 
calcium channels which are voltage-dependent calcium channels (VDCCs), 
members of either transient receptor potential (TRP) channels, or  Na+/Ca2+ 
exchangers (NCXS) (Linck et al., 1998). VDCCs have been categorised into two 
major groups; high voltage-activated (HVA) channels which are activated at 
voltages higher than -40 mV (depolarized potential) and low voltage-activated 
(LVA) channels which are activated at voltages between -80mV and -60mV 
(relatively small depolarisation) (Huguenard, 1998).   
Many events related to mammalian reproduction, such as gamete transport, 
fertilization, early embryonic development and embryo transport take place in 
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the oviduct. By virtue of its importance as an intracellular second messenger, 
calcium is likely to play a key role in morphological and functional changes in 
the oviduct epithelium.  Alterations in ciliary activity of oviduct, ampullary 
transport of the oocyte and early embryo, are controlled by estrogen and 
progesterone (Nozaki & Ito, 1987) and cytokines such as Platelet-Activating 
Factor (PAF), which is produced by preimplantation embryos (Velasquez et al., 
1995; Downing et al., 2002). PAF induces a transient increase in intracellular 
calcium concentration [Ca2+]i in bovine oviduct epithelial cells (Tiemann et al., 
1996) and increases the proliferation rate in human endometrial HEC-1B cells 
(Ahmed et al., 1994), bovine endothelial cells (Lin & Rui, 1994) and bovine 
endometrial stromal cells (Tiemann & Hansen, 1995). It has been shown that 
PAF-dependent increases in [Ca2+]i in bovine oviduct epithelial cells are 
dependent on Ca2+ influx from the extracellular environment (Tiemann et al., 
1996). Treatment of these cells with verapamil which is a voltage-gated Ca2+ 
channels inhibitor does not affect the PAF-dependent increase in [Ca2+]i 
(Tiemann et al., 1996). Flufenamic acid reduces the PAF-dependent increase in 
[Ca2+]i (Wangemann et al., 1986; Gögelein et al., 1990). Furosemide which is a 
Na+-K+-2Cl- cotransporter, reduces the effect of PAF on the potential difference 
and short-circuit current (ISCC) across human fallopian tubal epithelial cells 
(Downing et al., 2002). 
1.6 Calcium homeostasis in the endometrium 
The human endometrium is a regenerative tissue which remodels during each 
menstrual cycle by going through phases of growth, proliferation, differentiation, 
breakdown and shedding. There are several calcium transport-related proteins 
expressed in endometrium at different levels depending on the stage of the 
endocrine cycle indicating the importance of this molecule in endometrial 
activity during both the menstrual cycle and pregnancy.  
Ovarian hormones, estrogen and progesterone, play an important role in 
calcium homeostasis in endometrium by altering the expression of calcitonin, a 
short peptide hormone (Ding et al., 1994; Dong et al., 2003). Expression of 
P2X1–3,6,7, a ligand-gated ion channel which is activated by extracellular ATP 
is also up-regulated, on the apical side of epithelium at the time of implantation. 
14 
 
This has been interpreted as an important role of this receptor in supplying 
increased [Ca2+]i  in the endometrial epithelium (Slater et al., 2000). 
For example, in RL95-2, a human uterine epithelial cell line, increase in 
intracellular calcium ([Ca2+]i ) is related to adhesion of trophoblast-like JAR cells 
to the apical surface of these cells in culture. Pretreatment of RL95-2 cells with 
diltiazem, a voltage-activated calcium channel blocker, results in a reduction in 
intracellular calcium concentration. Furthermore, separation of established 
bonds between RL95-2 and trophoblast-like JAR cells induces an increase in 
[Ca2+]i which is reduced by SKF-96365, a blocker of transient receptor potential 
(TRP) channels; mainly receptor-activated Ca2+ channels and voltage-gated 
Ca2+ channels, but not by application of nifedipin or diltiazem, both of which are 
specific blockers of voltage-gated Ca2+ channels (Tinel et al., 2000). 
Studies such as these on human endometrium calcium homeostasis have 
mainly been carried out on primary cell lines or animal models due to the ethical 
and experimental difficulties of in vivo studies.  
In conclusion, this survey of the literature indicates there are very few studies 
on the mechanisms underlying calcium homeostasis in the endosalpinx and 
endometrium and how these may be linked to the transport of calcium across 
the epithelial cells. 
The aim of this thesis is to address this general lack of knowledge, focussing on 
the potential role of TRP channels in these processes. In order to devise a 
suitable experimental approach, it is necessary to summarise the role of TRP 
channels in epithelial cells and the mechanisms involved in their action. 
1.7  Epithelial cell connections and calcium homeostasis 
 The term Epithelium refers to a layer of connected individual cells which form a 
functional barrier between external and internal environments. The fundamental 
functions of epithelial cells are twofold: a) to maintain separation of different 
compartments within the organism and b) to regulate exchange of the ions and 
nutrients between these compartments (Weinstein & Windhager, 2001; 
González-Mariscal et al., 2003). (Goodenough, 1999). Exchange of ions and 
nutrients can be via passage between the cells (paracellular transport) or 
‘through’ the cells (transcellular) in epithelial tissues.  
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An important feature of epithelial cells is tight junctions which are specialized 
intracellular structures where the plasma membranes of adjacent epithelial cells 
are in very close contact. Several integral membrane proteins complex to form 
the tight junction. These include occludin, claudins and immunoglobulin 
superfamily members (Martìn-Padura. I. et al., 1998; Goodenough, 1999; 
Ebnet. K. et al., 2003).  
Gap junctions (Fig 1.4) are another cell connection mediator which allow direct 
communication between adjacent cells. Molecular exchange via gap junctions 
occurs by passive diffusion. Metabolites, ions, second messengers with 
molecular mass of up to 1000 Da, water and electrical impulses are exchanged 
through gap junctions (Kumar & Gilula, 1996; Alexander & Goldberg, 2003). 
Gap junctions are composed of two connexons, each of which consists of six 
connexin subunits. These subunits contain four transmembrane region, two 
extracellular loops, one cytoplasmic loop and cytoplasmic N and C termini (Söhl 
& Willecke, 2004).  
Desmosomes are another group of intracellular junctions in epithelial cells 
which are also present in myocardium. Intermediate filaments are bound to the 
plasma membrane by means of desmosomes. The desmosome is 
morphologically divided into three zones; the extracellular core region 
(desmoglea), the outer dense plaque (ODP) and the inner dense plaque (IDP) 
(Kowalczyk et al., 1994; Schmidt et al., 1994; Green & Jones, 1996; North et al., 
1999; Garrod & Chidgey, 2008). Desmosomes bind the adjacent cells to one 
another and provide the resiliency of the epithelium (Garrod et al., 1996). 
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Fig  1.4  Schematic drawing of gap junction and its subunits, connexins. A: Each of the adjacent 
cell contributes a hemi-channel to the gap junction. Changes in the configuration of subunits 
lead to opening and closing of the gap junction channels [Adapted from (Kandel et al., 1995)]. 
B: Topology of a connexin with four teansmembrane domains (M1-M4), two extracellular loop, 
one cytosolic and cytosolic N and C termini [Adapted from (Kumar & Gilula, 1996)]. 
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Ions can traverse an epithelium though the tight junctions. Movement of ions via 
tight junction depends on the electrical and concentration gradients across the 
epithelium and is described as passive transport since energy is not required to 
drive transport. However, hormones and other factors affecting the 
electrochemical gradient indirectly control the passive ion flow through tight 
junctions (Pappenheimer, 1987; Goodenough, 1999). Growth factors, cytokines, 
bacterial toxins, hormones and other factors modulate tight junction permeability 
(Garcia et al., 1998; Gopalakrishnan et al., 2002; Benais-Pont et al., 2003; 
Wang et al., 2004).  
Many cells express specific pathways for the transport of ions across their 
membranes and into the cell. Once internalised, these ions can either exit 
through the opposing membrane or can be affect the behaviour of the cell.   
One ion which has special importance is calcium due to its crucial role in many 
physiological events such as reproduction (Tesarik & Sousa, 1996; Jimenez-
Gonzalez et al., 2006). The maintenance of extracellular and intracellular 
calcium concentration is vital for many physiological functions in the body and 
as a consequence, exchange between the extracellular and intracellular 
environments is tightly controlled. Calcium entry into the epithelial cells is 
through calcium selective channels. Absorption of calcium in epithelial cells via 
calcium channels has been the subject of various studies (Lajeunesse et al., 
1994; Yu et al., 1995; Moreau et al., 2002). Several voltage-dependent like 
calcium channels are present in the epithelium of distal part of the nephron (Yu 
et al., 1995). PTH-induced calcium influx in the renal distal tubule via calcium 
channels is thought to be stimulated by both protein kinase A (PKA) and C 
(PKC) (Friedman et al., 1996; Hoenderop JG, 1999). Furthermore, it has been 
shown that 1,225-(OH)2D3- induced calcium channel activation in mammalian 
intestinal cells is via cAMP/PKA-pathway (Massheimer et al., 1994). Further 
studies and the discovery of Transient Receptor Potential (TRP) channel 
superfamily led to recognition of the critical role of TRP channels, more 
specifically TRPV5 and 6, in epithelial cell calcium transport (Peng et al., 1999; 
Hoenderop et al., 2002; Montell et al., 2002; Peng et al., 2003).  
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Calcium efflux across the basolateral membrane of absorptive epithelia which 
occurs against the electrochemical gradient, is mediated by two calcium 
transporters; the Na+/Ca2+ exchangers (NCX) and Ca2+- ATPase (PMCA).   
1.7.1 Na+/Ca2+ exchangers 
In mammals, three isoforms of NCX have been identified: NCX1, NCX2 and 
NCX3. NCX1 is distributed widely in many different mammalian tissue, and in 
the rabbit kidney, expression is restricted to the distal part of the nephron where 
it localizes mainly on the basolateral (basal) membrane (Hoenderop et al., 
2000; Loffing et al., 2001; Biner et al., 2002). By contrast, NCX2 and NCX3 
expression is restricted to brain and skeletal muscle (Li et al., 1994; Nicoll et al., 
1996). NCXs are activated by the membrane potential, protein kinase C (PKC) 
activation, nucleotides, calciotropic hormones and protons (Blaustein & Lederer, 
1999). Several functional studies suggest that calcium is extruded via the basal 
membrane of the kidney epithelium. However, this mechanism seems to play a 
minor role in the small intestine. 
K+ -dependent Na+/Ca2+ exchangers (NCKX), (Blaustein & Lederer, 1999; 
Philipson & Nicoll, 2000) are expressed in the epithelium of small intestine and 
kidney (Li et al., 2002; Cai & Lytton, 2004). The abundant expression of these 
channels in various tissues indicates their vital role in regulating the intracellular 
calcium concentration in mammalian cells. However, their exact role in epithelial 
calcium transport is yet to be determined.  
1.7.2 Ca2+- ATPases 
PMCAs are widely expressed in all eukaryotic cells where they maintain the 
resting intracellular calcium concentration (Blaustein et al., 2002). Each of the 
the four isoforms of PMCA (PMCA1-4) are encoded by four separate genes and 
each isoform has various splice variants which mainly differ in their carboxy-
terminal (Stauffer et al., 1993; Strehler & Zacharias, 2001). Unlike NCX, PMCA 
is expressed throughout the nephron segment although it is more abundant on 
the basal membrane of the epithelium lining the distal part of the nephron 
(Doucet & Katz, 1982; Borke et al., 1989). PMCA1 and PMCA4 have been 
proposed as ‘housekeeping genes’ which are crucial in the maintenance of 
cellular calcium homeostasis due to their abundant expression. However, 
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PMCA2 and PMCA3 are more tissue specific (Stauffer et al., 1993). Of various 
isoforms of PMCA, PMCA4b is a significant extruder of basolateral (basal) 
calcium in Madin-Darby Canine Kidney (MDCK) cells. Furthermore, in the small 
intestine PMCA1b is the predominant isoform of PMCAs (Kip & Strehler, 2003, 
). 
1.8 Transient Receptor Potential Superfamily Channels 
Transient Receptor potential (TRP) channels were first discovered through 
studying a mutation in photoreceptor cells of Drosophila melanogaster that 
alters eye responses to light by increasing cell membrane permeability to Ca2+ 
(Hardie, 1992), (Pak, 1970; Suss-Toby  E, 1991). Since then, 28 members of 
this superfamily have been identified. All the TRP members have a unique 
structure of six transmembrane domains, one intracellular N- terminal, one 
intracellular C-terminal and a pore domain which is located between the fifth 
(S5) and sixth (S6) segment (Fig 1.5). Despite their unique morphology, 
members of this superfamily differ widely in terms of their selectivity (Padinjat & 
Andrews, 2004) and specific activation mechanism (Venkatachalam K & Montell 
C, 2007).  Members of the mammalian TRP superfamily are divided into seven 
families based on amino acid homologies; the TRPC (Canonical) family, the 
TRPV (Vanilloid) family, the TRPM (Melastatin) family, the TRPP (Polycystin) 
family, the TRPML (MucoLipin) family, the TRPA (Ankyrin) family, and the 
TRPN (NOMPC) family (Montell C et al., 2002a; Montell C et al., 2002b; 
Clapham, 2003a; Corey DP, 2003; Delmas P, 2004; Pedersen SF et al., 2005) 
(Fig 1.6). 
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.  
Figure 1.5 TRP channel topology with six transmembrane domains. E1, E2 and E3 (the 
extracellular loops) are located between segments1 and 2, 3 and 4, 5 and 6 respectively.  
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Figure 1.6 Phylogenetic tree of the TRP family. The evolutionary tree is calculated using the 
neighbour joining method. The total branch length in Point Accepted Mutations units (PAM 
units) demonstrates the evolutionary distance. PAM units are the mean number of substitutions 
per 100 residues (Clapham DE et al., 2001). 
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1.8.1 Transient Receptor Potential Canonical (TRPC) 
The identification of TRPC1 as the first recognized member of mammalian TRP 
channels has led to the establishment of the TRPC subfamily (Wes PD et al., 
1995). On the basis of their sequence alignment and functional properties, the 
TRPC subfamily is further sub-divided into three groups; TRPC1-4-5 , TRPC3-
6-7, and TRPC2 (Clapham, 2003a). 
The TRPC1 gene is located on chromosome 3, q22-q24, and its full length 
polypeptide is composed of about 790 amino acids (Wes PD et al., 1995). Its 
structure is similar to the other TPC family members and contains three ankyrin 
repeat motifs, which mediate protein-protein interaction via its N-terminal 
(Lussier MP et al., 2005a; Rychkov G & Barritt GJ, 2007). 
TRPC2 is nonfunctional truncated protein (Vannier b et al., 1999), and as such 
is considered a pseudogene in the human. The human TRPC2 gene, which is 
located on chromosome 11, lacks the sequence of exon 16, which encodes the 
fifth transmembrane segment and half of the pore region in comparison to the 
functional rodent TRPC2 Yildirim E et al. (2003). 
Human TRPC3 is located on chromosome 4 and consists of 11 exons (Riccio A  
et al., 2002). The expression of TRPC3 is more noticeable in embryonic and 
developing tissues (Stru¨bing C et al., 2003). Human TRPC3 comprises 848 
amino acids which have 94% homology to mouse TRPC3 (Preuss KD et al., 
1997). A short splice variant of TRPC3 with a truncated N-terminus which is 
named Trp3sv has been isolated from a rat heart complementary DNA (cDNA) 
and comprises 736 amino acids (Ohki G et al., 2000).  By contrast, an extended 
splice variant has been detected in human, mouse and rat with one additional 
exon which leads to an extension at the N-terminus of the protein (hTRPC3a: 
921aa; mTRPC3a: 911aa; rTRPC3a: 910 aa) (Yildirim E et al., 2005). 
TRPC4 cDNA was first cloned from bovine adrenal gland (Philipp S et al., 
1996).  This was followed by the identification of various orthologues from 
mouse, rat and human(Mori Y et al., 1998; Mizuno N et al., 1999; McKay RR et 
al., 2000). To date, ten different splice variants have been reported of which 
TRPC4α has the longest sequence. In one group of these splice variants the C-
terminal region is deleted, while the six transmembrane segments are 
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conserved. TRPC4β is another splice variant that lacks 84 amino acids in the C-
terminal region. This deleted domain is the suggested region for calmodulin and 
inositol 1,4,5 triphosphate (IP3) receptors in TRPC4α. In another TRPC4 splice 
variant group, truncated channels at the second transmembrane segment (S2) 
are encoded (Plant TD & Schaefer M, 2003).    
The TRPC5 gene was initially known as CCE2 and was first cloned from rabbit 
and mouse brain (Philipp S et al., 1998). The human TRPC5 gene is located at 
Xq23 and consists of 11 exons with a length of about 308 Kb and the transcript 
length of 5.84 Kb (Sossey-Alaoui K et al., 1999) There are no splice variants 
reported for this member of TRPC family. TRPC5 protein is made of 973-975 
amino acids and its molecular weight has been predicted to be 111.4 kDa. 
Structural comparison of TRPC5 protein and voltage-gated potassium channels 
suggest four TRPC5 proteins form a tetrameric structure that act as a single 
channel. Over-expression of TRPC5 leads to the formation of functional 
channels which confirm the activity of homomeric TRPC5 (Greka A et al., 2003). 
However, several studies have shown that TRPC5 interacts with TRPC1 and 
TRPC4 (Strubing C et al., 2001; Goel M et al., 2002; Hofmann T et al., 2002; 
Strubing C et al., 2003). Furthermore, TRPC3 may be involved in this 
interaction in the presence of TRPC1(Strubing C et al., 2003). Wide expression 
of the other TRPC family members alongside with TRPC5 strongly suggests the 
heterotetrameric arrangement of endogenous TRPC5. 
TRPC5 channel is active at any voltage between -100 to +100 mV. Although 
TRPC5 is not considered as a “voltage-gated channel” its activity is voltage-
dependent (Zeng F et al., 2004). The current-voltage relationship,I-V of TRPC5 
is a double-rectification which is specific to this channel (Xu SZ et al., 2005). 
The permeability of the TRPC5 channel to sodium, caesium and potassium is 
equal, while it is impermeable to chloride and the large cationic molecules such 
as N-methyl-D- glucamine (Okada T et al., 1998; Schaefer M et al., 2000; 
Strubing C et al., 2001; Lee YM et al., 2003; Obukhov AG & Nowycky MC, 
2004; Xu et al., 2005). TRPC5 is also permeable to divalent cations such as 
calcium, barium, manganese and strontium (Okada T et al., 1998; Schaefer M 
et al., 2000; Venkatachalam K et al., 2003). 
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TRPC6 gene was first isolated from mouse brain (Boulay G et al., 1997). The 
human gene is located on chromosome 11q21-q22 and contains 13 exons 
(D’Esposito M et al., 1998; Hofmann T et al., 1999). The full length human and 
mouse TRPC6 proteins differ by just one amino acid (931 and 930 
respectively).  TRPC6 contains two glycosylation sites that control the receptor-
operated behaviors of the channel. These have been located in the first and 
second extracellular loops of the channel using glycosylation scanning (Asn473; 
Asn561) (Dietrich A et al., 2003). Application of different approaches such as 
cellular co-trafficking of TRPC subunits; fluorescence resonance energy transfer 
(FRET), differential functional suppression using dominant-negative subunits 
and co-immunoprecipitation has demonstrated that TRPC6 in its native 
environment form homo and heteromeric channel complexes (Hofmann T et al., 
2000).  
The amino acid sequence of TRPC6 contains three ankyrin domains in the 
amino terminus; an EWKFAR TRP box motif; two inositol 1, 4, 5 triphosphate 
(IP3) receptor binding domains and a calmodulin site which overlaps with the 
second IP3 receptor binding domain (Boulay G et al., 1999; Zhang L & SaffenD, 
2001; Zhang Z et al., 2001; Lussier MP et al., 2005b). 
Four splice variants (TRPC6B,C,D,E) of TRPC6 have been cloned from rat lung 
and human airway smooth muscle cells (Zhang L & SaffenD, 2001). 
The TRPC7 gene is located on chromosome 5q31.1 and consists of 12 exons. 
Translation of human and mouse TRPC7 gene results a protein of 862 amino 
acids (Okada T et al., 1999; Riccio A et al., 2002). 
Two splice variants have been reported for mTRPC7. In splice variant 1, a 
345bp domain, encoding 115 amino acids (261-376) of transmembrane 
segment 1(S1) is deleted. In variant 2, 165bp of the same region of the channel 
encoding 55amino acids(321-376) is deleted (Okada T et al., 1999; Walker RL 
et al., 2001). 
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1.9 Aims 
The aims of this research project were : 
 To discover which TRPC isoforms  are expressed in epithelial cells lining 
the female reproductive tract (oviduct/uterus) in the bovine (addressed in 
Chapter 3) and human (addressed in Chapter 6).  
 To discover if gene expression of TRPC channels changes throughout 
the estrous cycle in bovine oviduct and uterine epithelial cells (addressed 
in chapter 3) 
 To discover the localization of TRPC channels in oviduct/uterine 
epithelium and changes in protein expression of TRPC isoforms induced 
by sex hormones in the bovine (addressed in chapter 4) and in the 
human  (addressed in chapter 6)  
 To discover the physiological role of TRPC isofoms in regulating 
intracellular calcium concentration in bovine oviduct epithelial cells 
(addressed in chapter 5) 
 To examine the clinical relevance of a possible role of TRP channels in 
female reproduction (addressed in chapter 6) 
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Chapter 2 
 
Materials and Methods 
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2.1 Materials 
2- Methylbutan, Sigma Aldrich 
2-mercaptoenol, Sigma Aldrich 
2.5-Di-t-butylhydroquinone (DBQ), Sigma Aldrich 
30% Arylamide solution, Sigma Aldrich 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), Gibco Invitrogen 
8-well strips, Applied Biosystems  
Adhesive film, Applied Biosystems 
Albumin from Bovine Serum, Sigma Aldrich 
Alexa Four 647 donkey anti goat, Invitrogen 
Alexa Flour 488 donkey anti rabbit, Invitrogen 
Ammonium Persulfate (APS), Sigma Aldrich 
Amphotericin B, Gibco Invitrogen 
Aprotinin, Sigma Aldrich 
Bio-Rad Protein Assay Kit, Bio Rad 
Blotting sheets, Sigma Aldrich 
Bromophenol blue, Sigma Aldrich 
CaCl2 , Sigma Aldrich 
Cryomatrix, Shadon-Thermal Scientific 
D- Glucose, Sigma Aldrich 
Dimethyl sulfoxide (DMSO), Sigma Aldrich 
Donkey pAb to Rabbit IgG- HRP, Abcam 
Donkey serum, Sigma Aldrich 
Dulbecco’s Modified Eagle’s Medium (DMEM), Sigma Aldrich 
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Ethylene Glycol Tetraacetic Acid (EGTA), Sigma Aldrich 
EZ-First Strand cDNA Synthesis Kit, Geneflow, Isreal 
EZ-Run™ Pre-Stained Protein Ladder, Fisher BioReagents 
Foetal Calf Serum, Gibco Invitrogen 
Fura PE 3-AM, Sigma Aldrich 
Glycerol, Sigma Aldrich 
Glycine,  Sigma Aldrich 
Hank's Balanced Salt solution without CaCl and MgCl (HBSS), Gibco Invitrogen 
Hyperfilm ECL, GE Healthcare, Amersham Hybound™-P 
Hyperforin, Sigma Aldrich 
KCl, Sigma Aldrich 
PenStrep, Gibco Invitrogen 
L-Glutamine, Sigma Aldrich 
Lauryl sulfate, Sigma Aldrich 
Leupeptin, Sigma Aldrich 
Luminol, Sigma Aldrich 
MgCl2 , Sigma Aldrich 
Mouse mAb to  Actin-HRP, Abcam 
NaCl, Sigma Aldrich 
Newborn Calf Serum, Sigma Aldrich 
N,N,N',N'- Tetramethylethylenediamine (TEMED), Sigma Aldrich 
Non-Idet P-40, Sigma Aldrich 
NucleoSpin® RNA II isolation kit, Macherey- Nagel 
Nutrient Mixture F-12 Ham, Sigma Aldrich 
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P-Coumoric, Sigma Aldrich 
Pancreatin, Sigma Aldrich 
Paraformaldehyde (PFA), Sigma Aldrich 
PCR Master Mix (2X), Fermentas, Life Science 
Phenylmethanesulfonyl fluoride (PMSF), Sigma Aldrich 
PVDF transfer membrane, GE Healthcare, Amersham Hybound™-P 
Rabbit anti TRPC1, Alomone Labs 
Rabbit anti TRPC6, Alomone Labs 
Real-Time PCR optical 96 well plate, Applied Biosystems 
SKF96365, Sigma Aldrich 
Sodium deoxycholate, Sigma Aldrich 
Sodium orthovanadate, Sigma Aldrich 
strips of caps, Applied Biosystems 
SYBR Green Master Mix (2X), Applied Biosystems 
Tris base, Sigma Aldrich 
Tris HCl, Sigma Aldrich 
Triton X-100, Sigma Aldrich 
TRPC1 goat polyclonal IgG, Santa Cruz 
TRPC6 rabbit polyclonal IgG, Abcam 
Trypsin, Sigma Aldrich 
Tween-20,  Sigma Aldrich 
Vectashield with DAPI, Vector Laboratories 
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2.2 Methods 
2.2.1 Staging  the female bovine reproductive tract  
Fresh female bovine reproductive tracts were obtained from a local abattoir and 
transported to the laboratory immediately in Hans Balanced Salt solution 
without CaCl2 and MgCl2 (HBSS-Gibco Invitrogen) containing 10 mM HEPES 
(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid)(Gibco Invitrogen) which is 
a zwitterionic organic chemical buffering agent and 1 µM Aprotinin (Sigma 
Aldrich) which is a competitive serine protease inhibitor that inhibits trypsin, 
chymotrypsin, kallikrein and plasmin. The stage of estrous was determined 
according to the ovary characteristics shown in table 2.1 (Ireland et al., 1980). 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.1 Staging the female bovine reproductive tract. Taken from Ireland et al,. (1980). 
 
 
Characteristics I II III IV 
Estimated day 
of cycle 
1-4 5-10 11-17 18-20 
External 
appearance of  
corpus luteum 
(CL) 
Red, recently 
ovulated, point of 
rupture not covers 
by epithelium 
Point of rupture 
covered over, 
apex of CL red 
or brown 
Tan or 
orange 
Light 
yellow or 
white 
Internal 
appearance of  
corpus luteum 
Red, occasionally 
filled with blood, 
cells loosely 
organised 
Red or brown at 
apex only, 
remainder of CL 
is orange 
Orange Orange to 
yellow 
Diameter of  
corpus luteum 
0.5-1.5cm 1.6-2.0cm 1.6-2.0cm <1cm 
Vasculature on 
surface of  
corpus luteum 
Not visible Generally 
limited to 
periphery 
Will cover 
the apex of 
CL late in 
this stage 
Not visible 
Follicles >10mm 
in diameter 
Absent Present May be 
absent or 
present 
Present 
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2.2.2 Harvesting and culturing bovine oviduct epithelial cells 
The oviduct was dissected from the tract and connective tissue carefully 
removed. Epithelial cells were harvested by squeezing the oviduct from isthmus 
to infundibulum. Cells were collected into HBSS and centrifuged at 2500 x g for 
5 minutes. The supernatant  was removed and the cells were washed twice by 
being re-suspended in 10 ml HBSS and re-centrifuged at 2500 x g for 5 
minutes. The cell pellet was then re-suspended in 1 ml of cell culture medium 
and counted on a hemocytometer. The cells were seeded into a T25 culture 
flask at a density of 5x106/ml Cells were maintained at 39˚C in a 5%CO2 
incubator. The culture medium (Table 2.2) was first changed after 24 hours and 
then every 48 hours until the cells reached the confluence stage after 7-10 
days.  
Culturing the epithelial cells in a cell culture flask does not replicate the in vivo 
condition due to lack of permeability in the surface to which the cells are 
attached . Permeable transwell could be used to address this issue. However, 
using the permeable transwell membrane in this research project would have 
been extremely expensive. Furthermore, the number of cells that can be 
cultured on each transwell membrane would not have provided enough material 
for the proposed experiments in this research, notably, the  western blots. 
 
 
 
 
 
 
 
 
 
Table 2.2. Bovine oviduct and uterine epithelial cell culture medium 
Compound Concentration 
Dulbecco’s Modified Eagle’s 
Medium 
500 ml 
Nutrient Mixture F-12 Ham 500 ml 
Penicillin 270 U/ml 
Streptomycin 270 µg/ml 
Amphotericin B 20 µg/ml 
L-Glutamine 2 mM 
Newborn Calf Serum 2.5% v/v 
Foetal Calf Serum 2.5% v/v 
Albumin from Bovine Serum 
(essentially fatty acids free) 
0.1% w/v 
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2.2.3 Harvesting and culturing bovine uterine epithelial cells 
Fresh female bovine reproductive tracts were obtained as described in section 
2.1. The uterine epithelium was dissected and cut into 1 x 1 cm pieces and 
incubated at 4˚C for 1 hour in enzyme medium (Table 2.3). Samples were then 
incubated at room temperature for a further hour. The enzyme solution was 
removed and 10 ml HBSS was added to the pieces of tissue and vortexed 
vigorously for 1 minute. HBSS containing dissociated cells was gently 
transferred to a clean 50 ml centrifuge tube. The bovine uterine epithelial cells 
were then centrifuged at 2500 x g for 5 minutes and washed twice by 
resuspending the cell pellet in HBSS and re-centrifuging. Cells were treated as 
described in section 2.2.2 after this step. 
 
 
 
 
Table 2.3 Enzyme Medium 
 
2.2.4 RNA extraction 
Total RNA was isolated from epithelial cells using a NucleoSpin® RNA II 
isolation kit (Macherey- Nagel). Cells were harvested as described in Section 
2.2.2 and 2.2.3, and  the cell pellet was used for RNA isolation according to the 
manufacturer’s manual.  In order to lyse the cells, 350µl buffer RA1 and 3.5µl β-
mercaptoethanol were added to the cell pellet and this was vortexed until the 
cells were completely re-suspended. The cell lysate was then filtered, to reduce 
viscosity, using a NucleoSpin® filter. The lysate was poured onto the filter which 
was placed in a 2ml collection tube and centrifuged for 1 minute at 11,000x g. 
To adjust RNA binding to the silica membrane, 350µl 70% ethanol was added to 
the homogenized lysate and mixed by repeatedly pipetting up and down after 
discarding the NucleoSpin® filter. The cell lysate was then loaded onto the 
NucleoSpin® RNA II column (silica membrane) and centrifuged for 30 seconds 
at 11,000 X g. To desalt the silica membrane 350µl of membrane desalting 
Compound Concentration 
HBSS 200 ml 
Trypsin 0.05% w/v 
Pancreatin 2.7% w/v 
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buffer (MDB) was added to each NucleoSpin® RNA II column and subjected to 
a further centrifugation step at 11,000 x g for 1 minute.  
In order to digest any contaminating genomic DNA from the lysate, 90µl of 
Reaction buffer for rDnase which was provided by the manufacturer and 10µl of 
reconstituted rDnase were mixed and 95 µl of this mixture was applied directly 
onto the centre of the silica membrane of each column. The silica membrane 
was then incubated at room temperature for 15 min. Following this, the silica 
membrane was washed by adding 200µl Buffer RA2 to the column and 
centrifuging for 30 seconds at 11,000 x g.  This wash step was followed by 
adding 600µl Buffer RA3, which desalts the solution containing RNA, to the 
column which was placed into a fresh 2ml collection tube and centrifuged for 30 
seconds at 11,000x g. To complete washing of the silica membrane, 250µl 
Buffer RA3 was added to the NucleoSpin® RNA II column and centrifuged for 
2min at 11,000x g to dry the membrane completely. The RNA was eluted from 
the column by adding 40µl RNase-free H2O to the centre of the silica tube and 
then centrifuged for 1min at 11,000x g. 
RNA concentration and purity were assessed by measuring 260/280 nm 
absorbance on a nanospectrophotometer (Implen, Germany). RNA was then 
stored at -80˚C until further use. 
2.2.5 Reverse transcription 
Isolated total RNA was reverse transcribed to cDNA using the EZ-First Strand 
cDNA Synthesis Kit (Geneflow, Isreal) according to the manufacturer’s 
directions. These consisted of mixing 1 µg RNA and 2 µM Oligo (dT) Primer in a 
0.25 ml nuclease free eppendorf tube. DEPC-Treated water was used to bring 
the volume up to 10 µl. The mixture was then gently mixed and heated at +70˚C 
for 10 min in a thermocycler. Eppendorf tubes were placed rapidly on ice, 8 µl 
Reaction Mix (2.5X) and 2 µl DTT (100 mM) added to each tube and mixed 
gently by pipetting up and down. Samples were incubated at +42˚C for 60 min 
followed by a 15 minutes incubation at +70˚C to stop the cDNA synthesis 
reaction. cDNA was then stored at -20˚C until further use. 
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2.2.6 Solution Polymerase Chain Reaction (PCR) 
Expression of TRPCs genes was confirmed by solution PCR.  PCR Master Mix 
(2X) (Fermentas, Life Science), which consisted of 0.05 units/µl Taq DNA 
polymerase in reaction buffer, 4 mM MgCl2, and dNTPs (0.4 mM dGTP, 0.4 mM 
dATP, 0.4 mM dCTP, and 0.4 mM dTTP) was used.  All reagents were thawed 
on ice, gently vortexed and pulse-spun prior to mixing in a 0.25 ml thin walled 
eppendorf tube.  12.5 µl PCR Master Mix was mixed with 0.1 µM of each 
forward and reverse primers, 1 µg template DNA, and nuclease-free H2O to 
bring the volume up to 25 µl. The mixture was then vortexed and pulse-spun 
before being placed in an Applied Biosystem thermocycler. The thermal stages 
of PCR are shown in table 2.4. 
 
 
Table2.4 The steps of solution PCR. * All primers were designed with the same annealing 
temperature. ** Extension time varies depending on the PCR product size. However, in this 
case all PCR products were smaller than 500 bp and the extension time was the same for all 
the primers. 
 
Primers were designed using Primer Blast from the NCBI website. Each primer 
was ‘blasted’ to check for its specificity. Details of the primers are given in Table 
2.5 and 2.6. 
 
 
 
Temperature (°C) Time Description Cycle 
95 10 minutes Hot start 1 
95 30 seconds Denaturation 35 
60* 30 seconds Annealing 35 
72 30 seconds** Extension 35 
72 7 minutes Final extension 1 
4 infinite - - 
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Target Gene Primer Sequence Tm (˚C) 
Bovine β actin β actin F TTCAACACCCCTGCCATG 59.64 
β actin R TCACCGGAGTCCATCACGAT 59.73 
Bovine 
cytokeratin 18 
bCytkr18E3E4F TGAGATCGAGGCTCTCAAGG 60.63 
bCytkr18E3E4R TGAGCCAGCTCGTCATACTG 60.16 
Bovine TRPC1 bTRPC1E5E7F CTCGTGGAGGTGGAATTCAG 60.65 
bTRPC1E5E7R TGGACTGGGAAACAAACTCC 59.94 
Bovine TRPC2 bTRPC2E3E4F TCATCCTGACTGCCTTCCTC 60.35 
bTRPC2E3E4R ATGAGCATGTTGAGCAGCAC 60.02 
Bovine TRPC3 bTRPC3E2E4F CAAAAAGTTCGTGGCTCACC 60.67 
bTRPC3E2E4R GCCCAGGAAGATGATGAAAG 59.63 
Bovine TRPC4 bTRPC4E6E7F GACCAATGTCAAAGCACAGC 59.30 
bTRPC4E6E7R CATTGAAGGGGGTAGGAAGG 60.67 
Bovine TRPC5 bTRPC5E6E7F TGATCGCCATGATGAACAAC 60.49 
bTRPC5E6E7R TTGTTGAACCAGTTGCCAAG 59.73 
Bovine TRPC6 bTRPC6E6E7F TGCTTGATTTTGGAATGCTG 59.81 
bTRPC6E6E7R AGGGGTCCCACTTTATCCTG 60.18 
Bovine TRPC7 bTRPC7E3E4F TCCTGGCTGTCTTTGGAGTC 60.39 
bTRPC7E3E4R CTGATGCGTTCACAACCAAC 60.16 
 
Table 2.5 Primers for the solution PCR and their sequence for the gene detected in bovine 
oviduct and uterine epithelia. "E" in the primer's name indicates the exon that the primer is 
designed for.  
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Gene Primer Sequence Tm (˚C) 
Human β actin hβ actin F ACAGAGCCTCGCCTTTGC 59.70 
hβ actin R GGAATCCTTCTGACCCATGC 59.73 
Human 
cytokeratin 18 
H Cytkr18E1 F CAGCATGAGCTTCACCACTC 59.58 
H Cytkr18E1 R CTCCTTCTCGTTCTGGATGC 59.95 
Human TRPC1 hTRPC1E11E12F TGCTTACCAAACTGCTGGTG 59.90 
hTRPC1E11E12R AACTGTTTTGCCGTTTGACC 60.02 
Human TRPC3 hTRPC3E3E4F GCAGCTCTTGACGATCTGGT 60.56 
hTRPC3E3E4R CCTGTCTGAGGCATTGAACA 59.83 
Human TRPC4 hTRPC4E6E7F CTCTGGGAAGAATGCTCCTG 59.94 
hTRPC4E6E7R ATGCTGTGCTTTGACATTGG 59.72 
Human TRPC5 hTRPC5E4E5F ACCTTGGGCTGTTCATCAAG 60.11 
hTRPC5E4E5R CATCCATTCCACGACAGTTG 59.96 
Human TRPC6 hTRPC6E4E5F GCCAACAGCAACTTCTCTCC 60.00 
hTRPC6E4E5R TCCCAGAAAAATGGTGAAGG 59.90 
Human TRPC7 hTRPC7E5E6F AGTACGTGCTGCACTTGTGG 59.97 
hTRPC7E5E6R CGTAGAGCCCTTCCGATATG 59.69 
 
Table 2.6 Solution PCR primers and their sequence for the gene detected in human 
endometrium. 
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2.2.7 Real-Time PCR 
Relative TRPC gene expression level was determined by quantitative real-time 
PCR using SYBR green, an asymmetrical cyanine dye which absorbs blue light 
(λmax = 497 nm) and emits green light (λmax = 520 nm). SYBER green binds 
to double-stranded DNA. However, it also binds to single-stranded DNA with a 
lower performance and to RNA at a rate lower than that of single-stranded DNA. 
All experiments were carried out in triplicate. For each sample, 50 µl SYBR 
Green Master Mix (2X) (Applied Biosystems) was added to 300 nM of each 
forward and reverse primer (Table 2.7 and 2.8), 100 ng cDNA.  Finally, 
nuclease-free H2O was used to bring the final volume up to 100 µl.  This was 
mixed in a sterile 0.25 ml eppendorf tube. The mixture was then vortexed and 
gently centrifuged for 1 minute in a bench centrifuge.  For each sample, 25 µl of 
the above mixture was transferred in triplicate into a Real-Time PCR optical 96 
well plate (Applied Biosystems) which was sealed with adhesive film (Applied 
Biosystems), or into 8 well strips (Applied Biosystems) which were sealed with 
the strips of caps (Applied Biosystems). The 96 well plate or the 8 well strips 
were then centrifuged before being loaded into a Step-one Real-Time PCR 
machine (Applied Biosystems). For Real-Time PCR, cycles consisted of 95°C 
for 10 minutes (Hot start) followed by 40 cycles of 95°C for 15 seconds 
(Denaturation), 60°C for 1 minute (Annealing/ extension) and a cycle of melt 
curve consisted of 95°C for 15 seconds, 60ºC for 1minutes and 95°C for 15 
seconds. In all samples studied, β actin, was measured to act as a comparator 
‘house-keeping’ gene in parallel with the control which varied depending on the 
experiment. The relative gene expression was analyzed using StepOne 
software V2.0 and the baseline and threshold were set manually. Ct method 
(section 2.8) was used to analyse the RT-PCR data. 
The primers that were used in this research were not designed to detect the 
splice variants of each TRPC isoforms. This might affect the data interpretation 
as the exact amount of mRNA which are used for protein synthesis (translation) 
might not have been measured.     
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Gene Primer Sequence Tm (˚C) 
Bovine 
TRPC1 
QbTRPC1E6E7F CCGGCAGTGTAAAATGTTTGC 59 
QbTRPC1E6E7R CATTGGATGTATGGTTTAGGATAACTTC 58 
Bovine 
TRPC2 
QbTRPC2E4F GGCCGGGCCCTCTATG 58 
QbTRPC2E4R GAGCATGTTGAGCAGCACAATC 59 
Bovine 
TRPC3 
QbTRPC3E8F ACAGTGATGTAGAGTGGAAGTTTGCT 59 
QbTRPC3E8R GGAGGTAATGTTTTTCCATCATCAA 59 
Bovine 
TRPC4 
QbTRPC4E6F TGGTCAATATTTGGGCTCATCA 59 
QbTRPC4E6R CGGTGAATTCATGCTGTGCTT 60 
Bovine 
TRPC6 
QbTRPC6E4F CCCATCCAAACTGCCAACAG 60 
QbTRPC6E4R GCGAGGACCACAAGGAACTT 59 
 
Table 2.7 Primers for Real-Time PCR and their sequence for the TRPC genes 
detected in bovine oviduct  and uterine epithelium. 
 
Gene Primer Sequence Tm (˚C) 
Human 
TRPC1 
QhTRPC1E11F CATTGGCACCTGCTTTGCT 58 
QhTRPC1E11R AAGATTGCCACATGCGCTAA 58 
Human 
TRPC6 
QhTRPC6E5 F CGCAGCCTCCTTCACCATT 60 
QhTRPC6E5 R TCAAATCTGTCAGCTGCATTCA 58 
Human 
TRPC7 
QhTRPC7E6F ACATTCTGCCAGCCAACGA 59 
QhTRPC7E6R TCACAGTTCTCCCTAGCGAGAT 58 
 
Table 2.8 Primers for Real-Time PCR and their sequence for the TRPC genes 
detected in human. 
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2.2.8 Analysing Real-Time PCR using Ct method 
Ct is a relative quantification method to analyse the data from Real-Time 
quantitative PCR. Changes in expression of the target gene are measured 
relative to a reference gene (a housekeeping gene) in the control group. A 
series of equations and assumptions are required to analyse the RT-PCR data 
using the Ct method (Livak & Schmittgen, 2001). The exponential 
amplification of PCR is described in the equation below : 
                  
   
   represents the number of target genes at cycle n of the reaction,    is the 
initial number of target genes. The efficiency of target amplification is 
represented by    and n is the number of cycles.   which is the threshold cycle 
and indicates the fractional cycle number at which the amount of amplified 
target is a fixed threshold. Therefore, 
                
         
   represents the threshold number of target genes, the threshold cycle for 
target amplification is shown by      and    is a constant. 
The equation for the endogenous gene (internal control reference) is  
               
        
   represents the threshold number of the reference gene, the initial number of 
reference genes and the efficiency of reference amplification are shown by    
and    respectively.     represents the threshold cycle for reference 
amplification.    is a constant. 
Expression is derived from dividing    by     
  
  
  
         
   
          
    
  
  
  
  
Assuming efficiencies of the target and the reference are the same, 
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or 
         
       
   represents the normalized amount of target 
  
  
 and the difference in 
threshold and cycle (         ) is shown by    . 
The expression is derived by rearranging the equation  
            
     
Finally    for any target gene (q) is divided by    for the calibrator (cb) 
    
     
  
       
      
              
              
                        
When amplicons designed to be less than 150 bp and the RT=PCR reaction are 
optimized, the efficiency is close to one. Thus, the amount of target gene when 
normalized to an endogenous reference gene and to a calibrator is 
Amount of target gene          
2.2.9 Cell Lysate preparation for Western Blot 
Confluent bovine oviduct epithelial cultured cells were first washed twice with 
PBS. 40 µl of RIPA (RadioImmuno Precipitation Assay) buffer which consists of 
1% non-Idet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 10µg/ml 
Phenylmethanesulfonyl fluoride (PMSF dissolved in isopropanol), 1nM Sodium 
orthovanadate, 10ng/ml Leupeptin and 30ul/ml Aprotinin (Sigma Aldrich) made 
up in PBS were added to each T25 cell culture flask and incubated on ice for 20 
minutes. Cells were then scraped and transferred into a fresh pre-chilled 
eppendorf and centrifuged at 4˚C for 10 minutes at 11,000 x g. The supernatant 
containing the whole cell protein was then transferred into a fresh eppendorf 
tube and stored at -80˚C.  
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2.2.10 Protein assay 
In order to measure the concentration of protein in the cell lysates prepared for 
western blot, a commercial colorimetric assay, based on that of Lowry (1951) 
was used (DC Protein Assay Reagents Package, BioRad). The reaction 
between the protein, an alkaline copper tartrate solution and Foiln reagent 
forms the basis of the protein assay.  The colour development is a result of the 
reaction of protein with the copper in an alkaline medium which is followed by 
reduction of Folin reagent by the copper-treated protein. The main amino acids 
involved in this process are tyrosine and tryptophan, and to a lesser extent, 
cystine, cysteine, and histidine (Lowry et al., 1951; Peterson, 1979). Reduction 
of the Folin reagent occurs by loss of 1, 2, or 3 oxygen atoms leading to the 
production of one or more possible reduced species which produce blue colour 
with maximum absorbance at 750 nm and minimum absorbance at 405 nm.  
To measure the protein concentration in a microplate (Nalge Nunc, Fisher 
Scientific), 20 µl of reagent ‘S’ a proprietary component of the kit was added to 
each ml of reagent ‘A’ (the alkaline copper tratrate solution). To obtain a 
standard curve, 4 different concentrations of Bovine Serum Albumin (BSA) (0.2, 
0.5, 1 and 1.5 mg/ml) were prepared. 5µl of BSA and samples were added into 
wells of a 96 well plate with a flat bottom followed by the addition of 25 µl of 
reagent ‘A’. 200 µl of reagent ‘B’ which is a dilute Folin reagent was then added 
to each well.  The microplate was gently agitated to mix the reagents. 
Absorbance was measured using a plate reader after 15 minutes incubation of 
the microplate at room temperature in the dark. There was less than 5% change 
in the absorbance after an hour. 
2.2.11 SDS-Page 
According to the size of proteins of interest 10% Acrylamide gel was adequate 
for protein separation. SDS-page is a term used for Sodium Dodecyl Sulfate 
PolyAcrylamide Gel Electrophoresis. In this technique separation of proteins 
occurs based on their molecular weight. Polymerization of acrylamide and 
N,N,N',N'- Tetramethylethylenediamine (TEMED) results in formation of SDS-
page gel which is a hydrophilic, neutral, three-dimensional networks of long 
hydrocarbons crosslinked by methylene groups. The size of the pore within the 
gel determine the separation of proteins according to their molecular weight. 
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The amount of acrylamide and crosslinker determines the size of the pore within 
the gel. The increase in the amount of the acrylamide results in the decrease in 
the pore size. The total acrylamide present in the gel is given as a percentage 
(w/v). The percentage of the gel determines the rate of migration and separation 
of proteins (Table 2.9). 
 
 
Protein size (kDa) Gel percentage (%) 
4-40 20 
12-45 15 
10-70 12.5 
15-100 10 
25-200 8 
 
Table 2.9 Percentage of SDS-page Gel.   
 
 6.48 ml dH2O, 5.3ml 30% Acrylamide solution and 4 ml buffer I (Table 2.10), 65 
µl of 10% Ammonium Persulfate (APS) and 5.3 µl N,N,N',N'- 
Tetramethylethylenediamine (TEMED) were added to the above solution to 
polymerise the gel. Acrylamide gel (resolving gel) was poured into the sandwich 
assembly. To ensure a level interface was obtained, the resolving gel was 
overlaid with 100% methanol. 
 
 
Compound Concentration g/L 
Tris base 1.5 M 181.5 
Lauryl sulfate 0.4% w/v 4 
pH was adjusted to 8.8 using HCl 
 
Table 2.10 Composition of Buffer I, used for making resolving gel. 
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The resolving gel was left at room temperature to set for 45 minutes.  The 
methanol was then removed completely before addition of 3.1% stacking gel on 
top of the resolving gel. The 3.1% stacking gel was prepared for two mini size 
SDS-Page gel by mixing 4.87 ml dH2O, 0.75 ml 30% Acrylamide solution and 
1.87 ml buffer II (table 2.11).  Similar to the resolving gel, 75 µl of 10% APS and 
10 µl of TEMED were added to the mixture just before pouring it in the sandwich 
cassette. Combs were rinsed with 100% methanol and placed into the sandwich 
cassette.  
 
 
 
 
Table 2.11 Composition of Buffer II, used for making stacking gel. 
 
SDS-Page gels were maintained at room temperature for 20-30 minutes to be 
polymerized.  The SDS-Page gel was then placed into a tank chamber which 
was filled with SDS-Page running buffer (Table 2.12). 
 
Compound Concentration g/L 
Glycine 0.192 M 14.4 
Tris base 0.025 M 3.03 
Lauryl sulfate 0.1% w/v 1 
 
Table 2.12 SDS-Page running buffer. 
 
 
 
 
 
Compound Concentration g/L 
Tris base 0.5 M 60.5 
Lauryl sulfate 0.4% w/v 4 
pH was adjusted to 6.8 using HCl 
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Cell lysates were boiled alongside Laemmli buffer containing 2-mercaptoethanol 
(Table 2.13) to linearise the proteins for 5 minutes before being loaded on to the 
gel.  The linearised protein binds the SDS giving it a negative charge.  This then 
leads to the separation of protein on the resolving gel solely based on molecular 
weight and not electrical charge. 
 
     
      
 
 
 
 Table 2.13 Composition of Laemmli buffer. 
 
35 µg of cell lysate was loaded into each well. In order to detect the size of each 
band on the gel, 10µl of 10 kDa to 170 kDa protein marker ladder (EZ-Run™ 
Pre-Stained Protein Ladder, Fisher BioReagents) was also loaded into a well. 
SDS-Page gel was then electrophoresed at 120 v for 150minutes.  
2.2.12 Western Blot 
PVDF transfer membrane (GE Healthcare, Amersham Hybound™-P) was 
primed before protein transfer. PVDF transfer membrane was cut into 10 x 10 
cm pieces which were slightly larger than the gel size, and placed into 100% 
methanol for 1min at room temperature. PVDF transfer membrane was then 
washed for 10min in dH2O before being soaked in transfer buffer (Table 2.14) 
for a minimum of 5 minutes. 
 
 
 
 
Table 2.14 Transfer buffer. 
Compound Concentration 
Lauryl sulfate 12% w/v 
2-mercaptoenol 30% v/v 
Glycerol 60% w/v 
bromophenol blue 0.012% v/v 
Tris HCl 0.375 M 
pH was adjusted to 6.8 
Compound Concentration g/L 
Tris base 25 mM 3 
Glycine 0.2 M 75.07 
Methanol 20% v/v 200 ml 
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Filter paper (Blotting sheets, 3MM- Sigma Aldrich) and fibre pads were cut to 
the dimensions of the transfer cassette (10 x 10 cm) and then soaked in transfer 
buffer for a minimum of 5 minutes.  
The transfer cassette was placed into a tray containing transfer buffer; two fibre 
pads were placed on the transfer cassette and two filter papers were placed 
onto the fibre pads. SDS-Page was removed from the cassette by separating 
the glass plates. The stacking gel was then cut away, the gel was gently placed 
onto the filter paper, and then covered fully with transfer buffer. The PVDF 
membrane was placed on the gel and any air bubbles removed by rolling over 
with a serological pipette. Two filter papers and two fibre pads were placed on 
the PVDF membrane. Any further air bubbles were removed before closing the 
cassette and placing it in the tank chamber for electrophoresis.  The tank 
chamber, containing the transfer cassette and filled with transfer buffer, was 
placed on ice and electrophoresed at 100 V for 150 minutes. 
2.2.13 Immunodetection 
The transfer cassette was disassembled and the PVDF membrane was cut into 
the approximate dimensions of the gel.  The membrane was washed with Tris 
Base Saline-Tween (TBST) (Table 2.14) buffer for 5 minutes. The PVDF 
membrane was then incubated with TBST containing 10% BSA for 30 minutes 
at room temperature to block the non-specific binding sites for the antibody. The 
PVDF membrane was then rinsed for 5 minutes with TBST. 
 
Compound Concentration g/L 
NaCl 150 mM 8.28 
Tris base 20 mM 2.42 
Tween-20 0.1% 1ml/L 
pH was adjusted to 7.6 before addition of Tween-20 using HCl 
 
Table 2.15 Tris Base Saline-Tween (TBST) Buffer 
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Primary antibodies were diluted 1:200 (0.2 µg/ml for both TRPC1 and TRPC6) 
Both TRPC1 and TRPC6 antibodies were raised in rabbit (Alomone Labs). 
TBST buffer containing 2% BSA. Primary antibodies were then added to the 
protein-bound surface of the PVDF membrane which was incubated with the 
primary antibodies at 4°C overnight. Primary antibodies were removed and 
PVDF membrane was washed with TBST buffer three times each for 10 
minutes.  
Donkey pAb to Rabbit IgG- HRP (Abcam) was used as the secondary antibody.  
It was diluted 1:10000 (2 µg/ml) in TBST buffer containing 2% BSA. The 
transfer membrane was incubated with the secondary antibody for 60 minutes 
at room temperature before being washed three times with TBST buffer at 10 
minutes intervals. To develop the PVDF membrane, a 1:1 ratio of ECL1 (Table 
2.15 ) and ECL2 (Table 2.16) was mixed and added to the membrane which 
was then shaken in the dark at room temperature for 5 minutes. Excess ECL 
solution was removed and membrane wrapped in cling film and placed in a 
developing cassette. In a dark room, a Hyperfilm ECL (Amersham) was 
exposed to the PVDF membrane for an appropriate length of time depending on 
the amount of detected protein on the PVFD membrane. The exposed 
Hyperfilm ECL was then placed into a tray containing 1:5 dilution of Kodak® 
processing chemicals for autoradiography films/developer (Sigma Aldrich) and 
shaken vigorously for 1 minute. Hyperfilm ECL was then transferred to another 
tray containing 1:5 dilution Kodak® processing chemicals for autoradiography 
films/fixer (Sigma Aldrich) and shaken for 1-2 minutes. Hyperfilm ECl was 
washed in H2O for 2-3 minutes.  
 
 
 
 
 
 
Table 2.16 Composition of ECL1 reagent. 
 
Compound Concentration 
Luminol (dissolved in DMSO) 2.5 mM 
P-Coumoric (dissolved in 
DMSO) 
0.45 mM 
Tris base 0.1 M 
H2O To adjust the volume 
Stored at 4˚ C 
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Table 2.17 Composition of ECL2 reagent. 
 
The PVDF membrane was washed four times with TBST buffer at 30 minutes 
intervals and was then blocked with TBST containing 10% BSA for 30 minutes 
at room temperature. To detect β actin protein as the control for the experiment 
the membrane was incubated with 1:500 (2µg/ml) of Mouse mAb (Abcam) to  
Actin-HRP in TBST containing 2% BSA for 60 minutes at room temperature. 
The antibody was removed and the PVDF membrane was washed with TBST 
buffer three times at 10 minutes intervals. The membrane was developed as 
described in section 2.13. 
2.2.14 Paraffin embedding and sectioning of the bovine uterus and 
oviduct 
Fresh tissue was obtained from the local abattoir and staged according to 
section 2.1. 
The oviduct and the uterine horns were dissected and cut into approximately 
0.5 x 0.5 cm sections. Tissue sections were placed into a labelled embedding 
cassette that was immersed in 10% formalin overnight. The embedding 
cassettes containing the tissue section were then washed in 70% ethanol on a 
shaker for 10 minutes. Ethanol was replaced with fresh 70% ethanol for a 
further 10 minutes wash step. The embedding cassettes were then placed into 
absolute ethanol for 10 minutes; this step was repeated three times. Tissue 
sections in the embedding cassettes were then placed into isopropanol for 10 
minutes on a shaker. Isopropanol was replaced with xylene or histoclear for a 
further 30 minutes on shaker, refreshing the xylene or histoclear at 10 minutes 
intervals. Excess xylene or histoclear was removed by blotting the embedding 
cassette thoroughly with a tissue. The embedding cassettes containing the 
Compound Concentration 
H2O2 0.1% v/v 
Tris base 0.1 M 
H2O To adjust the volume 
Stored at 4˚ C 
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tissue sections were then placed into three consecutive wax pots melted in a 
60˚C incubator. The time of incubation in melted wax differed depending on the 
thickness and dimensions of the tissue. The sections of uterus were incubated 
in the first wax pot overnight and for one hour in each of the two subsequent 
wax pots, while the oviduct sections were incubated for 1 hour in each of the 
three wax pots. After this time, tissue sections were removed from the 
embedding cassettes and placed in a sectioning frame before being covered 
with melted wax and left at room temperature till the wax was solidified. Paraffin 
embedded tissue was then cut into 10 micron sections using a Microm HM 3555 
microtome (Thermo Scientific).    
2.2.15 Deparaffinization of paraffin embedded tissue sections 
The paraffin embedded tissue was placed on a Super Frost plus slide (Thermo 
Scientific)  and washed twice with xylene, each time for 3 minutes. The tissue 
sections were then washed with 1:1 dilution of xylene in absolute ethanol for 3 
minutes followed by three washing steps of three minutes with 95%, 70%, and 
50% ethanol in turn. The tissue sections were finally rinsed with running cold 
tap water. 
2.2.16 Frozen sectioning of bovine uterus and oviduct 
Fresh tissue was obtained from the local abattoir and staged according to 
section 2.1. 
The oviduct and the uterine horns were dissected and cut into approximately 
0.5 x 0.5 cm sections. Each specimen was placed on a 1cm x 1cm square 
shaped cork with thickness less than 0.5 cm which was covered with 1-2 drops 
of Cryomatrix (Shadon, Thermal Scientific). After adjusting the position of the 
specimen, it was completely covered with Cryomatrix. A scalpel with a plastic 
handle was used to hold the cork which was dipped in a container filled with 2- 
Methylbutan (Sigma Aldrich) and then placed in liquid nitrogen. As the tissue 
freezes and Cryomatrix solidifies, it was placed directly into liquid nitrogen for 1-
2 minutes. Frozen tissue was either cut into 10 micron sections using a Microm 
HM 505E cryostat (Thermo Scientific) or was stored at -80˚C. 
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2.2.17 Immunohistochemistry 
Immunohistochemistry was used to determine the localization of TRPC1 and 
TRPC6 in bovine oviduct and uterine epithelia and human endometrium. 
The tissue sections were either permeabilized to detect intracellular localization 
of TRPC1 and TRPC6, or were used for localization of the TRPC1 and TRPC6 
channels on the cell membrane (non- permeabilized).  
To permeabilize the tissue sections, slides were first placed in a Coplin jar 
containing ice cold Methanol for 5 minutes then incubated in PBS with 0.1% 
Triton X-100 for an hour at room temperature. Triton X-100 (C14H22O(C2H4O)n) 
is a non-ionic surfactant. 0.1% Triton X-100 PBS was removed and the slides 
were washed three times with 0.25% Tween 20 in PBS each time for 5 minutes. 
To block the non specific binding sites, slides were placed in a humidifier 
chamber and tissue sections were covered with PBS containing 2% donkey 
serum (Sigma Aldrich), the host for the secondary antibodies, for 30 minutes at 
room temperature. PBS containing 2% donkey serum was replaced with 1:250 
(1µg/ml) dilution of each of TRPC1 goat polyclonal IgG (Santa Cruz) and 
TRPC6 rabbit polyclonal IgG (Abcam) primary antibodies diluted in PBS 
containing 1% FCS. Slides in the humidified chamber were then incubated at 
4°C overnight. Primary antibodies were removed and the slides washed three 
times, each time for 5 minutes, with PBS containing 0.25% Tween 20 (Sigma 
Aldrich). Secondary antibodies, 4µg/ml Alexa Four 647 donkey anti goat 
(Invitrogen) (against TRPC1 primary) and 4µg/ml Alexa Flour 488 donkey anti 
rabbit (Invitrogen) (against TRPC6 primary), were diluted 1:500 in PBS 
containing 1% FCS. Tissue sections were wrapped in foil paper in a humidified 
chamber and incubated with secondary antibodies for an hour at room 
temperature. Secondary antibodies were removed, the slides were placed in a 
Coplin jar and washed three times with 0.25% Tween 20 in PBS each time for 5 
minutes. 
Excess wash solution was removed and 1 to 2 drops of Vectashield containing 
1.5 µg/ml 4',6-diamidino-2-phenylindole (DAPI) (Vector Laboratories) used to 
cover each specimen. DAPI counterstains DNA and is used to visualise the cell 
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nucleus. Tissue sections were then covered with a coverslip which was sealed 
with nail polish and stored at 4°C. until visualisation 
Non permeabilized staining was done according to the method above with the 
omission of the first two steps of permeabilization with ice cold Methanol and 
PBS containing 0.1% Triton X-100. 
Similarly to the primers used in this research, primary antibodies used for 
TRPC1 and TRPC6 might not be capable to detect the splice variant of these 
isoforms. Furthermore, there is always the possibility of non-specific binding of 
antibodies. Moreover, in immunohistochemistry unlike to the western blot intact 
proteins are the target of the antibodies. Configuration of the proteins within the 
cells and tissue as well as interaction of the target protein with other proteins 
might affect the efficiency of the antibodies.    
2.2.18 Immunocytochemistry 
Confluent bovine oviduct epithelial cells cultured in T25 culture flasks were 
trypsinised then seeded into 8 well chambered coverglass (Nalge Nunc, 
Thermo Scientific). Cells were seeded at a density of 2x105/ml. The oviduct 
epithelial cells regained confluency 7 to 10 days after being seeded into the 
chambers.  
In order to fix the cells, the culture medium was removed using a vacuum 
aspirator and cells were washed with PBS. The epithelial cells were then 
incubated with 4% Paraformaldehyde (PFA) for 15 minutes at room 
temperature. Cells were either immediately stained or stored covered with PBS 
and placed in a humidifier chamber at 4°C. 
Other than the fixation step, immunocytochemistry followed the same procedure 
as described in section 2.2.17. However, cells were not covered with coverslips 
after counterstaining of DNA with DAPI and were stored in humidifier chamber 
at 4°C. 
2.2.19 Image Acquisition 
a Zeiss LSM 710 confocal microscope and Zen software was used for image 
acquisition. Details for wavelength used is given in the figure legend. 
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2.2.20 Measuring Fluorescent Intensity 
Fluorescent Intensity was measured using Image analysing software, ImageJ. 
Integrated density was divided by the measured area. The value obtained was 
in Fluorescence per µm2.  Fluorescent Intensity in epithelial tissues was 
measured from 3 parts of tissue; apical, basal and lateral membrane as shown 
in Fig 2.1. Epithelial cells are assymmetrical due to their polarity and epithelial 
specific connections, such as tight junctions, connexins/gap junctions and 
desmosomes. To analyse the data, the epithelial tissue was therefore divided 
into basal, apical and lateral sections so that the possible role of TRPC1 and 
TRPC6 could be detected, for example, the possible involvement of the TRPC 
channels in tight junctions which are located on the facing membranes of  
adjacent cells.    
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Fig 2.1 Area used for fluorescent intensity measurements of epithelial tissue. 
 
. 
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2.2.21 Calcium assay 
Confluent bovine oviduct epithelial cells cultured in T25 culture flasks were 
trypsinised then seeded at a density of 2x105 cells/ml into sterile black 
polystyrene 96 well plates (Nalge Nunc, Fisher Scientific). The oviduct epithelial 
cells regained confluency 7 days after being seeded into the 96 well plates.  
Culture medium was removed from the wells and confluent bovine oviduct 
epithelial cells were washed with calcium free solution (Table 2.17). Cells were 
then incubated with calcium free solution containing 10µM Fura PE 3-AM 
(Sigma Aldrich) for 30 minutes at 39˚C in a 5% CO2 incubator. Fura PE 3-AM 
was removed from the well and the cells  washed 2-3 times with calcium free 
solution. Cells were kept in the dark after treatment with Fura PE 3-AM to avoid 
non-specific bleaching. The 96 well plate containing the BOECs was placed in 
an Infinite M200 Tecan plate reader (Tecan). i-Control 1.6 software was used to 
control the experiment. Cells were kept at 37˚ C in the plate reader. After 
measuring the basal intracellular calcium, calcium free solution was replaced 
with calcium solution (Table 2.18). Depending on the number of agonists and 
antagonists used and their required time of action, different numbers of kinetic 
cycle without intervals were used for each experiment. 
Fura PE 3-AM is a Cell permeable fluorescent probe for Ca2+ that provides a 
ratiometric readout which reduces effects caused by leaking or bleached dyes 
or varying assay conditions. The emission wavelength for Fura PE 3-AM is 
380nm which shifts to 340nm when bound to calcium. Cells were first excited at 
510 nm and the absorbance measured at 380 and 340 nm. For each emission 
wavelength, multiple readings were carried out per well (2x2 circle with border 
of 450 µm). The ratio of absorbance at 340 nm and 380 nm was used to 
determine the changes in intracellular calcium. Agonist and antagonist used in 
this study are shown in table 2.19. 
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Compound Concentration 
NaCl 130 mM 
KCl 5 mM 
MgCl2 1.2 mM 
HEPES 10 mM 
Glucose 8 mM 
EGTA 0.4 mM 
pH 7.4 
 
Table 2.18 Calcium free solution. 
 
Compound Concentration 
NaCl 130 mM 
KCl 5 mM 
MgCl2 1.2 mM 
HEPES 10 mM 
Glucose 8 mM 
CaCl2 1.5 mM 
pH 7.4 
 
Table 2.19 Calcium solution. 
 
Compound Concentration Function 
2.5-Di-t-butylhydroquinone (DBQ) 15 µM SERCA channel blocker 
Hyperforin 25 µM TRPC6 channel activator 
SKF96365 25 µM General TRPC channel blocker 
 
Table 2.20 Agonist and antagonist used in calcium assay. 
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Chapter 3 
 
Gene expression of TRPC channels in 
female reproductive tract epithelia 
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3. Transient Receptor Potential Canonical (TRPC) genes in female bovine 
reproductive tract 
The role of TRPC channels in the female bovine reproductive tract is largely 
unknown although a number of research groups have reported the presence of 
some of the TRPC isoforms in human and rat myometrium (Babich et al., 2004). 
However, the presence and role of these channels in the epithelium of the 
female reproductive tract has yet to be investigated. Experiments in this chapter 
were designed to identify the TRPC isoforms in bovine oviduct and uterine 
epithelial tissue and to determine the expression pattern of these genes 
throughout the estrous cycle.  Further experiments were conducted to discover 
possible regulator molecules or pathways in these tissues. The bovine was 
used as a model for the human due to the difficulties in obtaining human 
biopsies and  the numerous similarities in human  and bovine female 
reproductive systems (Navara et al., 1995; Anderiesz et al., 2000).  
3.1 Expression of the TRPC family in bovine oviduct epithelium 
Fig 3.1 indicates that the genes that encode TRPC 1 (Lane 2), 2 (Lane 3) , 3 
(Lane 4), 4 (Lane 5) and 6 (Lane 7) are expressed in bovine oviduct epithelium.  
These results were collected from cDNA generated from total mRNA extracted 
from bovine oviduct epithelial tissue.  Expression of β actin confirmed that PCR 
conditions were optimised (Lane 1, Fig 3.1). Positive expression of 
Cytokeratin18 (Lane 9, Fig 3.1), a marker specific to epithelial cells, confirmed 
that template cDNA was from epithelial cells. The expected size of the PCR 
products were β actin 100 bp, TRPC1 232 bp, TRPC2 233 bp, TRPC3 244 bp, 
TRPC4 227 bp, TRPC5 179 bp, TRPC6 183 bp, TRPC7 168 bp and 
Cytokeratin18 181 bp. 
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Fig 3.1  TRPC isofoms expressed in bovine oviduct epithelium. PCR Products eletrophoresed 
on a 2% agarose gel, indicating positive expression of TRPC 1, 2, 3, 4 and 6 in bovine oviduct 
tissue. Expression of TRPC5 and TRPC7 was not detected.  PCR products were loaded on the 
gel as following: lane 1; β actin (100 bp), lane 2; TRPC1 (232 bp), lane 3; TRPC2 (233bp), lane 
4; TRPC3 (244 bp), lane 5; TRPC4 (227 bp), lane 6 ; TRRPC5 (179 bp), lane 7; TRPC6 (183 
bp), lane 8; TRPC7 (168 bp) and lane 9; Cytokeratin18 (181 bp).  
 
 
 
 
 
 
 
 
 
58 
 
3.2 Expression of TRPC genes in bovine oviduct epithelium throughout 
the estrous cycle 
Relative gene expression of members of the TRPC family in bovine oviduct 
epithelial tissue is shown in Fig 3.2.  In general, the expression patterns of all 
the TRPC family members showed remarkable similarity throughout the estrous 
cycle. Expression level of TRPC1 was decreased by 0.24 (p= 0.0006) and 0.35 
(p= 0.0007) fold at stage 2 and 4 respectively relative to stage 1 of the estrous 
cycle. However, at stage 3, expression of TRPC1 was up-regulated by 1.49 fold 
(p= 0.01) compared to stage 1 of the estrous cycle (Fig 3.2, A). Expression of 
TRPC2 was down regulated by 0.10 (p= 8.95 x 10-6), 0.72 (p= 0.01) and 0.28 
(p= 0.01) fold at stage 2, 3 and 4 respectively compared to stage 1 of the 
estrous cycle (Fig 3.2, B). Expression level of TRPC3 was decreased by 0.069 
(p= 7.6 x 10-5), 0.65 (p= 0.007) and 0.17 (p= 0.0005) fold at stages 2, 3 and 4 
respectively relative to stage 1 of the estrous cycle (Fig 3.2, C). TRPC4 
expression was down regulated by 0.065 (p= 3.97 x 10-5), 0.63 (p= 0.01) and 
0.17 (p= 8.79 x 10-5) fold at stage 2, 3 and 4 respectively compared with stage 1 
of the estrous cycle (Fig 3.2, D). Furthermore, expression level of TRPC6 was 
decreased by 0.51 (p= 0.01), 0.79 (p= 0.01) and 0.41 (p= 0.006) fold at stages 
2, 3 and 4 of the estrous cycle respectively compared to the stage 1 (Fig 3.2, 
E).  
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Fig 3.2 Changes in expression of TRPC genes in bovine oviduct epithelium throughout the 
estrous cycle. Expression of each TRPC isoforms throughout the estrous cycle was normalized 
to stage 1 of the cycle as a comparator. Expression level of TRPC2 (3.2, B), TRPC3 (3.2, C), 
TRPC4 (3.2, D) and TRPC6 (3.2, E) was lower at stage 2, 3 and 4 of the estrous cycle 
compared of that of the stage 1. However, unlike other TRPC isoforms, expression of TRPC1 
gene (3.2, A) was higher at stage 3 of the estrous cycle compared to the stage 1. All data are 
expressed as a mean of 3 experiments ± 1 standard deviation. (* = p<0.05; ** = p<0.01; *** = 
p<0.001). 
Stage 1 Stage 2 Stage 3 Stage 4
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
TRPC1
*
***
***
A
 
R
e
la
ti
v
e
 e
x
p
re
s
s
io
n
Stage 1 Stage 2 Stage 3 Stage 4
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
TRPC2
*
*
***
B
 
R
e
la
ti
v
e
 e
x
p
re
s
s
io
n
Stage 1 Stage 2 Stage 3 Stage 4
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
TRPC3
**
***
***
C
 
R
e
la
ti
v
e
 e
x
p
re
s
s
io
n
Stage 1 Stage 2 Stage 3 Stage 4
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
TRPC4
*
***
***
D
 
R
e
la
ti
v
e
 e
x
p
re
s
s
io
n
Stage 1 Stage 2 Stage 3 Stage 4
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
TRPC6
*
**
*
E
 
R
e
la
ti
v
e
 e
x
p
re
s
s
io
n
60 
 
3.3 Differences in gene expression of TRPC isoforms in bovine oviduct 
epithelial tissue and cultured cells 
The pattern of expression of TRPC isoforms by bovine oviduct epithelial cells 
collected from tissue representative of the different phases of the estrous cycle 
and cultured in vitro differed markedly to that observed in intact tissue (Fig 3.3). 
The expression of TRPC1 at stage 2 (p= 0.08) in the Bovine Oviduct Cultured 
Cells (BOEC) was not significantly different to that of the stage 1. However, at 
stage 3 and 4 of the estrous cycle TRPC1 was up regulated by 1.98 (p= 0.02) 
and 10.98 (p= 0.004) fold respectively compared to stage 1. Comparing the 
expression level of TRPC1 between the bovine oviduct epithelial tissue and 
BOEC indicates that although the pattern of expression at stage 2 and 4 of the 
cycle in BOEC was similar to that of the tissue, expression of TRPC1 at stage 2 
in BOEC was 1.68 fold (p= 0.004) higher than that of the tissue. However, 
expression of TRPC1 at stage 4 in BOEC was lower by 0.48 fold (p= 0.002) 
compared to that of the tissue. At stage 3, expression of TRPC1 was up 
regulated in tissue compared to that of the stage 1 but in BOEC there was no  
significant difference in expression of TRPC1 at stage 3 compared to that of the 
BOEC at stage 1(Fig 3.3, A). 
Expression of TRPC2 at stage 2 in BOEC was not significantly different (p= 0.6) 
compared to that of the stage 1. However, expression of TRPC2 at stage 2 of 
the estrous cycle in BOEC was higher by 10.76 fold (p= 0.03) compared to that 
of the tissue. Expression of TRPC2 at stage 3 of the estrous cycle was down 
regulated by 0.64 fold (p= 0.04) relative to the stage 1.There was no significant 
difference (p= 0.4) in expression of TRPC2 at stage 3 in BOEC compared to 
that of the tissue. Expression of TRPC 2 at stage 4 of the estrous cycle was up 
regulated by 1.96 fold (p= 0.002) compared to that of the stage 1 in BOEC. 
Expression of TRPC2 at stage 4 in BOEC was 6.86 fold (p= 0.0004) higher than 
that of the tissue (Fig 3.3, B).  
With regard to TRPC3, expression at stage 2 of the estrous cycle was down 
regulated by 0.44 fold (p= 0.01) in BOEC compared to stage 1. Expression of 
TRPC3 at stage 2 was higher by 6.35 fold (p= 0.02) compared to that of the 
tissue. TRPC3 was down regulated by 0.62 fold (p= 0.03) at stage 3 in BOEC 
relative to the stage 1. There was no significant difference (p= 0.7) in 
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expression of TRPC3 at stage 3 in BOEC and the tissue. At stage 4 of the 
estrous cycle, expression of TRPC3 was down regulated by 0.16 fold (p= 0.002) 
relative to the stage 1. There was no significant difference (p= 0.9) in 
expression of TRPC3 at stage 4 in BOEC and the tissue (Fig 3.3, C). 
Expression level of TRPC4 in BOEC at stage 2 was down regulated by 0.07 fold 
(p= 0.0001) compared to the stage 1. No significant difference (p= 0.5) was 
observed in expression of TRPC4 at stage 2 in BOEC compared to the tissue. 
At stage 3 expression of TRPC4 in BOEC was down regulated by 0.33 fold (p= 
0.001) relative to that of the stage 1. In BOEC expression of TRPC4 at stage 3 
of the estrous cycle was lower by 0.52 fold (p= 0.007) compared to that of the 
tissue. At stage 4 of the estrous cycle, expression of TRPC4 was down 
regulated by 0.07 fold (p= 5.68 x 10-5) relative to the stage 1. Expression of 
TRPC4 in BOEC at stage 4 was lower by 0.41 fold (p= 0.001) compared to that 
of the tissue (Fig 3.3, D). 
Expression of TRPC6 at stage 2 of the estrous cycle in BOEC was reduced by 
0.25 fold (p= 0.005) compared to stage 1. In BOEC at stage 2 of the estrous 
cycle, expression of TRPC6 was lower by 0.49 fold (p= 0.02) compared to that 
of the tissue. Expression of TRPC6 in BOEC at stage 3 (p= 0.6) was not 
significantly different to that of the stage 1. Furthermore, there was no 
significant difference (p= 0.6) in expression of TRPC6 at stage 3 in BOEC 
compared to that of the tissue. At stage 4 expression of TRPC6 was down 
regulated by 0.29 fold (p= 0.01) relative to that of the TRPC6 at stage 4 of the 
estrous cycle was not significantly different (p= 0.3) in BOEC compared to the 
tissue (Fig 3.3, E). 
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Fig 3.3 Gene expression of TRPC isoforms in bovine oviduct epithelial cultured cells differ 
compared with that of tissue throughout the estrous cycle. Expression of TRPCs at stages 2,3 
and 4 is normalized to stage 1 of the estrous cycle. In cultured bovine oviduct epithelial cells 
expression of  TRPC1 (3.3, A) at stage 2, 3 and 4, TRPC2 (3.3, B) at stage 2 and 4, TRPC3 
(3.3, C) at stage 2, TRPC4 (3.3, D) at stage 3 and 4 and TRPC6 (3.3, E) at stage 2 were 
significantly different compared to the tissue. Data are expressed as mean 3 experiments ± 1 
standard deviation. (* = p<0.05; ** = p<0.01; *** = p<0.001). * represents the P value, 
comparing the changes in the gene expression at different stage of the estrous cycle to the 
stage 1 in  BOEC. * represents the P value, comparing the changes in the gene expression at 
each stage of the estrous cycle in BOEC to that of the same stage in the tissue. 
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3.4 Effect of Sex Steroids, Follicle Stimulating Hormone (FSH) and 
Luteinizing Hormone (LH) on gene expression of TRPC isoforms in 
cultured bovine oviduct epithelial cells 
Acute 24 hour treatment with Progesterone, 17β- estradiol, Follicle Stimulating 
Hormone (FSH) and Luteinizing Hormone (LH) induced significant changes in  
expression of TRPC isoforms BOEC (Fig 3.4). The effect of sex hormones on 
expression of each member of the TRPC family is described in turn.  As FSH 
and LH act synergistically and their circulating levels throughout the estrous 
cycle mirror each other, BOEC cultures were treated with 0.5 International Unit 
(IU) of FSH and LH simultaneously. The concentrations of sex steroids used in 
this experiment chosen were 2 pg/ml of 17β- estradiol (Est) and 10 nM of 
progesterone (Prog) (Ginther et al., 2010). 
3.4.1  TRPC1 
Expression of TRPC1 at stage 1 was 0.60 fold (p= 0.01) lower in response to 
Est when compared to BOEC cultured in the absence of hormonal 
supplementation. However, expression of TRPC1 in FSH/LH-treated BOEC was 
up regulated by 8.12 fold (p= 0.02) relative to the control group. Treatment of 
BOEC with Prog caused a modest, 0.40 fold (p= 0.008) fall in the expression of 
TRPC1 at stage 1 of the estrous cycle. However concurrent treatment of BOEC 
with Prog and Est (p= 0.6) and Prog, FSH and LH (p= 0.3) did not cause any 
change in the expression of TRPC1 at stage 1 of estrous cycle compared to 
that of untreated BOEC. Synchronous treatment of BOEC with Est, Prog, FSH 
and LH promoted a dramatic increase in the expression of TRPC1; a greater 
than 32 fold (p= 0.003) increase compared to that of the untreated BOEC. 
When Prog was combined with the other hormones, no significant changes (p= 
0.05) were observed in expression of TRPC1 relative to the control group (Fig 
3.4, A).  
In cells harvested from stage 2 of the estrous cycle, Est treated BOEC 
displayed a 1.39 fold (p= 0.01) increase in the gene expression of TRPC1 
compared to untreated BOEC. Expression of TRPC1 in FSH and LH treated 
BOEC at stage 2 of the estrous cycle was 3.49 fold (p= 0.02) higher than 
control cells and also greater than that of the effect seen in BOEC treated with 
Est alone. Treatment of stage 2 BOEC with Prog increased TRPC1 expression 
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by 1.50 fold (p= 0.02). A combination of Prog and Est induced a 2.70 fold (p= 
0.01) increase in expression of TRPC1 in BOEC harvested from stage 2 of the 
estrous cycle relative to the control group. Prog, FSH and LH combined, 
increased the expression level of TRPC1 2.63 fold (p= 0.001) compared to that 
of untreated BOEC. A mixture of Est, FSH and LH increased TRPC1 expression 
by 16.82 fold (p= 0.02) relative to the untreated group. However, treating BOEC 
with Prog, Est, FSH and LH led to only a modest 3.24 fold (p= 0.01) increase of 
TRPC1 expression in relation to that of untreated BOEC (Fig 3.4, B). 
In BOEC harvested from stage 3 of the estrous cycle, the expression TRPC1 
fell 0.72 (p= 0.03) fold in response to Est compared to the untreated group. FSH 
and LH treatment led to a 3-fold (p= 0.01) increase in the expression of TRPC1  
relative to the control group whereas Prog down-regulated the TRPC1 
expression level by 0.55 fold (p= 0.02) compared to untreated stage 3 BOEC. 
TRPC1 expression was not significantly different (p= 0.1) in stage 3 BOEC in 
response to treatment with Prog and Est in combination compared to that of the 
control group. Furthermore, treatment of stage 3 BOEC with a mixture of Prog, 
FSH and LH or with Prog, Est, FSH did not induce any significant change (p= 
0.1) in expression of TRPC1 compared to the untreated group. However, a 
combination of Est, FSH and LH increased the expression of TRPC1 in stage 3 
BOEC by 61.31 fold (p= 0.004) relative to the controls. When Prog was added 
to the mixture of Est, FSH and LH, expression of TRPC1 fell to 0.53 fold (p= 
0.01) compared to the control group (Fig 3.4, C). 
At stage 4 of the estrous cycle, a general up-regulation in the expression of 
TRPC1 was observed in response to exposure to each of Est, FSH, LH, Prog 
and their combinations. Est treatment increased the expression level of TRPC1 
by 3.44 fold (p= 0.004) in stage 4 BOEC compared to that of the untreated 
group. TRPC1 expression in stage 4 BOEC in response to FSH and LH was 
22.12 fold (p= 0.01) higher compared to the control group. Prog-treated BOEC 
showed a 5.44 fold (p= 0.004) increase in TRPC1 expression relative to the 
untreated BOEC. When added in combination, Prog and Est up-regulated 
TRPC1 gene expression 20.0 fold (p= 0.002) whereas the up-regulation of 
TRPC1 in response to the mixture of Prog, FSH and LH was only 5.03 fold (p= 
0.02) compared to the control BOEC. Simultaneous treatment of BOEC with 
Est, FSH and LH led to a dramatic 86 fold (p= 0.02) increase in TRPC1 gene 
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expression compared to untreated BOEC. However, addition of Prog to the 
above mixture reduced this extensive up-regulation to a more modest 2.4 fold 
(p= 0.03) increase in expression compared to control cells (Fig 3.4, D).  
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
Fig 3.4 Effect of sex hormones on the expression of TRPC1 throughout the estrous cycle. 
Expression of TRPC1 in BOEC at stage 1 (3.4, A), 2 (3.4, B), 3 (3.4, C) and 4 (3.4, D)  of the 
estrous cycle was altered by each of the sex hormones individually and combined. However, 
combination of Est/Prog and Prog/FSH/LH did not induce any significant effect on the 
expression of TRPC1 in stage 3 BOEC. Changes induced in expression of TRPC1 in BOEC 
was introduced as a fold of that of the untreated BOEC. Data are expressed as mean 3 
experiments ± 1 standard deviation. (* = p<0.05; ** = p<0.01; *** = p<0.001). 
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3.4.2 TRPC2 
In cells harvested from oviducts at stage 1 of the estrous cycle, treatment with 
Est had no significant effect (p= 0.1) on expression of TRPC2 compared to 
untreated cells. Treatment with FSH and LH led to an 11.47 fold (p= 0.002) 
increase in TRPC2 expression. However at stage 1, BOEC treated with Prog, 
expression of TRPC2 was reduced by 0.49 fold (p= 0.01) of that of the 
untreated BOEC. A combination of Prog and Est did not change (p= 0.8) the 
expression of TRPC2 in cells from stage 1 of the estrous cycle compared to that 
of untreated BOEC. When treated with a mixture of Prog, FSH and LH 
expression of TRPC2 was unchanged (p= 0.4) compared to the control group. 
In stage 1 BOEC treated with Est, FSH and LH, expression of TRPC2 was 
greatly increased by 194 fold (p= 0.04) compared to that of untreated BOEC. 
However, expression of TRPC2 in stage 1 BOEC treated with Prog, Est, FSH 
and LH combined was not significantly different (p= 0.3) to that of the control 
group (Fig 3.5, A). 
At stage 2 of the estrous cycle, treatment of BOEC with Est did not significantly 
(p= 0.2) alter the expression of TRPC2 relative to the control group. Treatment 
of stage 2 BOEC with FSH and LH produced a more marked response as 
TRPC2 expression was 4.64 fold (p= 0.01) higher than that in untreated BOEC. 
Treatment with Prog alone reduced TRPC2 expression by 0.31 fold (p= 0.01) 
compared to the control group. Simultaneous treatment of stage 2 BOEC with 
Prog and Est did not significantly (p= 0.06) affect the expression of TRPC2 
compared to untreated BOEC. Furthermore, a mixture of Prog, FSH and LH did 
not elicit a significant (p= 0.5) response, however concurrent treatment of 
BOEC with Est, FSH and LH dramatically up-regulated TRPC2 expression by 
138 fold (p= 0.04) relative to untreated BOEC. When Prog was added to the 
mixture of Est, FSH and LH, up-regulation of TRPC2 expression was not 
significantly (p= 0.1) different compared to that of control group (Fig 3.5, B). 
Fig 3.5,C shows the expression of TRPC2 at stage 3 of the estrous cycle in 
response to the sex hormones. Treatment of BOEC with Est did not result in 
any significant difference (p= 0.2) in expression of TRPC2 compared to the 
control group. TRPC2 expression was significantly increased by 93 fold (p= 
0.03) in response to FSH and LH treatment. Prog induced a 16.1 fold (p= 0.02) 
increase in the expression level of TRPC2, furthermore, when combined with 
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Est, expression of TRPC2 was up-regulated 18.8 fold (p= 0.002) relative to the 
untreated group. Together, Prog, FSH and LH increased the expression level of 
TRPC2 by 10.2 fold (p= 0.04) compared to the control group whereas 
simultaneous treatment of BOEC with Est, FSH and LH led to an extensive 
increase in expression of TRPC2 by 1702 fold (p= 0.04) relative to that of 
untreated BOEC. When Est, FSH and LH were combined with Prog expression 
of TRPC2 was merely 15.23 fold (p= 0.02) higher than untreated cells (Fig 3.5, 
C). 
As shown in Fig 3.5,D  at stage 4 of the estrous cycle, Est induced a 14.2 fold 
(p= 0.01) increase in expression of TRPC2 in BOEC. The effect of FSH and LH 
was stronger than Est as TRPC2 was up-regulated by 30.93 fold (p= 0.008) 
relative to the untreated BOEC. Expression of TRPC2 in BOEC treated with 
Prog was not significantly different (p= 0.07) compared to the control. A 
combination of Prog and Est increased the expression level of TRPC2 by 55 
fold (p= 0.03), whereas combined Prog, FSH and LH down regulated TRPC2 
expression by 0.55 fold (p= 0.02) relative to that of untreated BOEC. 
Simultaneous treatment of BOEC with Est, FSH and LH resulted in a greater 
than 420-fold (p= 0.008) increase in TRPC2 expression however addition of 
Prog to Est, FSH and LH reduced this up-regulation and no significant 
difference (p= 0.09) was observed compared to the untreated BOEC (Fig 3.5, 
D). 
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Fig 3.5 Effect of sex hormones on the expression of TRPC2 throughout the estrous cycle. 
Expression of TRPC2 in BOEC at stage 1 (3.5, A), 2 (3.5, B), 3 (3.5, C) and 4 (3.5, D)  of the 
estrous cycle was altered by sex hormones. At stage 1 and 2 of the estrous cycle, TRPC2 
expression was changed in BOEC treated with FSH/LH, Prog and the mixture of Est, FSH/LH 
(3.5, A and B). Expression of TRPC2 at stage 3 was altered in BOEC treated with each of the 
sex hormones individually and their combination. However, Est did not induce any significant 
change on the expression of TRPC2 in stage 3 BOEC (3.5, C). At stage 4, expression of 
TRPC2 in BOEC was not affected by Prog and the mixture of Prog, Est, FSH/LH (3.5, D). The 
graphs are plotted on a logarithmic scale for ease of interpretation. Data are expressed as 
mean 3 experiments ± 1 standard deviation. (* = p<0.05; ** = p<0.01; *** = p<0.001). 
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3.4.3 TRPC3  
Figure 3.6 shows expression of TRPC3 in response to sex hormone treatment.  
At stage 1 of the estrous cycle, expression of TRPC3 was not changed (p= 0.7) 
in response to Est in BOEC compared to the control group. By contrast, FSH 
and LH induced an 11.6 fold (p= 0.04) increase in expression of TRPC3 in 
stage 1 BOEC relative to the untreated BOEC. However, treatment of stage 1 
BOEC with Prog resulted in a 0.49 fold (p= 0.003) down-regulation in 
expression of TRPC3. Treatment of stage 1 BOEC with Prog and Est together 
did not induce any significant effect (p= 0.1) in expression of TRPC3 compared 
to the control group. Prog, FSH and LH together, up-regulated the expression of 
TRPC3 in stage 1 BOEC by 1.79 fold (p= 0.002) relative to the untreated group. 
When combined, Est, FSH and LH increased the expression of TRPC3 by 91.5 
fold (p= 0.0001) at stage 1 of the estrous cycle relative to the untreated BOEC. 
However, addition of Prog to the mixture of Est, FSH and LH decreased this up-
regulation from 91.48 fold the same expression level (p= 0.8) observed in 
untreated BOEC (Fig 3.6 ,A). 
In cells harvested from oviducts at stage 2 of the estrous cycle, treatment with 
Est prompted a 1.59 fold (p= 0.03) increase in expression of TRPC3 relative to 
the control group. Treatment of stage 2 BOEC with FSH and LH also induced 
an increase in the expression of TRPC3 by 2.42 fold (p= 0.01). However, 
treatment with Prog did not have any significant effect (p= 0.3) on the 
expression level of TRPC3 in BOEC at stage 2 of the estrous cycle. A similar 
result was observed in BOEC treated with Prog and Est (p= 0.09). Furthermore, 
simultaneous treatment of BOEC with Prog, FSH and LH did not induce any 
significant effect (p= 0.3) in expression of TRPC3 relative to the untreated 
BOEC. Expression of TRPC3 at stage 2 of the estrous cycle in BOEC treated 
with Est, FSH and LH was 56 fold (p= 3.42 x 10-5) higher than the control group. 
However, addition of Prog to the mixture of Est, FSH and LH abolished this 
increase and up-regulated the TRPC3 expression by 3.47 fold (p= 0.03) relative 
to the control group (Fig 3.6 ,B). 
At stage 3 of the estrous cycle, expression of TRPC3 in BOEC treated with Est 
was not significantly different (p= 0.5) from that of the control group. However, 
FSH and LH together caused a 35.59 fold (p= 0.02) increase in TRPC3 
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expression compared to the control group. Expression of TRPC3 in BOEC 
treated with Prog was not significantly different (p= 0.05) compared to that of 
the untreated BOEC. Furthermore, Prog and Est did not alter (p= 0.1) the 
expression level of TRPC3 in stage 3 BOEC compared to the control group. 
Treatment of stage 3 BOEC with the mixture of Prog, FSH and LH resulted in 
no significant difference (p= 0.1) in expression of TRPC3 relative to the control 
group. As seen in each of the other groups studied, Est, FSH and LH together 
resulted in a large rise in expression of TRPC3; 483 fold (p= 0.0006) increase 
compared to the untreated BOEC. This dramatic effect was not reduced??  (p= 
0.7) by the addition of Prog to the hormone mixture (Fig 3.6 ,C). 
At stage 4 of the estrous cycle, Est treated BOEC displayed a 7.83 (p= 0.007) 
fold increase in the gene expression of TRPC3. When BOEC were treated with 
FSH and LH, a 17.2 fold (p= 0.0001) increase was detected in expression of 
TRPC3 compared to the control group. Furthermore, Prog up-regulated the 
expression of TRPC3 in BOEC by 7.43 fold (p= 0.004) compared to the control 
group. Expression of TRPC3 in BOEC treated with Prog and Est was 29.6 fold 
(p= 0.007) higher than the control group. However, a combination of Prog, FSH 
and LH resulted in only a modest 2.76 fold (p= 0.02) increase in expression of 
TRPC3 in BOEC. By contrast, simultaneous treatment of BOEC with Est, FSH 
and LH led to a 182 fold (p= 0.003) increase of TRPC3 compared to the 
untreated group. When Prog was added to the mixture of Est, FSH and LH, the 
expression of TRPC3 was up regulated by 1.71 fold (p= 0.03) relative to the 
control BOEC (Fig 3.6 ,D). 
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Fig 3.6 Changes of expression of TRPC3 in BOEC throughout the estrous cycle in response to 
sex hormones. Expression of TRPC3 in BOEC at stage 1 (3.6, A), 2 (3.6, B), 3 (3.6, C) and 4 
(3.6, D)  of the estrous cycle was altered by sex hormones. At stage 1, TRPC3 expression was 
changed in BOEC treated with FSH/LH, Prog, combination of Prog, FSH/LH and the mixture of 
Est, FSH/LH (3.6, A).At stage 2, expression of TRPC3 was altered in BOEC treated with Est, 
FSH/LH, mixture of Est,FSH/LH and combination of Prog, Est, FSH/LH (3.6, B).Expression of 
TRPC3 in stage 3 BOEC was affected only by FSH/LH and mixture of Est, FSH/LH (3.6, C). At 
stage 4, expression of TRPC3 was altered by each of the sex hormones individually and their 
combination (3.6, D). The graphs are plotted on a logarithmic scale for ease of interpretation. 
Data are expressed as mean 3 experiments ± 1 standard deviation. (* = p<0.05; ** = p<0.01; *** 
= p<0.001). 
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3.4.4 TRPC4 
In cells harvested from oviducts at stage 1 of the estrous cycle, expression of 
TRPC4 was marginally down regulated by 0.62 fold (p= 0.001) in response to 
the treatment with Est. Furthermore, expression of TRPC4 was 0.43 fold (p= 
0.02) lower in BOEC treated with FSH and LH. Similarly, treatment of BOEC 
with Prog resulted in small 0.36 fold (p= 0.005) down regulation in expression of 
TRPC4 at stage 1 of the estrous cycle compared to the control group. When 
added in combination, Prog and Est did not alter (p= 0.6) the TRPC4 gene 
expression compared to the control cells. Furthermore, when combined, Prog, 
FSH and LH resulted in no significant difference (p= 0.3) in expression of 
TRPC4 relative to the control group. In contrary, treatment of BOEC with Est, 
FSH and LH up regulated the expression of TRPC4 by 3.79 fold (p= 0.003) at 
stage 1 of the estrous cycle. The expression of TRPC4 in BOEC treated with 
the combination of Prog, Est, FSH and LH was the same as (p= 0.7) the 
untreated BOEC (Fig 3.7, A).  
At stage 2 of the estrous cycle, supplementation of the culture medium with Est 
did not caused any significant difference (p= 0.07) in expression of TRPC4 
compared to the control group. Furthermore, there was no real change (p= 0.1) 
in TRPC4 expression when BOEC were treated with FSH and LH.  However 
Prog up regulated the expression of TRPC4 by 21.2 fold (p= 0.004) in BOEC at 
stage 2 compared to the untreated group. This increase in expression was 
enhanced to 39 fold (p= 0.004) by a combination of Prog and Est.  Furthermore, 
a 51 fold (p= 0.002) increase in expression of TRPC4 was detected when 
BOEC was treated with the combination of Prog, FSH and LH compared to the 
control group. Treatment of stage 2 BOEC with Est, FSH and LH also up 
regulated TRPC4 expression in BOEC by 33.9 fold (p= 0.009) relative to the 
untreated group. Treatment of BOEC with the mixture of Prog, Est, FSH and LH 
all together resulted in a 46 fold (p= 0.02) increase in expression of TRPC at 
stage 2 of the estrous cycle (Fig 3.7, B). 
At stage 3 of the estrous cycle, Est-treatment of BOEC had a 0.30 fold (p= 
0.0005) decrease in TRPC4 expression. By contrast, FSH and LH dramatically 
up regulated the gene expression of TRPC4 in BOEC by 115.4 fold (p= 0.001) 
compared to the control group, while Prog induced only a modest 4.7 fold (p= 
73 
 
0.002) increase in expression of TRPC4 at stage 3. When Prog was combined 
with Est TRPC4 expression was increased by 5.39 fold (p= 0.01) compared to 
the control. Prog, FSH and LH together up regulated the expression of TRPC4 
in stage 3 BOEC by 3.59 fold (p= 0.04). Synchronous treatment of BOEC with 
Est, FSH and LH led to an extensive up regulation of TRPC4 expression by 
more than 2380 fold (p= 0.01) compared to the untreated group. However, 
combining Prog with the mixture of Est, FSH and LH resulted in a modest 3.25 
fold (p= 0.003) increase of TRPC4 expression relative to that of the control 
group at stage 3 of the estrous cycle (Fig 3.7, C). 
At stage 4 of the estrous cycle, Est induced a 2.02 fold (p= 0.004) increase in 
expression of TRPC4 in BOEC compared to the untreated cells. Treatment of 
BOEC with FSH and LH in combination also resulted in a 5.62 fold (p= 0.01) up 
regulation of TRPC4. Furthermore, Prog treated BOEC displayed a 32.18 fold 
(p= 0.003) increase in the expression of TRPC4 at stage 4 of the estrous cycle. 
When Prog was combined with Est, expression of TRPC4 was 86 fold (p= 
0.005) higher than that of the control group. However, BOEC treated with the 
combination of Prog, FSH and LH displayed a more modest 14.5 fold (p= 0.005) 
increase in expression of TRPC4. Simultaneous treatment of BOEC with Est, 
FSH and LH caused a dramatic 281 (p= 0.0005) fold increase in TRPC4 
expression relative to the control group. This up regulation was decreased by 
addition of Prog to the mixture of Est, FSH and LH by a 16.45 fold (p= 0.002) 
increase in expression level of TRPC4 at stage 4 of the estrous cycle (Fig 3.7, 
D). 
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Fig 3.7 Sex hormones alter the TRPC4 in BOEC throughout the estrous cycle. Expression of 
TRPC4 in BOEC at stage 1 (3.7, A), 2 (3.7, B), 3 (3.7, C) and 4 (3.7, D)  of the estrous cycle 
was altered by sex hormones. At stage 1, TRPC4 expression was changed in BOEC treated 
with Est, FSH/LH, Prog and combination of Est, FSH/LH (3.7, A).At stage 2, expression of 
TRPC4 was altered in BOEC treated with Prog and different  mixtures of sex hormones but not 
with Est and FSH/LH (3.7, B).Expression of TRPC4 in stage 3 and 4 BOEC was affected by 
each of the sex hormones individually and the mixture of them (3.7, C and D). The graphs in Fig 
3.7 C and D are plotted on a logarithmic scale for ease of interpretation. Data are expressed as 
mean 3 experiments ± 1 standard deviation. (* = p<0.05; ** = p<0.01; *** = p<0.001). 
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3.4.5 TRPC6 
Expression of TRPC6 at stage 1 of the estrous cycle was largely independent of 
hormone treatment when provided individually [Est (p= 0.2), FSH/LH (p= 0.1), 
Prog (p= 0.1) and Prog/FSH/LH(p= 0.08)]. Only a combination of Est and Prog 
promoted a 9.18 fold (p= 0.04) increased in expression of TRPC6 in stage 1 
BOEC. Furthermore, mixture of Est, FSH and LH up regulated the expression 
level of TRPC6 by 175 fold (p= 0.0007). When Prog was added to the mixture 
of Est, FSH and LH a 27.1 fold (p= 0.02) increase was observed in expression 
of TRPC6 in stage 1 BOEC (Fig 3.8, A). 
Est did not produce a significant change (p= 0.3) in gene expression of TRPC6 
in BOEC at stage 2 of the estrous cycle compared to the control group. 
However, a 14.43 fold (p= 0.03) increase in expression of TRPC6 was detected 
in BOEC treated with FSH and LH at stage 2 relative to the untreated group. 
Prog supplementation led to a 8.1 fold (p= 0.01) up-regulation in expression of 
TRPC6 in BOEC compared to the control group. A mixture of Prog and Est 
caused a 14.2 fold (p= 0.0004) rise in expression of TRPC6; an effect similar to 
that of FSH and LH. When combined, Prog, FSH and LH up-regulated the 
expression of TRPC6 by 65.6 fold (p= 0.005) at stage 2 of the estrous cycle; 
lower than the 382 fold (p= 0.002) increase in TRPC6 expression that was seen 
in response to the combination of Est, FSH and LH.  However, treating BOEC 
with Pro, Est, FSH and LH led to a 31.4 fold (p= 0.02) increase in expression 
TRPC6 at stage 2 of the estrous cycle (Fig 3.8, B). 
At stage 3 of the estrous cycle, no changes (p= 0.9) were detected in 
expression level of TRPC6 in BOEC treated with Est compared to the control 
group. However, treatment of BOEC with FSH and LH resulted in a 70.4 fold 
(p= 0.001) increase in gene expression of TRPC6 and Prog treated BOEC 
displayed an 8.6 fold (p= 0.002) increase in expression of TRPC6. Prog and Est 
together induced a 9.71 fold (p= 0.04) increase in expression of TRPC6 
compared to the control group. When combined, Prog, FSH and LH up 
regulated the expression of TRPC6 in BOEC by more than 13 fold (p= 0.01) at 
stage 3 of the estrous cycle. Synchronous treatment of BOEC with Est, FSH 
and LH dramatically up regulated the expression of TRPC6; a greater than 933 
fold (p= 0.006) increase was seen in comparison to that of the untreated BOEC. 
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However, treating BOEC with Prog, Est, FSH and LH led to a 10.5 fold (p= 
0.02) increase of TRPC6 expression at stage 3 of the estrous cycle (Fig 3.8, C). 
At stage 4 of the estrous cycle, Est treated BOEC displayed an 11.5 fold (p= 
0.005) increase in expression of TRPC6 compared to the untreated BOEC. The 
increase in gene expression of TRPC6 was higher in FSH and LH treated 
BOEC; a greater than 74 fold (p= 0.002) up-regulation. Furthermore, treating 
BOEC with Prog resulted in a 17 fold (p= 0.02) increase in expression of 
TRPC6 relative to the control group. BOEC treated with Pro and Est together 
displayed a greater than 183 fold (p= 0.01) up regulation in TRPC6 expression. 
However, combination of Prog, FSH and LH induced only a slight, 2.4 fold (p= 
0.02) increase in TRPC6 expression. By contrast, BOEC treated with 
combination of Est, FSH and LH dramatically up regulated expression of 
TRPC6 by 726 fold (p= 9.6 x 10-5) compared to the control group. However, 
when Prog was added to the mixture of Est, FSH and LH the massive increase 
in expression of TRPC6 was abolished and only  a 3.39 fold (p= 0.007) increase 
in expression of TRPC6 was detected in stage 4 BOEC compared to the 
untreated BOEC (Fig 3.8, D). 
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Fig 3.8 Effect of sex hormones on TRPC6 expression in BOEC throughout the estrous cycle.  
Expression of TRPC6 in BOEC at stage 1 (3.8, A), 2 (3.8, B), 3 (3.8, C) and 4 (3.8, D)  of the 
estrous cycle was altered by sex hormones. At stage 1, TRPC6 expression was changed in 
BOEC treated with combination of Prog/Est,  Est/FSH/LH and Prog/Est/FSH/LH (3.8, A).At 
stage 2 and 3, expression of TRPC6 was altered in BOEC treated with each of the sex 
hormones individually, other than Est, and their combination (3.8, B and C).Expression of 
TRPC6 in stage 4 BOEC was affected by each of the sex hormones individually and the mixture 
of them (3.8, D). The graphs are plotted on a logarithmic scale for ease of interpretation. Data 
are expressed as mean 3 experiments ± 1 standard deviation. (* = p<0.05; ** = p<0.01; *** = 
p<0.001). 
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3.5 Expression of TRPC genes in bovine uterine epithelial tissue 
Fig 3.9 indicates that the genes encoding TRPC 1 (Lane 2), 2 (Lane 3), 3 (Lane 
4), 4 (Lane 5) and 6 (Lane 7) were expressed in bovine uterine epithelium.  The 
cDNA was generated from total mRNA extracted from bovine uterine epithelial 
tissue.  Expression of β actin confirmed that the PCR conditions were optimised 
(Lane 1, Fig 3.9). Positive expression of Cytokeratin18 (Lane 9, Fig 3.9), a 
marker specific to epithelial cells, confirmed that the template cDNA was from 
epithelial cells. The expected size of the PCR products were β actin 100 bp, 
TRPC1 232 bp, TRPC2 233 bp, TRPC3 244 bp, TRPC4 227 bp, TRPC5 179 
bp, TRPC6 183 bp, TRPC7 168 bp and Cytokeratin18 181 bp. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
79 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.9  TRPC isoforms expressed in bovine uterine epithelium. PCR Products eletrophoresed 
on a 2% agarose gel, indicating positive expression of TRPC 1, 2, 3, 4 and 6 in bovine uterine 
tissue. Expression of TRPC5 and TRPC7 was not detected in the bovine uterine epithelial 
tissue.  PCR products were loaded on the gel as following: lane 1; β actin (100 bp), lane 2; 
TRPC1 (232 bp), lane 3; TRPC2 (233bp), lane 4; TRPC3 (244 bp), lane 5; TRPC4 (227 bp), 
lane 6 ; TRRPC5 (179 bp), lane 7; TRPC6 (183 bp), lane 8; TRPC7 (168 bp) and lane 9; 
Cytokeratin18 (181 bp). 
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3.6 Expression of TRPC genes in bovine uterine epithelial tissue 
throughout the estrous cycle 
Relative gene expression of TRPC family members throughout the estrous 
cycle in bovine uterine epithelial tissue is shown in Fig 3.10 Changes in 
expression level of TRPCs throughout the estrous cycle was measured relative 
to stage 1 of the cycle. In general, the expression patterns of all the TRPC 
family members show similarity at stage 4 of the estrous cycle.   
In bovine uterine epithelial tissue, expression of TRPC1 was not significantly 
different (p= 0.08) at stage 2 compared to that of stage 1. At stage 3, 
expression of TRPC1 was slightly up-regulated, by 1.29 fold (p= 0.001) relative 
to the stage 1. Expression of TRPC1 at stage 4 was up-regulated by 10.98 fold 
(p= 0.004) compared to stage 1 of the estrous cycle (Fig 3.10, A). 
TRPC2 gene expression was down-regulated by 0.48 fold (p= 0.01) at stage 2 
of the estrous cycle relative to that of the stage 1. However, at stage 3, a 2.41 
fold (p= 0.02) increase was detected in expression level of TRPC2 in bovine 
uterine epithelium. This increase was greater by 39.9 fold (p= 0.005) at stage 4 
of the cycle relative to stage 1 (Fig 3.10, B). 
Expression of TRPC3 appeared to be suppressed in bovine uterine epithelial 
tissue at stage 2 of the estrous cycle by 0.3 fold (p= 0.003). However, at stage 
3, expression of TRPC3 was not significantly different (p= 0.2) to that of the 
stage 1. By contrast, at stage 4 of the cycle, expression of TRPC3 was 
increased by 6.40 fold (p= 0.004) compared to  stage 1 of the estrous cycle (Fig 
3.10, C). 
The expression of TRPC4 at stage 2 of the estrous cycle was not significantly 
different (p= 0.2) compared to stage 1. By contrast, a 2.7 fold (p= 0.02) increase 
in expression of TRPC4 was detected at stage 3 of the estrous cycle. This 
increase was followed by a further 31.2 fold (p= 0.01) up-regulation at stage 4 
of the estrous cycle relative to the stage 1 (Fig 3.10, D).  
Similar to TRPC4, the expression level of TRPC6 was not significantly different 
(p= 0.4) at stage 2. Furthermore, at stage 3 of the estrous cycle, no significant 
change (p= 0.07) was detected in expression of TRPC6 compared to that of the 
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stage 1. However, at stage 4 of the cycle, expression of TRPC6 was up-
regulated by 11.67 fold (p= 0.01) relative to that of the stage 1 (Fig 3.10, E).  
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Fig 3.10 Changes in expression of TRPC genes in bovine uterine epithelial tissue throughout 
the estrous cycle. The expression level of TRPC genes at different stages of the estrous cycle 
was measured relative to the stage 1. Expression of TRPC1 (3.10, A) was not significantly 
changed at stage 2 but  up regulated at stage 3 and 4 of the cycle in comparison to that of the 
stage 1.  Expression level of TRPC2 (3.10, B) was down regulated at stage 2 but up regulated 
at stage 3 and 4 of the estrous cycle. TRPC3 expression (3.10, C) was decreased at stage 2 
compared to stage 1. However, no significant difference in expression of TRPC3 was observed 
at stage 3. TRPC3 expression was increased at stage 4 compared to that of the stage1. 
Expression of TRPC4 (3.10, D) was not significantly different at stage 2 but was up regulated at 
stage 3 and 4 of the estrous cycle in relation to that of stage 1. Expression level of TRPC6 
(3.10, E) in bovine uterine epithelial tissue at stage 2 and 3 was similar to that of the stage 1. 
However, an up regulation in TRPC6 expression was observed at stage 4 of the estrous cycle 
comparing to that of stage 1. Data are expressed as mean 3 experiments ± 1 standard 
deviation. (* = p<0.05; ** = p<0.01; *** = p<0.001). 
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3.7 Differences in gene expression of TRPC isoforms in bovine uterine 
epithelial tissue and cultured cells 
The pattern of expression of TRPC isoforms in cultured bovine uterine epithelial 
cells (BUEC) throughout the estrous cycle differed markedly to that observed in 
the tissue. The changes in expression level of TRPCs in both bovine uterine 
epithelial tissue and cultured cells at different stages of the estrous cycle were 
measured in relation to the stage 1 of the cycle and are presented in Fig 3.11. 
The expression level of TRPC1 in stage 2 BUEC was not significantly different 
to that of stage 1 BUEC (p= 0.1) and stage 2 bovine uterine tissue (p= 0.07). 
The change in expression of TRPC1 at stage 3 of the estrous cycle in BUEC 
and tissue was similar and 1.29 fold higher than that of the stage 1 (p= 0.001). 
At stage 4 of the estrous cycle, expression of TRPC1 was down-regulated in 
BUEC by 0.62 fold (p= 0.0004) and lower by 0.05 fold (p= 0.003) compared to 
that of the tissue relative to the stage 1 (Fig 3.11, A). 
Expression of TRPC2 in BUEC at stage 2 of the estrous cycle was higher by 
1.88 fold (p= 0.001) relative to stage 1 which was 3.89 fold (p= 0.0002) higher 
than that of the tissue at stage 2 of the estrous cycle. Similar to the bovine 
uterine epithelial tissue, expression of TRPC2 at stage 3 of the estrous cycle 
was up-regulated by 2.23 fold (p= 0.003) compared to the stage 1. This change 
was close to that observed in the tissue (p= 0.5). Expression of TRPC2 in 
BUEC at stage 4 was not significantly different (p= 0.1) to that of the stage 1 
and was lower than that of the tissue by 0.02 fold (p= 0.005) (Fig 3.11, B). 
While expression of TRPC3 was down-regulated in the tissue at stage 2, it was 
up-regulated by 2.07 fold (p= 0.009) in stage 2 BUEC compared to stage 
1.Changes in expression of TRPC3 at stage in the BUEC was higher by 6.55 
fold (p= 0.0005) compared to that of the tissue. At stage 3 of the estrous cycle, 
expression of TRPC3 in BUEC was slightly up-regulated by 1.33 fold (p= 0.03) 
compared to that of the stage 1 and was 1.73 fold (p= 0.02) higher than that of 
the tissue. Expression of TRPC3 in stage 4 BUEC was not significantly different 
(p= 0.1) to that of the stage 1, and was lower by 0.19 fold (p= 0.005) compared 
to that of the uterine epithelial tissue at stage 2 of the estrous cycle (Fig 3.11, 
C).   
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Expression of TRPC4 at stage 2 was not significantly in tissue compared to 
stage 1, although it was down-regulated by 0.56 fold (p= 0.002) in stage 2 
BUEC. However, this change was not significantly different (p= 0.1) to that of 
the tissue.  When TRPC4 was up-regulated at stage 3 in the bovine uterine 
epithelial tissue, it was down-regulated by 0.22 fold (p= 4.87 x10-5) in stage 3 
BUEC. The change in the expression of TRPC4 in stage 3 BUEC was 0.08 fold 
(p= 0.01) lower than that of the tissue. At stage 4 of the estrous cycle, TRPC4 
was down-regulated in the BUEC by 0.43 fold (p= 0.0009) while it was up-
regulated in the tissue. Expression of TRPC4 in stage 4 BUEC was 0.01 fold 
(p= 0.01) lower than that of the tissue (Fig 3.11, D).   
Expression of TRPC6 in bovine uterine epithelial tissue was not significantly 
different at stage 2 and 3, however it was up-regulated by 3.96 (p= 0.002) and 
5.92 (p= 0.01) fold in stage2 and 3 BUEC respectively. Expression of TRPC6 
was up-regulated in stage 4 BUEC similar to that of the tissue. Up-regulation of 
TRPC6 in stage 4 BUEC was 3.32 fold (p= 0.007) relative to that of the stage 1 
and 0.28 fold (p= 0.03) lower than that of the tissue (Fig 3.11, E). 
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  Fig 3.11 Expression of TRPC isoforms in bovine uterine epithelial cultured cells differs to that 
of the tissue throughout the estrous cycle. Data are expressed as mean 3 experiments ± 1 
standard deviation. (* = p<0.05; ** = p<0.01; *** = p<0.001). * represents the P value, 
comparing the changes in the gene expression at different stages of the estrous cycle to the 
stage 1 in  BOEC. * represents the P value, comparing the changes in TRPCs gene expression 
between tissue and cultured cells at each stage of the estrous cycle. 
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3.8 Discussion  
The objective of this chapter was to investigate whether the genes encoding for 
members of Transient Receptor Potential Canonical channels (TRPC) are 
expressed in bovine oviduct and uterine epithelia.  Once this had been 
established, the secondary aim was to discover whether the pattern of gene 
expression, at the mRNA level, differed varied throughout the estrous cycle. 
Gene expression of TRPC family proteins in bovine oviduct and uterine 
epithelial tissue was investigated due to their importance in calcium 
homeostasis in a variety of tissues since calcium plays vital roles in a plethora 
of fundamental cellular physiological functions including proliferation, growth, 
contraction, secretion and death (Berridge et al., 1998b). TRPC channels, a 
subfamily of Transient Receptor Potential channels, are a novel class of calcium 
permeable cationic channels and it has been proposed they are G protein-
coupled receptor-operated Ca2+ channels (ROCs) or internal Ca2+ store-
operated channels (SOCs) (Xu & Beech, 2001; Clapham, 2003b).  
In the present research, of 7 members of TRPC family; TRPC1, 2, 3, 4 and 6 
genes were expressed in both bovine oviduct and uterine epithelial tissue (Fig 
3.1 and 3.9).. It was also apparent that the expression levels of all TRPC gene 
isoforms in both bovine oviduct and uterine epithelial tissue changed throughout 
the estrous cycle (Fig 3.2 and 3.10).  Moreover, the pattern of expression in the 
oviduct epithelium was different to that of the uterus.  Such cyclical regulation 
suggests a possible role(s) of these channels in the female bovine reproductive 
tract during the cyclical physiological remodelling associated with estrous.  
In general, expression of all the TRPC isoforms present in the bovine oviduct 
epithelium was the highest at stage 1 of the estrous cycle where progesterone 
is the dominant hormone and 17β- estradiol, FSH and LH are at their lowest 
concentration (Fig 3.2).  A notable exception to this was TRPC1 whose 
expression was the highest at stage 3.  By contrast, expression of uterine levels 
of all the TRPC isoforms was highest at stage 4 of the estrous cycle where 17β- 
estradiol is the dominant hormone and progesterone is at its lowest level. It is 
also notable that the concentrations of FSH and LH peak at stage 4 of the 
estrous cycle.  
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At stage 1 (day 1-4) of the estrous cycle, the production of 17β-estradiol from 
the corpus luteum (CL) is reduced which leads to a dramatic fall in 
concentration of 17β estradiol as the CL increases secretion of progesterone. At 
stage 2 (day 5-10), the concentration of progesterone remains high and 17β-
estradiol rises slightly at day 4 before falling to its lowest level throughout the 
cycle at day 7 (Echternkamp & Hansel, 1973; Randel, 1980). At stage 3 (day 
11-17), progesterone is the dominant hormone present in the blood stream 
(Adeyemo & Heath, 1980; Eduvie & Dawuda, 1986; Llewelyn et al., 1987). 
However, by stage 4 of the cycle prostaglandin F2α (PGF2α) which is secreted 
from the uterine epithelium suppresses the secretion of progesterone (LaVoie et 
al., 1975). Secretion of PGF2α is a consequence of oxytocin binding to its 
specific receptor in the uterine epithelium. Oxytocin induces an increase in 
inositol phosphates (IPs) which are involved in store-operated calcium entry 
(Clapham, 2003b) and regulation of intracellular calcium concentration in bovine 
uterine epithelial cultured cells (Asselin et al., 1997). Secretion of PGF2α from 
uterine epithelium starts at the end of stage 3 and beginning of stage 4 of the 
estrous cycle where the expression of TRPC isoforms are at their highest level 
in the uterine epithelium. This suggests a possible role of TRPC isoforms in 
regulating intracellular calcium concentration required for physiological events in 
bovine uterine epithelium. Oxytocin is synthesized in the CL (Abdelgadir et al., 
1994). Secretion of PGF2α occurs at the end of mid luteal phase (stage 3) and 
increases at the beginning of the late luteal phase (stage 4) where TRPC 
isoforms are at their highest level in bovine uterine epithelial tissue (Fig 3.10).  
Furthermore, at this stage, the newly recruited follicle will initiate secretion of 
17β- estradiol. Hence, release of Gonadotropin-releasing hormone (GnRH) from 
the hypothalamus leads to secretion of FSH and LH from the pituitary 
(Kaltenbach et al., 1974; Schams et al., 1974). It has been reported that 
progesterone triggers secretion of dipeptidyl peptidase-IV by endometrium of 
ewe and cow (Liu & Hansen, 1995; Gregoraszczuk et al., 2001). Therefore, 
progesterone could possibly induce its effect by regulating the intracellular 
concentration via TRPC channels. Increasing levels of plasma progesterone 
leads to the secretion of nutrients and electrolytes from oviduct epithelium to 
provide the microenvironment for spermatozoa, mature oocyte, fertilization and 
early embryo. Furthermore, after ovulation, the number of ciliated epithelial cells 
increases to help transport  the oocyte from the infundibulum to the site of 
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fertilization in the ampullary-isthmus junction (AIJ) and to facilitate the 
movement of the early embryo to the uterus (Hunter, 1994; Croxatto, 2002b). 
Both the secretion (Richardson et al. (1985); (Sharma & Rao, 1992; Dickens et 
al., 1996) and motility of ciliated cells (Salathe, 2006) are dependent on 
changes in intracellular calcium concentration. It has been reported that TRP 
channels are involved in the secretion (Uchida & Tominaga, 2011) and motility 
of ciliated cells (Lorenzo et al., 2008) and so it may be the case that the TRPC 
expression pattern is important in regulating the physiology of the epithelia of 
the female reproductive environment. As demonstrated in this chapter, 
expression of TRPC isoforms in oviduct epithelium at stage 1 (day 1-4) of the 
estrous cycle ,which is the most eventful time of the cycle in oviduct (oocyte 
pick up by infundibulum (Talbot et al., 1999), fertilization and early embryo 
transport), is higher than the other stage of the estrous cycle suggesting the 
possible role of these channels in this process. Moreover, such changes in 
expression of TRPC isoforms in bovine oviduct and uterine epithelial tissue may 
result from, hormonal changes throughout the estrous cycle and the different 
expression patterns in uterus and oviduct; possibly due to the different 
expression pattern and level of estrogen receptors (α and β as well as 
progesterone receptor in these tissues (Tibbetts et al., 1998; Wang et al., 2000; 
Mendoza-Rodriguez et al., 2003). 
Due to the necessity of using cultured cells for a significant part of this project, 
changes in the expression level of the TRPC isoforms present in the bovine 
oviduct and uterine epithelium were studied in both Bovine Oviduct Epithelial 
Cultured cells (BOEC) and Bovine Uterine Epithelial Cultured Cells (BUEC) 
throughout the estrous cycle. Furthermore, these changes were compared to 
those of fresh tissue at equivalent stages of the estrous cycle. It was found that 
expression levels of TRPC isoforms present in bovine oviduct and uterine 
epithelium were different in at least one or all the stages of the estrous cycle in 
both BOEC and BUEC compared to tissue at equivalent stages of the estrous 
cycle (Fig 3.3 and 3.11).  For instance, at stage 4 of the estrous cycle TRPC2 
expression was down-regulated in bovine oviduct epithelial tissue, whereas an 
increase was detected in TRPC2 expression in BOEC (Fig 3.3, B).  
The differences in the pattern of gene expression of TRPC isoforms between 
bovine oviduct and uterine epithelium and BOEC/BUEC highlight a possible role 
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for the sex hormones since their concentrations change periodically throughout 
the estrous cycle. These hormones were absent from the basic epithelial cell 
culture medium (Table 2.2), but have been shown previously to have regulatory 
effects on gene expression; for instance, the role of progesterone on gene 
expression regulation in the endometrium of rhesus monkey (Okulicz & Ace, 
1999), role of 17β estradiol in gene regulation in breast cancer (Charpentier et 
al., 2000), FSH-induced gene regulation in pig granulosa primary cells (Bonnet 
et al., 2006) and LH-induced gene regulation in mouse granulosa cells (Carletti 
& Christenson, 2009). To determine if the sex hormones had a regulatory role in 
the expression of TRPC isoforms, BOEC cultures were treated acutely with 
physiological concentrations(Ginther et al., 2010) of 17β estradiol (Est), 
Progesterone (Prog) and Follicle-Stimulating Hormone (FSH) and  Luteinizing 
hormone (LH). In general, an up-regulation in expression of all the TRPC 
isoforms was induced at all 4 stages of the estrous cycle in BOEC treated with 
FSH and LH. This effect was boosted by the addition of Est to a mixture FSH 
and LH. When Prog was combined with the mixtures of either FSH and LH or 
Est, FSH and LH, the up-regulatory effect on expression level of TRPC isoforms 
throughout the estrous cycle was not seen, with modest exceptions. The 
FSH/LH-induced increase in the expression level of TRPC3 and 6 at stage 2 of 
the estrous cycle was not inhibited by addition of Prog (Fig 3.6 and 3.8, B). 
Furthermore, the FSH/LH-induced up-regulation of TRPC4 was not inhibited at 
stage 1 of the estrous cycle (Fig 3.7, A) when Prog was present. At stage 2 of 
the estrous cycle, Prog promoted an increase in expression of TRPC4 
individually and in combination with each or all of Est, FSH and LH (Fig 3.7, B). 
In BOEC treated with Est solely, expression of TRPC1 and 4 was down-
regulated at stage 1 and 3 of the estrous cycle. Similarly, an inhibitory effect of 
Est on expression of TRPC4 was reported in Bovine Aortic Endothelial Cell 
(Chang et al. (1997). However, Est up-regulated the expression of TRPC 1 and 
3 at stage 2 and 4 and TRPC2 and 4 and 6 at stage 4 of the estrous cycle.  
The apparent regulatory effect of Prog on TRPC4 at stage 1 and 2 and Est on 
TRPC1 and 4 at stage 1 and 3 compared to stage 2 and 4 could either be due 
to different expression levels of receptor of these hormone or the presence of 
TRPC1 (Dedman et al., 2004; Dedman et al., 2005) and 4 (Schaefer et al., 
2002) splice variants which might have a different regulation pathway. 
90 
 
Furthermore, the up-regulatory effect of a mixture of FSH/LH on expression of 
TRPC isoforms throughout the estrous cycle could be related to the FSH 
receptor which is a member of the rhodopsin-like subfamily of G-protein-
coupled receptors (Marion et al., 2002). Rhodopsin-like receptor could be 
involved in TRPC activation by stimulation of phospholipase C (PLC) through 
Gαq/11 activation (Grasberger et al., 2007; Kero et al., 2007; Kleinau et al., 
2010). Furthermore, activation of LH receptor induces its effect on steroid 
biosynthesis and secretion via G-protein Gαs (Dufau, 1998). As was mentioned 
above, TRPCs are G-protein coupled receptors- channels (Clapham, 2003b). 
Therefore, activation of TRPC channels by FSH/LH could have a positive 
impact on their gene expression level. It has also been reported that Tumor 
Necrosis Factor α (TNF α) up regulates the mRNA expression of TRPC1 in 
Human Umbilical Vein Endothelial Cells (HUVEC) via activation of Nuclear 
Factor-Kappa B (NF-κB)(Paria et al., 2003). Both FSH (Wang et al., 2002b) and 
LH (Gründker et al., 2000) are involved in activation of NF-κB which could be 
related to the regulatory effect of FSH and LH on TRPC genes expression. 
These finding suggest that TRPC gene expression is regulated by sex 
hormone(s) in Bovine Oviduct Epithelial cells and that Est, Prog, FSH and LH 
interact with each other to regulate the expression of TRPC genes in this tissue. 
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Chapter 4 
 
Localization and abundance of TRPC 
channels in female reproductive tract 
epithelia 
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4.1 Localization of TRPC1 and TRPC6 in female bovine reproductive tract 
Localization of TRPC1 and TRPC6 in female bovine reproductive tract was 
studied using immunohistochemistry, immunochytochemistry and confocal 
microscopy techniques. Specific TRPC1 and TRPC6 antibodies were used to 
determine the localization of these cation channels in epithelial tissue lining the 
bovine oviduct and uterus. 
4.1.1 Localization of TRPC1 and TRPC6 in bovine oviduct throughout the 
estrous cycle 
The oviduct consists of three sections; infundibulum, ampulla and isthmus. 
Various physiological events occur in each part of the oviduct. Localization and 
abundance of TRPC1 and TRPC6 was studied in each section of the oviduct 
throughout the estrous cycle. 
4.1.1.1 Localization and abundance of TRPC1 and TRPC6  in non-
permeabilized bovine oviduct epithelium at stage 1 of the estrous cycle 
TRPC1 channels were equally located on the apical and basal sides of the 
bovine infundibulum epithelial tissue and at a lower level on the lateral side of 
the epithelium in non-permeabilized immunostained tissue (Fig 4.1, A). 
However, in bovine ampulla epithelium theTRPC1 channel was equally 
distributed on the apical and lateral sides of the epithelium but its localization 
was lower on the basal side of the epithelium (Fig 4.1, B). In bovine isthmus 
epithelial tissue, the TRPC1 channel was located on the lateral side of the 
epithelial tissue at a higher level compared to the apical and basal side at stage 
1 of the estrous cycle (Fig 4.1, C). At stage 1 of the estrous cycle, localization of 
TRPC6 channel was higher on the apical side of the non-permeabilized bovine 
infundibulum epithelial tissue compared to that of the basal side. On the lateral 
side of the bovine infundibulum localization of TRPC6 was lower than that of the 
apical and basal sides (Fig 4.1, A). Localization of TRPC6 channels in non-
permeabilized bovine ampulla tissue was highest on the lateral and the lowest 
on basal side of the epithelium (Fig 4.1, B). Localization of TRPC6 was slightly 
greater on the lateral side of the non-permeabilized bovine isthmus epithelial 
tissue compared to that of the apical and basal sides where equal distribution 
was observed (Fig 4.1,c.
93 
 
0 
 
 
 
 
 
 
 
 
 
Fig 4.1 Localization of TRPC1 and TRPC6 at stage 1 of the estrous cycle in non-permeabilized epithelial tissue of bovine Infundibulum (4.1,A), Ampulla 
(4.1, B) and Isthmus (4.1,C). Nuclei are labelled with DAPI (Blue), TRPC1 with Alexa Four 647 FITC conjugated (Red) and TRPC6 with Alexa Flour 488 
(Green). 
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Measuring the fluorescence intensity (FI) indicated that the abundance of 
TRPC1 on the apical side of the non-permeabilized bovine oviduct epithelium 
was higher by 9.9 fold (p= 0.01) compared to that of the infundibulum. 
Furthermore, abundance of TRPC1 in isthmus was 16.5 fold (p= 0.0001) higher 
relative to the infundibulum (Fig 4.2, A). On the basal side of the tissue, 
abundance of the TRPC1 channel was 9.6 fold (p= 0.01) higher in ampulla 
compared to the infundibulum. In isthmus, TRPC1 was more abundant by 23.3 
fold (p= 0.0006) compared to the infundibulum (Fig 4.2, B). On the lateral side 
of the non-permeabilized bovine oviduct epithelium at stage 1 of the estrous 
cycle abundance of TRPC1 was higher by 15.3 fold (p= 0.009) in ampulla and 
41.4 fold (p= 0.0002) in isthmus compared to the infundibulum (Fig 4.2, C).  
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Fig 4.2 Abundance of TRPC1 in non-permeabilized bovine oviduct epithelium at stage 1 of the 
estrous cycle in apical (4.2,A), Basal (4.2,B) and the lateral (4.2,C) side of the tissue. 
Abundance of the TRPC1 was higher in ampulla and isthmus on apical, basal and lateral side of 
the epithelium compared to that of the infundibulum. All data are expressed as a mean of 3 
replicates ± 1 standard deviation. (* = p<0.05; ** = p<0.01; *** = p<0.001). 
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FI measurements of the apical side indicated that the abundance of TRPC6 
channels was higher by 10 fold (p= 0.003)  in ampulla and 135 fold (p= 0.03) 
higher in isthmus compared to that of the infundibulum at stage 1 of the estrous 
cycle in non-permeabilized immunostained tissue (Fig 4.3, A). Abundance of 
TRPC6 protein on the basal side of the bovine oviduct epithelium was higher by 
14 fold (p= 0.008) in ampulla and 280 fold (p= 0.004) in isthmus compared to 
that of the infundibulum (Fig 4.3, B). The abundance of TRPC6 on the lateral 
side of the bovine oviduct epithelial tissue at stage 1 of the estrous cycle in non-
permeabilized tissue was higher by 38 fold (p= 0.001) in ampulla epithelium and 
425 fold (p= 0.02) in isthmus compared to that of the (Fig 4.3, C).  
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Fig 4.3 Abundance of TRPC6 in non-permeabilized bovine oviduct epithelium at stage 1 of the 
estrous cycle in apical (4.3,A), Basal (4.3,B), the lateral (Fig 4.3, C) side of the tissue. 
Abundance of TRPC6 was higher in ampulla and isthmus of the oviduct epithelium in non-
permeabilized tissue at stage 1 of the estrous cycle compared to that of the infundibulum. All 
data are expressed as a mean of 3 replicates ± 1 standard deviation. (* = p<0.05; ** = p<0.01; 
*** = p<0.001). 
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4.1.1.2 Localization and abundance of TRPC1 and TRPC6 in permeabilized 
bovine oviduct epithelium at stage 1 of the estrous cycle 
At  stage 1 of the estrous cycle,  TRPC1 channel was localized on the apical, 
basal and lateral sides of the bovine infundibulum permeabilized tissue (Fig 4.4, 
A). However, its localization was lower on the lateral side of the epithelium. 
Localization of TRPC1 channel in bovine ampulla epithelium was higher on the 
apical side compared to the basal side of the permeabilized tissue. Distribution 
of the TRPC1 channel on the lateral side of ampulla epithelium was less than 
that on apical and basal side permeabilized tissue (Fig 4.4, B). In permeabilized 
bovine isthmus epithelial tissue, more TRPC1 channel was present on the 
apical side of the tissue compared to that of the basal and lateral sides where 
equal distribution of TRPC1 protein was observed (Fig 4.4, C).  
At stage 1 of the estrous cycle, the TRPC6 channel was equally distributed on 
the basal, apical and lateral sides of the permeabilized bovine infundibulum 
epithelial tissue (Fig 4.4, A). In bovine ampulla, localization of TRPC6 was 
slightly greater on the lateral side of the epithelium compared to the apical and 
basal side (Fig 4.4, B). However, in isthmus epithelial tissue, localization of 
TRPC6 channel was highest on the lateral side and lowest on the basal side of 
the epithelium (Fig 4.4, C). 
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Fig 4.4 Localization of TRPC1 and TRPC6 at stage 1 of the estrous cycle in permeabilized epithelial tissue of bovine Infundibulum (4.4, A), Ampulla 
(4.4, B) and Isthmus (4.4, C). Nuclei are labelled with DAPI (Blue), TRPC1 with Alexa Four 647 FITC conjugated (Red) and TRPC6 with Alexa Flour 
488 (Green). 
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Measuring the fluorescence intensity indicated that at stage 1 of the estrous 
cycle, abundance of TRPC1 channel on the apical side of permeabilized 
immunostained bovine ampulla and isthmus epithelial tissue was 8 (p= 0.02) 
and 7 (p= 0.001) fold higher than that of infundibulum  respectively (Fig 4.5, A). 
On the basal side of the epithelial tissue, abundance of TRPC1 channel was 9.6 
fold (p= 0.02) higher on bovine ampulla epithelium compared to bovine 
infundibulum. Abundance of TRPC1 channel was highest in isthmus epithelium 
where the FI was  23.4 fold (p= 0.004) higher than that of the infundibulum (Fig 
4.5, B). Abundance of TRPC1 channel on the lateral side of the bovine oviduct 
epithelial tissue was 6 fold (p= 0.02) higher in ampulla compared to the 
infundibulum. This is slightly higher in the isthmus by 6.43 fold (0.0004) 
increase in comparison to the infundibulum (Fig 4.5, C).  
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Fig 4.5 Abundance of TRPC1 in permeabilized bovine oviduct epithelium at stage 1 of the 
estrous cycle in apical (4.5, A), Basal (4.5, B) and lateral (4.5, C) side of the tissue. Abundance 
of TRPC1 on apical, basal and lateral sides of the tissue in infundibulum was lower than that of 
ampulla and isthmus. On the apical, basal and lateral sides of the epithelium, abundance of 
TRPC1 in isthmus was lower than that of ampulla and higher than that of the infundibulum. All 
data are expressed as a mean of 3 replicates ± 1 standard deviation. (* = p<0.05; ** = p<0.01; 
*** = p<0.001). 
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At stage 1 of the estrous cycle on the apical side of the permeabilized bovine 
oviduct epithelial tissue, TRPC6 channel was 15.5 fold (p= 0.02) more abundant 
in the ampulla compared to the infundibulum. This was higher in isthmus by 23 
fold (p= 0.003) compared to that of the infundibulum (Fig 4.6, A). On the basal 
side of the bovine oviduct epithelium, abundance of TRPC6 channel was 18.6 
fold (p= 0.004) higher in ampulla compared to the infundibulum. Abundance of 
TRPC6 in isthmus was 21.45 fold (p= 0.001) higher than that of the 
infundibulum (Fig 4.6, B). Abundance of TRPC6 channels on the lateral side of 
bovine ampulla epithelium was 19 fold (p= 0.01) higher than that of bovine 
infundibulum epithelial tissue. This was higher in isthmus by 30.19 fold (p= 
0.001) compared to the infundibulum (Fig 4.6, C). 
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Fig 4.6 Abundance of TRPC6 in permeabilized bovine oviduct epithelium at stage 1 of the 
estrous cycle in apical (4.6, A), basal (4.6, B), and the lateral (4.6, C) side of the tissue. 
Abundance of TRPC6 was higher in both ampulla and isthmus on the apical, basal and lateral 
sides of the permeabilized bovine oviduct epithelium at stage 1 of the estrous cycle compared 
to that of the infundibulum.   All data are expressed as a mean of 3 replicates ± 1 standard 
deviation. (* = p<0.05; ** = p<0.01; *** = p<0.001). 
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4.1.1.3 Localization and abundance of TRPC1 and TRPC6 in non-
permeabilized bovine oviduct epithelium at stage 2 of the estrous cycle 
At stage 2 of the estrous cycle, the TRPC1 channel was distributed equally on 
apical, basal and lateral sides of the non-permeabilized bovine infundibulum 
epithelial cells (Fig 4.7, A). Similar to the infundibulum region of the bovine 
oviduct, TRPC1 was localized equally on the apical, basal and the lateral sides 
of the ampulla and isthmus epithelial tissue (Fig 4.7, B and C).  
Localization of TRPC6 channel in non-permeabilized bovine oviduct epithelium 
at stage 2 of the estrous cycle, was higher on the apical side compared to the 
basal and the lateral sides in infundibulum, ampulla and isthmus (Fig 4.7 , A, B 
and C). 
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Fig 4.7 Localization of TRPC1 and TRPC6 at stage 2 of the estrous cycle in non-permeabilized epithelial tissue of bovine Infundibulum (4.7, A), 
Ampulla (4.7, B) and Isthmus (4.7, C). Nuclei are labelled with DAPI (Blue), TRPC1 with Alexa Four 647 FITC conjugated (Red) and TRPC6 with Alexa 
Flour 488 (Green). 
 
 
 
106 
 
Abundance of TRPC1 channel on the apical side of the non-permeabilized 
bovine oviduct epithelium at stage 2 of the estrous cycle was 3 fold (p= 0.04) 
and 6 fold (p= 0.01) higher on ampulla and isthmus epithelium respectively 
compared to that of the infundibulum (Fig 4.8, A). On the basal side of the 
tissue, abundance of TRPC1 channels in ampulla was higher by 1.95 fold (p= 
0.02 ) compared to the infundibulum. Abundance of the TRPC1 was 4.15 fold 
(p= 0.0006) higher in isthmus relative to the infundibulum (Fig 4.8, B). On the 
lateral side of the bovine oviduct epithelium, abundance of TRPC1 was higher 
by 1.74 fold (p= 0.03) and 1.84 fold (p= 0.02) in ampulla and isthmus epithelium 
respectively compared to that of the infundibulum (Fig 4.8, C). 
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Fig 4.8 Abundance of TRPC1 in non-permeabilized bovine oviduct epithelium at stage 2 of the 
estrous cycle in apical (4.8, A), Basal (4.8, B), and the lateral (4.8, B) side of the tissue. 
Abundance of TRPC1 was higher in ampulla and isthmus on the apical, basal and the lateral 
sides of the non-permeabilized bovine oviduct epithelium at stage 2 of the estrous cycle 
compared to that of the infundibulum. All data are expressed as a mean of 3 replicates ± 1 
standard deviation. (* = p<0.05; ** = p<0.01; *** = p<0.001). 
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At stage 2 of the estrous cycle on the apical side of the non-permeabilized 
bovine ampulla epithelial tissue, there was not a significant difference in 
abundance of TRPC6 channel compared to the infundibulum (p= 0.4). Similarly 
in isthmus (p= 0.1) abundance of TRPC6 channel was equal to that of the 
infundibulum (Fig 4.9, A). Furthermore, on the basal side of the tissue, 
abundance of TRPC6 in ampulla (p= 0.1) was not significantly different to that 
of the infundibulum. However, in isthmus, abundance of TRPC6 was higher by 
1.92 fold (p= 0.002) compared to that of the infundibulum (Fig 4.9, B). On the 
lateral side of the non-permeabilized bovine oviduct epithelial tissue at stage 2 
of the estrous cycle, TRPC6 channel was 2.4 fold (p= 0.008) more abundant in 
ampulla region compared to the infundibulum. In contrast, in isthmus epithelium, 
abundance of TRPC6 channel was not significantly different (p= 0.2) to that of 
infundibulum (Fig 4.9, C).  
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Fig 4.9 Abundance of TRPC6 in non-permeabilized bovine oviduct epithelium at stage 2 of the 
estrous cycle in apical (4.9, A), basal (4.9, B), the lateral side of the tissue. On the apical side of 
the tissue there was not a significant difference in abundance of the TRPC6 in ampulla and 
isthmus compared to the infundibulum. Furthermore, on the basal side of the tissue abundance 
of TRPC6 was not significantly different  in ampulla compared to the infundibulum. However, in 
isthmus, abundance of TRPC6 was higher than that of the infundibulum. On the lateral side 
abundance of TRPC6 was higher in ampulla compared to infundibulum. In the contrary, 
abundance of TRPC6 in isthmus was lower than that of the infundibulum.  All data are 
expressed as a mean of 3 replicates ± 1 standard deviation. (* = p<0.05; ** = p<0.01; *** = 
p<0.001). 
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4.1.1.4 Localization and abundance of TRPC1 and TRPC6 in permeabilized 
bovine oviduct epithelium at stage 2 of the estrous cycle 
In permeabilized bovine oviduct epithelium at stage 2 of the estrous cycle, 
TRPC1 channel was localized on the apical side of the tissue more than basal 
and lateral side in the infundibulum region (Fig 4.10, A). In the ampulla region of 
the oviduct, localization of TRPC1 was highest on the apical side and lowest on 
the lateral side of the tissue (Fig 4.10, B). However, in the isthmus region of the 
oviduct TRPC1 distribution was highest on the basal side and equal on apical 
and lateral sides of the epithelium (Fig 4.10, C). 
Similar to TRPC1 channel, TRPC6 was localized on the apical side of the 
infundibulum and ampulla epithelium to a greater extent  than the basal and the 
lateral sides of the epithelium where the channel was distributed equally (Fig 
4.10, A and B). However, in isthmus epithelium TRPC6 channel was distributed 
equally on the apical, basal and lateral sides of the epithelium (Fig 4.10, C). 
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Fig 4.10 Localization of TRPC1 and TRPC6 at stage 2 of the estrous cycle in permeabilized epithelial tissue of bovine Infundibulum (4.10, A), Ampulla 
(4.10, B) and Isthmus (4.10, C). Nuclei are labelled with DAPI (Blue), TRPC1 with Alexa Four 647 FITC conjugated (Red) and TRPC6 with Alexa Flour 
488 (Green). 
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In the permeabilized bovine oviduct epithelium at stage 2 of the estrous cycle, 
abundance of TRPC1 channel on apical side of the tissue was 0.53 fold (p= 
0.007) lower in ampulla compared to the infundibulum. Furthermore, abundance 
of TRPC1 channel was 0.6 fold (p= 0.03) less in isthmus epithelium compared 
to the infundibulum (Fig 4.11, A). On the basal side of permeabilized bovine 
oviduct epithelium, abundance of TRPC1 channel was not significantly different 
in ampulla (p= 0.1) compared to the infundibulum. Furthermore, there was no  
significant difference in abundance of TRPC1 in the isthmus region (p= 0.8) of 
the oviduct compared to the infundibulum (Fig 4.11, B). On the lateral side of 
bovine oviduct epithelial tissue, abundance of TRPC1 was 2.56 fold (p= 0.003) 
higher in infundibulum compared to the ampulla. Hence, abundance of TRPC1 
channel was 1.4 fold (p= 0.04) higher on the lateral side of the infundibulum in 
comparison to that of the isthmus (Fig 4.11, C). 
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Fig 4.11 Abundance of TRPC1 in permeabilized bovine oviduct epithelium at stage 2 of the 
estrous cycle in apical (4.11,A), Basal (4.11, B), and the lateral (4.11, C) of the tissue. On the 
apical side of the tissue, abundance of TRPC1 was lower in both ampulla and isthmus 
compared to the infundibulum. However, on the basal side abundance of TRPC1 was not 
significantly different nor in ampulla neither in isthmus compared to the infundibulum. On the 
lateral side of the tissue abundance of TRPC1 was lower in both ampulla and isthmus 
compared to the infundibulum. All data are expressed as a mean of 3 replicates ± 1 standard 
deviation. (* = p<0.05; ** = p<0.01; *** = p<0.001). 
Infundibulum Ampulla Isthmus
0
500
1000
Apical Stage 2
*
**
A
 
F
lu
o
re
s
c
e
n
c
e
/µ
m
2
Infundibulum Ampulla Isthmus
0
500
1000
Basal Stage 2B
 
F
lu
o
re
s
c
e
n
c
e
/µ
m
2
Infundibulum Ampulla Isthmus
0
500
1000
Lateral Stage 2
*
**
C
 
F
lu
o
re
s
c
e
n
c
e
/µ
m
2
114 
 
Abundance of TRPC6 channels in permeabilized bovine infundibulum epithelial 
tissue at stage 2 of the estrous cycle was 2.25 fold (p= 0.005) higher on the 
apical side compared to that of the ampulla. Abundance of TRPC6 on the apical 
side of isthmus epithelium was 0.5 fold (p= 0.03) less than that of infundibulum 
(Fig 4.12, A). Abundance of TRPC6 channel on the basal side of permeabilized 
oviduct ampulla at stage 2 of the estrous cycle was lower by 0.4 fold (p= 0.04) 
relative to that of the infundibulum. Furthermore, abundance of TRPC6 in 
isthmus (p= 0.6) was not significantly different to the infundibulum on the basal 
side of the tissue (Fig 4.12, B).  Abundance of TRPC6 on the lateral side of the 
bovine oviduct epithelium was higher by 2.6 fold (p= 0.01) in ampulla compared 
to the infundibulum. However, abundance of TRPC6 in isthmus (p= 0.3) was not 
significantly different to that of the infundibulum region (Fig 4.12, C).  
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Fig 4.12 Abundance of TRPC6 in permeabilized bovine oviduct epithelium at stage 2 of the 
estrous cycle in apical (4.12, A), basal (4.12, B) and the lateral side of the tissue. On the apical 
side of the tissue, abundance of TRPC6 was lower in both ampulla and isthmus compared to 
that of the infundibulum. On the basal and lateral side of the epithelium, abundance of TRPC6 
was lower in ampulla relative to the infundibulum. However, abundance of TRPC6 on the basal 
and lateral sides of the isthmus epithelium was equal to that of the infundibulum. All data are 
expressed as a mean of 3 replicates ± 1 standard deviation. (* = p<0.05; ** = p<0.01; *** = 
p<0.001). 
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4.1.1.5 Localization and abundance of TRPC1 and TRPC6 in non-
permeabilized bovine oviduct epithelium at stage 3 of the estrous cycle 
In non-permeabilized bovine infundibulum epithelium at stage 3 of the estrous 
cycle, localization of TRPC1 was slightly greater on the apical side, and its 
distribution was equal on basal and  lateral sides of the tissue (Fig 4.13, A). In 
the ampulla region of the oviduct epithelium, TRPC1 channel was equally 
localized to the apical and basal sides of the tissue while its distribution was 
lower on the lateral side of the ampulla epithelium (Fig 4.13, B). Localization of 
TRPC1 channel in the isthmus region of the bovine oviduct epithelium was 
higher on the apical side compared to the basal side and the lateral side where 
TRPC1 was localized evenly (Fig 4.13, C). 
Localization of TRPC6 channels was higher on the apical side of the non-
permeabilized bovine infundibulum compared to the basal and lateral sides of 
the epithelial tissue at stage 3 of the estrous cycle (Fig 4.13, A).  In bovine 
ampulla epithelum the localization of TRPC6 was  highest on the apical side 
and lowest on the lateral side of the tissue (Fig 4.13, B). In the isthmus region of 
the oviduct, the localization of TRPC6 channel was highest on the apical side 
and lowest on the basal side of the epithelium (Fig 4.13, C). 
 
 
 
 
 
 
 
117 
 
 
 
 
 
 
 
  
  
  
  
  
 Fig 4.13 Localization of TRPC1 and TRPC6 at stage 3 of the estrous cycle in non-permeabilized epithelial tissue of bovine Infundibulum (4.13, A), 
Ampulla (4.13, B) and Isthmus (4.13, C). Nuclei are labelled with DAPI (Blue), TRPC1 with Alexa Four 647 FITC conjugated (Red) and TRPC6 with 
Alexa Flour 488 (Green). 
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In non-permeabilized bovine oviduct epithelium at stage 3 of the estrous cycle 
on apical side of the tissue, the abundance of TRPC1 in ampulla (p= 0.2) was 
not significantly different to that of the infundibulum. However, in isthmus, 
abundance of TRPC1 was higher by 1.95 fold (p= 0.003) compared to the 
infundibulum (Fig 4.14, A). On the basal side of the bovine oviduct epithelium, 
abundance of TRPC1 was not significantly different in ampulla (p= 0.07) 
compared to that of the infundibulum. However, in the isthmus region of the 
oviduct abundance of TRPC1 was higher by 1.4 fold (p= 0.02) compared to that 
of the infundibulum (Fig 4.14, B). On the lateral side of the bovine oviduct 
epithelium, the abundance of TRPC1 channel in ampulla (p= 0.2)  and isthmus 
(p= 0.1) was equal to that of the infundibulum (Fig 4.14, C). 
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Fig 4.14 Abundance of TRPC1 in non-permeabilized bovine oviduct epithelium at stage 3 of the 
estrous cycle in apical (4.14, A), basal (4.14, B) and the lateral (4.14, C) side of the tissue. On 
the apical and basal side of the tissue, abundance of TRPC1  in ampulla was equal to that of 
the infundibulum. However, on the apical and basal sides of the isthmus the abundance of 
TRPC1 was higher than that of the infundibulum. Abundance of TRPC1 on the lateral side of 
the non-permeabilized bovine oviduct epithelium at stage 3 of the estrous cycle was even in 
infundibulum, ampulla and isthmus region. All data are expressed as a mean of 3 replicates ± 1 
standard deviation. (* = p<0.05; ** = p<0.01; *** = p<0.001). 
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On the apical side of the non-permeabilized bovine oviduct epithelium at stage 
3 of the estrous cycle, abundance of TRPC6 channel was 1.5 fold (p= 0.001) 
higher in infundibulum compared to the ampulla. However, abundance of 
TRPC6 in isthmus (p= 0.2) was not significantly different to that of the 
infundibulum (Fig 4.15, A). On the basal side of bovine oviduct epithelium, 
abundance of TRPC6 was 1.8 fold (p= 0.006) higher in infundibulum compared 
to the ampulla. However, abundance of TRPC6 on the basal side of the isthmus 
(p= 0.08) epithelium was not significantly different to that of the infundibulum 
(Fig 4.15, B). On the lateral side of the bovine oviduct epithelium, TRPC6 
abundance was 2.75 fold (p= 0.004) higher in the infundibulum region 
compared to the ampulla. In contrast, abundance of TRPC6 on the lateral side 
of the isthmus epithelium was 1.7 fold (p= 0.002) higher than that of the 
infundibulum (Fig 4.15, C).  
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Fig 4.15 Abundance of TRPC6 in non-permeabilized bovine oviduct epithelium at stage 3 of the 
estrous cycle in apical (4.15, A), basal (4.15, B) and the lateral (4.15, C) side of the tissue. On  
the apical and basal sides of the non-permeabilized bovine oviduct epithelial tissue at stage 3 of 
the estrous cycle, abundance of TRPC6 was lower in ampulla compared to the infundibulum. 
However, that of the isthmus was not significantly different to the infundibulum. On the lateral 
side of the tissue, abundance of TRPC6 was lower in ampulla and higher in isthmus compared 
to the infundibulum.  All data are expressed as a mean of 3 replicates ± 1 standard deviation. (* 
= p<0.05; ** = p<0.01; *** = p<0.001). 
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4.1.1.6 Localization and abundance of TRPC1 and TRPC6 in permeabilized 
bovine oviduct epithelium at stage 3 of the estrous cycle 
In permeabilized oviduct epithelium at stage 3 of the estrous cycle, the TRPC1 
channel was equally localized on the apical, basal and lateral sides of the 
infundibulum epithelial tissue (Fig 4.16, A). In the ampulla region of the oviduct 
localization of TRPC1 channel was slightly higher on the apical side of the 
epithelium compared to the basal and lateral sides (Fig 4.16, B). Localization of 
TRPC1 was highest on the apical side and lowest on the lateral side of the 
isthmus epithelium (Fig 4.16, C). 
Localization of TRPC6 in permeabilized bovine infundibulum epithelial tissue at 
stage 3 of the estrous cycle was  highest on the basal side and lowest on apical 
side (Fig 4.16, A). In the ampulla region of the oviduct, localization of TRPC6 
channel was at its highest level on the apical side and its lowest level on the 
lateral side of the epithelial tissue (Fig 4.16, B). Localization of TRPC6 in 
isthmus was similar to that of the ampulla and was the highest on the apical 
side and lowest on the lateral side of the tissue (Fig 4.16, C). 
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Fig 4.16 Localization of TRPC1 and TRPC6 at stage 3 of the estrous cycle in permeabilized epithelial tissue of bovine Infundibulum (4.16, A), Ampulla 
(4.16, B) and Isthmus (4.16, C). Nuclei are labelled with DAPI (Blue), TRPC1 with Alexa Four 647 FITC conjugated (Red) and TRPC6 with Alexa Flour 
488 (Green). 
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At stage 3, abundance of TRPC1 in the permeabilized bovine oviduct epithelium 
on the apical side was 32.7 fold (p= 0.0005) higher in ampulla compared to the 
infundibulum and 7.8 fold (p= 0.01) higher in the isthmus region relative to the 
infundibulum (Fig 4.17, A). On the basal side of the epithelium, TRPC1 channel 
was 29.5 fold (p= 0.01) higher in the ampulla compared to the infundibulum. 
Furthermore, abundance of TRPC1 was 5.65 fold (p= 0.02) higher in the 
isthmus compared to the infundibulum (Fig 4.17, B). On the lateral side of the 
epithelium, abundance of the TRPC1 channel was 21.4 fold (p= 0.005) higher in 
ampulla compared to the infundibulum and 4.8 fold (p= 0.009) higher in isthmus 
compared to the infundibulum (Fig 4.17, C).  
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Fig 4.17 Abundance of TRPC1 in permeabilized bovine oviduct epithelium at stage 3 of the 
estrous cycle in apical (4.17, A), basal (4.17, B), and the lateral (4.17, C) side of the tissue. 
Abundance of TRPC1 on the apical, basal and lateral sides of the epithelium was the highest in 
ampulla and the lowest in infundibulum. All data are expressed as a mean of 3 replicates ± 1 
standard deviation. . (* = p<0.05; ** = p<0.01; *** = p<0.001). 
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Abundance of TRPC6 on the apical side of the permeabilized bovine oviduct 
epithelium at stage 3 of the estrous cycle was higher by 58 (p= 0.004) and 3.45 
fold (p= 0.00003) in ampulla and isthmus respectively compared to that of the 
infundibulum (Fig 4.18, A). On the basal side of the epithelium, TRPC6 was 38 
fold (p= 0.02) and 1.95 fold (p= 0.001) higher in ampulla and isthmus region 
respectively compared to the infundibulum (Fig 4.18, B). Abundance of TRPC6 
on the lateral side of the oviduct epithelium was 29.6 (p= 0.005) and 1.4 fold (p= 
0.02) higher in ampulla and isthmus respectively compared to that of the 
infundibulum (Fig 4.18, C). 
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Fig 4.18 Abundance of TRPC6 in permeabilized bovine oviduct epithelium at stage 3 of the 
estrous cycle in apical (4.18, A), basal (4.18, B), and the lateral (4.18, C) side of the epithelium 
tissue. On the apical, basal and lateral side of the permeabilized bovine oviduct epithelium 
abundance of TRPC6 was dramatically higher in ampulla compared to the infundibulum and 
isthmus region. A modest increase was observed in abundance of TRPC6 in isthmus on apical, 
basal and lateral side of the tissue compared to the infundibulum.  All data are expressed as a 
mean of 3 replicates ± 1 standard deviation.  (* = p<0.05; ** = p<0.01; *** = p<0.001). 
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4.1.1.7 Localization and abundance of TRPC1 and TRPC6 in non-
permeabilized bovine oviduct epithelium at stage 4 of the estrous cycle 
In non-permeabilized bovine oviduct epithelial tissue at stage 4 of the estrous 
cycle,  TRPC1 was localized equally on the apical, basal and lateral sides of the 
infundibulum epithelium (Fig 4.19, A). In the ampulla, localization of TRPC1 
channel was highest on the apical side and lowest on the lateral side of the 
epithelium (Fig 4.19, B). Localization of TRPC1 channel was highest on the 
apical side and similar on the basal and lateral sides of the epithelium (Fig 4.19, 
C). 
The TRPC6 channel was localized equally on the apical and basal sides of the 
non-permeabilized epithelial tissue of infundibulum at stage 4 of the estrous 
cycle. However, localization of TRPC6 was lower on the lateral side of the 
infundibulum epithelium compared to the apical and basal sides of the tissue 
(Fig 4.19, A).  In the ampulla and isthmus, localization of TRPC6 was slightly 
greater on the basal side of the epithelium compared to the apical side. 
Localization of TRPC6 was lowest on the lateral side of the epithelium 
compared to the apical and basal sides in both ampulla and isthmus (Fig 4.19, 
B and C). 
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Fig 4.19 Localization of TRPC1 and TRPC6 at stage 4 of the estrous cycle in non-permeabilized epithelial tissue of bovine Infundibulum (4.19, A), 
Ampulla (4.19, B) and Isthmus (4.19, C). Nuclei are labelled with DAPI (Blue), TRPC1 with Alexa Four 647 FITC conjugated (Red) and TRPC6 with 
Alexa Flour 488 (Green). 
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Abundance of TRPC1 channel on the apical side of the non-permeabilized 
bovine oviduct epithelium was not significantly different in ampulla (p= 0.05) and 
isthmus (p= 0.7) compared to that of the infundibulum (Fig 4.20, A). On the 
basal side of the bovine oviduct epithelium, abundance of TRPC1 in ampulla 
(p= 0.08) was equal to that of the infundibulum. However, abundance of TRPC1 
was 0.5 fold (p= 0.03) less in the isthmus compared to the infundibulum (Fig 
4.20, B). On the lateral side of the bovine oviduct epithelium, abundance of 
TRPC1 was equal in infundibulum and ampulla (p= 0.9). TRPC1 was 0.4 fold 
less abundant in isthmus (p= 0.01) compared to both infundibulum and ampulla 
(Fig 4.20, C). 
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Fig 4.20 Abundance of TRPC1 in non-permeabilized bovine oviduct epithelium at stage 4 of the 
estrous cycle in apical (4.20, A), basal (4.20, B) and the lateral (4.20, C) side of the tissue. On 
the apical, basal and lateral sides of the tissue abundance of TRPC1 was equal in infundibulum 
and ampulla in non-permeabilized bovine oviduct epithelium at stage 4 of the estrous cycle. 
There was no significant difference in abundance of TRPC1 on the apical side of the isthmus 
compared to that of the infundibulum. However, on the basal and lateral sides of the tissue 
abundance of TRPC1 was lower in isthmus relative to the infundibulum. All data are expressed 
as a mean of 3 replicates ± 1 standard deviation. 
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Abundance of TRPC6 channels on the apical side of non-permeabilized bovine 
oviduct epithelium at stage 4 of the estrous cycle was not significantly different 
in ampulla (p= 0.5) and isthmus (p= 0.6) compared to the infundibulum (Fig 
4.21, A). Furthermore, on the basal side of the non-permeabilized bovine 
oviduct epithelium at stage 4 of the estrous cycle, abundance of TRPC6 was 
equal in ampulla (p= 0.8) and isthmus (p= 0.1) relative to the infundibulum (Fig 
4.21, B). On the lateral side of the tissue, abundance of TRPC6 in ampulla (p= 
0.3) was equal to that of the infundibulum. However, TRPC6 was more 
abundant by 1.27 fold (p= 0.02) on the lateral side of the isthmus relative to the 
infundibulum (Fig 4.21, C). 
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Fig 4.21 Abundance of TRPC6 in non-permeabilized bovine oviduct epithelium at stage 4 of the 
estrous cycle in apical (4.21, A), basal (4.21, B), and the lateral (4.21, C) side of the tissue. On 
the apical and basal side of the non-permeabilized bovine oviduct epithelial tissue at stage 4 of 
the estrous cycle, abundance of TRPC6 was equal in infundibulum, ampulla and isthmus 
region. Furthermore, abundance of the TRPC6 in ampulla on the lateral side of the tissue was 
not significantly different to that of the infundibulum. however, on the lateral side of the isthmus 
abundance of the TRPC6 was higher than that of both infundibulum and ampulla. All data are 
expressed as a mean of 3 replicates ± 1 standard deviation.  (* = p<0.05; ** = p<0.01; *** = 
p<0.001). 
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4.1.1.8 Localization and abundance TRPC1 and TRPC6 in permeabilized 
bovine oviduct epithelium at stage 4 of the estrous cycle 
In permeabilized bovine oviduct epithelium at stage 4 of the estrous cycle, 
TRPC1 channel was equally localized on the apical, basal and lateral sides of 
the infundibulum region (Fig 4.22, A). Distribution of TRPC1 in ampulla was 
similar to that of the infundibulum and TRPC1 was equally localized on the 
apical, basal and lateral sides of the tissue (Fig 4.22, B). In the isthmus region 
of the oviduct epithelium, localization of TRPC1 was highest on the apical side 
and lowest on the lateral side of the tissue (Fig 4.22, C).  
TRPC6 was localized equally on the apical and lateral sides of the 
permeabilized infundibulum epithelial tissue at stage 4 of the estrous cycle, and 
its localization was higher on the basal side of the epithelium compared to both 
apical and lateral sides (Fig 4.22, A).  Localization of TRPC6 was similar on the 
apical and basal sides of the ampulla but less on the lateral side compared to 
both the apical and basal sides of the epithelium (Fig 4.22, B). In the isthmus 
region, localization of TRPC6 was highest on the apical side and lowest on the 
lateral side of the epithelium (Fig 4.22, C). 
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Fig 4.22 Localization of TRPC1 and TRPC6 at stage 4 of the estrous cycle in permeabilized epithelial tissue of bovine Infundibulum (4.22, A), Ampulla 
(4.22, B) and Isthmus (4.22, C). Nuclei are labelled with DAPI (Blue), TRPC1 with Alexa Four 647 FITC conjugated (Red) and TRPC6 with Alexa Flour 
488 (Green). 
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On the apical side of permeabilized bovine oviduct epithelium at stage 4 of the 
estrous cycle, abundance of TRPC1 was 1.9 fold (p= 0.01) higher than that of 
ampulla. However, abundance of TRPC1 in the isthmus region (p= 0.2) of the 
tissue was equal to that of the infundibulum (Fig 4.23, A). On the basal side of 
the epithelium, abundance of TRPC1 in infundibulum was 1.94 (p= 0.01) and 
2.1 fold (p= 0.02) higher than that of ampulla and isthmus respectively (Fig 
4.23, B). Abundance of TRPC1 on the lateral side of the bovine oviduct 
epithelium in infundibulum was 2.15 fold (p= 0.001) higher than that of ampulla 
and 2.6 fold (p= 0.006) higher than that of isthmus (Fig 4.23, C). 
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Fig 4.23 Abundance of TRPC1 in permeabilized bovine oviduct epithelium at stage 4 of the 
estrous cycle in apical (4.23, A), basal(4.23, B), and lateral (4.23, C) side of the tissue. On the 
apical side of the tissue abundance of TRPC1 was the highest in infundibulum and the lowest in 
ampulla. On the basal side of the tissue TRPC1 was most abundant in infundibulum and less 
abundant  in ampulla and isthmus where equal abundance was observed. Abundance of 
TRPC1 on the lateral side was lower in ampulla and isthmus compared to the infundibulum. All 
data are expressed as a mean of 3 replicates ± 1 standard deviation.  (* = p<0.05; ** = p<0.01; 
*** = p<0.001).  
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Abundance of TRPC6 on the apical side of permeabilized bovine oviduct 
epithelial tissue at stage 4 of the estrous cycle was equal in infundibulum and 
ampulla (p= 0.6) and 2 fold (p= 0.002 ) higher in isthmus compared to the 
infundibulum (Fig 4.24, A). Similar to the apical side, on the basal side of the 
oviduct epithelium, abundance of TRPC6 was equal in infundibulum and 
ampulla (p= 0.5) and higher by 1.33 fold (p= 0.004) in isthmus relative to the 
infundibulum (Fig 2.24, B). Furthermore, abundance of TRPC6 on the lateral 
side of the ampulla (p= 0.2) was not significantly different to that of the 
infundibulum. In isthmus, abundance of TRPC6 was decreased by 0.61 fold (p= 
0.03) on the lateral side of the tissue compared to the infundibulum (Fig 4.24, 
C).  
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Fig 4.24 Abundance of TRPC6 in permeabilized bovine oviduct epithelium at stage 4 of the 
estrous cycle in apical (4.24, A), basal (4.24, B) and the lateral (4.24, C) side e of the tissue. On 
apical, basal and lateral side of the permeabilized bovine oviduct epithelium at stage 4 of the 
estrous cycle,  abundance of TRPC6 was equal in infundibulum and ampulla. On the apical and 
basal side of the isthmus epithelial tissue, abundance of TRPC6 was higher than that of the 
infundibulum. However, on the lateral side of the isthmus abundance of the TRPC6 was lower 
than that of infundibulum. All data are expressed as a mean of 3 replicates ± 1 standard 
deviation. (* = p<0.05; ** = p<0.01; *** = p<0.001). 
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4.1.1.9 Changes in localization and abundance of TRPC1 and TRPC6 in 
non-permeabilized bovine infundibulum epithelium throughout the 
estrous cycle 
The localization pattern of TRPC1 and TRPC6 channels changed in bovine 
infundibulum epithelial tissue throughout the estrous cycle (Fig 4.25).  
In non-permeabilized tissue, there was no  significant difference in abundance 
of TRPC1 on apical side of the infundibulum at stage 2 (p= 0.1) compared to 
stage 1 of the estrous cycle.. Abundance of TRPC1 on the apical side of the 
tissue was increased by  7 fold (p= 0.002) at stage 3 relative to stage 1. 
Abundance of TRPC1 was 8.9 fold (p= 0.005) higher at stage 4 compared to 
stage 1(Fig 4.26, A). On the basal side of the infundibulum epithelial tissue, 
abundance of TRPC1 channels at stage 2 (p= 0.08) was not significantly 
different compared to that of stage 1. At stage 3 of the estrous cycle a 6.6 fold 
(p= 0.007) increase in abundance of TRPC1 was observed on the basal side of 
the infundibulum epithelial tissue compared to stage 1. This increase was 
higher at stage 4 by 10 fold (p= 0.009) (Fig 4.26, B). On the lateral side of the 
non-permeabilized bovine infundibulum epithelial tissue, abundance of TRPC1 
was higher by 6.5 fold (p= 0.02) at stage 2 compared to stage 1. At stage 3, 
abundance of TRPC1 was 8.67 fold (p= 0.0005) higher than that of stage 1. 
Abundance of TRPC1 channel on the lateral side of the tissue was increased by 
12.75 fold (p= 0.002) at stage 4 compared to the stage 1 (Fig 4.26, C). 
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Fig 4.25 Localization of TRPC1 and TRPC6 in non-permeabilized bovine infundibulum epithelial 
tissue at stage 1 (4.25, A), stage 2 (4.25, B), stage 3 (4.25, C) and stage 4 (4.25,D) of the 
estrous cycle. nuclei are labelled with DAPI (Blue), TRPC1 with Alexa Four 647 FITC 
conjugated (Red) and TRPC6 with Alexa Flour 488 (Green). 
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Fig 4.26 Abundance of TRPC1 in non-permeabilized bovine infundibulum epithelium throughout 
the estrous cycle on apical (4.26, A), basal (4.26, B) and the lateral (4.26, C) side of the tissue. 
Abundance of TRPC1 on both apical and basal side of the tissue at stage 2 was not significantly 
different to that of the stage 1. However, abundance of TRPC1 at stage 3 and 4 was higher than 
that of the stage 1 on both apical and basal side of the tissue. On the lateral side of the tissue, 
abundance of TRPC1 was the lowest at stage 1 and the highest at stage 4 of the estrous cycle. 
Abundance of TRPC1 at stage 2, 3 and 4 of the estrous cycle was higher than that of the stage 
1. All data are expressed as a mean of 3 replicates ± 1 standard deviation. (* = p<0.05; ** = 
p<0.01; *** = p<0.001). 
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At stage 2 of the estrous cycle on the apical side of the non-permeabilized 
bovine infundibulum epithelial tissue, abundance of TRPC6 was higher by 18.17 
fold (p= 0.01) relative to stage 1. Furthermore, abundance of TRPC6 on the 
apical side of the tissue was higher by 19.64 (p= 0.0007) and 18.67 (p= 0.02) 
fold at stage 3 and 4 respectively compared to that of the stage 1 (Fig 4.27, A). 
On the basal side of the epithelium, abundance of TRPC6 was 9.27 fold (p= 
0.01) higher at stage 2 compared to that of stage 1. TRPC6 was 34.22 (p= 
0.004) and 36.64 (p= 0.01) fold more abundant at stage 3 and stage 4 of the 
estrous cycle respectively compared to stage 1 (Fig 4.27, B). On the lateral side 
of the bovine infundibulum epithelial tissue, abundance of TRPC6 was 19.87 
fold (p= 0.04) higher at stage 2 compared to that of stage 1. At stage 3 of the 
estrous cycle, TRPC6 was more abundant by 41.36 fold (p= 0.001) on the 
lateral side of the epithelium compared to stage1. Abundance of TRPC6 on the 
lateral side of non-permeabilized bovine infundibulum epithelium was 21.4 fold 
(p= 0.003) higher than that of stage 1 (Fig 4.27, C). 
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Fig 4.27 Abundance of TRPC6 in non-permeabilized bovine infundibulum epithelium  
throughout the estrous cycle on apical (4.27, A), basal (4.27, B) and the lateral (4.27, C) side of 
the tissue. On the apical side of the tissue, abundance of TRPC6 was equal at stage 2, 3 and 4 
where it was higher than the stage 1. On basal side of the epithelium, abundance of TRPC6 
was equal at stage 3 and 4 where it was higher than stage 2 and 1. Abundance of TRPC6 on 
the basal side was the lowest at stage 1 of the estrous cycle. On the lateral side of the non-
permeabilized infundibulum epithelium, abundance of TRPC6 was equal at stage2 and stage 4 
of the estrous cycle. The highest abundance of TRPC6 on the lateral side was observed at 
stage 3 and the lowest abundance was observed at stage 1 of the estrous cycle. All data are 
expressed as a mean of 3 replicates ± 1 standard deviation. (* = p<0.05; ** = p<0.01; *** = 
p<0.001). 
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4.1.1.10 Changes in localization and abundance of TRPC1 and TRPC6 in 
permeabilized bovine infundibulum epithelium throughout the estrous 
cycle 
Abundance of TRPC1 on the apical side of the epithelium at stage 2 of the 
estrous cycle in permeabilized bovine infundibulum epithelial tissue was 1.82 
fold (p= 0.008) higher than that of stage 1. However, abundance of TRPC1 was 
reduced by 0.23 fold (p= 5.32 x 10-5) at stage 3 of the estrous cycle compared 
to stage1. A 1.95 fold (p= 0.03) increase in abundance of TRPC1 was observed 
on the apical side of  permeabilized bovine infundibulum epithelial tissue at 
stage 4 of the estrous cycle compared to that of stage 1 (Fig 4.29, A). On the 
basal side of the permeabilized bovine infundibulum epithelial tissue, 
abundance of TRPC1 at stage 2 (p= 0.2) was equal to that of stage 1. In 
contrast, at stage 3 of the estrous cycle abundance of TRPC1 channel was 
reduced by 0.24 fold (p= 0.001) compared to stage 1.  At stage 3 of the estrous 
cycle, abundance of the TRPC1 was increased by 2.12 fold (p= 0.007) relative 
to that of stage 1 (Fig 4.29, B). Abundance of TRPC1 channels on the lateral 
side  of the permeabilized bovine infundibulum epithelial tissue, was 1.9 fold (p= 
0.01) higher at stage 2 of the estrous cycle compared to stage1. However, 
abundance of TRPC1 at stage 3 of the estrous cycle was reduced by 0.27 fold 
(p= 0.0001) compared to stage 1 of the estrous cycle. At stage 4 abundance of 
TRPC1 was increased by 2.6 fold (p= 0.006) compared to stage 1 (Fig 4.29, C). 
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Fig 4.28 Localization of TRPC1 and TRPC6 in permeabilized bovine infundibulum epithelial 
tissue at stage 1 (4.28, A), stage 2 (4.28, B), stage 3 (4.28, C) and stage 4 (4.28, D) of the 
estrous cycle. Nuclei are labelled with DAPI (Blue), TRPC1 with Alexa Four 647 FITC 
conjugated (Red) and TRPC6 with Alexa Flour 488 (Green). 
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 Fig 4.29 Abundance of TRPC1 in permeabilized bovine infundibulum epithelium throughout the 
estrous cycle on apical (4.29, A), basal (4.29, B) and the lateral (4.29, C) side of the tissue. On 
the apical side of the tissue, abundance of TRPC1 at stage 2 and 4 was higher than that of the 
stage 1. However, at stage 3 of the estrous cycle abundance of TRPC1 was lower than that of 
the stage 1.On the basal side of the tissue, there was no significant difference in abundance of 
the TRPC1 at stage2 compared to that of the stage 1.  Similarly to the apical side, abundance of 
TROC1 at stage 2 and 4 was higher than that of the stage 1 of the estrous cycle. However, at 
stage 3 abundance of TRPC1 was decreased compared to that of the stage 1. All data are 
expressed as a mean of 3 replicates ± 1 standard deviation. (* = p<0.05; ** = p<0.01; *** = 
p<0.001). 
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Abundance of TRPC6 channel on the apical side of the permeabilized bovine 
infundibulum epithelial tissue was 1.66 fold (p= 0.04) higher at stage 2 
compared to that of stage 1 of the estrous cycle. At stage 3 of the estrous cycle, 
abundance of TRPC6 channel was reduced by 0.65 fold (p= 0.01) relative to 
stage 1. However, abundance of TRPC6 on the apical side of the permeabilized 
bovine infundibulum epithelium at stage 4 (p= 0.1) was equal to that of stage 1 
of the estrous cycle (Fig 4.30, A). On the basal side of the permeabilized bovine 
infundibulum epithelial tissue, there was no significant difference in abundance 
of TRPC6 at stage 2 (p= 0.5) compared to stage 1. However, abundance of 
TRPC6 was decreased by 0.75 (p= 0.001) and 0.68 (p= 0.03) fold at stage 3 
and 4 respectively compared to that of stage 1 (Fig 4.30, B). On the lateral side 
of the permeabilized bovine infundibulum epithelial tissue, abundance of 
TRPC6 at stage 2 (p= 0.2) was equal to that of stage 1 of the estrous cycle. 
Abundance of TRPC6 was reduced by 0.73 fold (p= 0.03) at stage 3 relative to 
stage 1. However, there was no  significant difference in abundance of TRPC6 
at stage 4 (p= 0.6) compared to stage 1 of the estrous cycle (Fig 4.30, C). 
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Fig 4.30 Abundance of  TRPC6 in permeabilized bovine infundibulum epithelium throughout the 
estrous cycle in apical (4.30, A), basal (4.30, B) and the lateral (4.30, C) side of the tissue. 
Abundance pattern of TRPC6 was the same on apical and lateral side of the tissue. On the 
apical side of the tissue, abundance of TRPC6 at stage 2 of the estrous cycle was higher than 
that of the stage 1. However, at stage 3 abundance of TRPC6 was decreased compared to that 
of the stage 1. There was no significant difference in abundance of TRPC6 on apical side of the 
tissue at stage 4 compared to the of the satge1. On the basal side  of the permeabilized bovine 
infundibulum epithelial tissue, no significant difference was observed in abundance of TRPC6 
between stage 1 and 2 of the estrous cycle. However, abundance of TRPC6 at both stage 3 
and 4 was lower than that of the stage 1. On the lateral side of the tissue, there was no 
significant difference in abundance of TRPC6 at stage 2 and 4 compared to that of the stage1. 
However, abundance of TRPC6 was decreased at stage 3 compared to the stage 1 of the 
estrous cycle. All data are expressed as a mean of 3 replicates ± 1 standard deviation. (* = 
p<0.05; ** = p<0.01; *** = p<0.001). 
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4.1.1.11 Changes in localization and abundance of TRPC1 and TRPC6 in 
non-permeabilized bovine ampulla epithelium throughout the estrous 
cycle 
`On the apical side of non-permeabilized bovine ampulla epithelial tissue, 
abundance of TRPC1 at stage 2 (p= 0.4) was equal to that of stage 1. Similarly 
to stage 2, at stage 3 (p= 0.3) and 4 (p= 0.05) of the estrous cycle abundance of 
TRPC1 channel was not significantly different compared to  stage 1. (Fig 4.32, 
A). Furthermore, on the basal side of the non-permeabilized bovine ampulla 
epithelial tissue, abundance of TRPC1 channel at stage 2 (p= 0.2) and 3 (p= 
0.3) and 4 (p= 0.08) (Fig 4.32, B) was not significantly different to that of the 
stage 1 (Fig 4.32, B). On the lateral side of the non-permeabilized bovine 
ampulla epithelium, abundance of TRPC1 channel was not significantly different 
at stage 2 (p= 0.08) and 4 (p= 0.2) to that of stage 1 of the estrous cycle. 
However, at stage 3 of the estrous cycle abundance of TRPC1 was lower by 
0.61 fold (p= 0.02) relative to stage 1 of the estrous cycle (Fig 4.32, C). 
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Fig 4.31 Localization of TRPC1 and TRPC6 in non-permeabilized bovine ampulla epithelial 
tissue at stage 1 (4.31, A), stage 2 (4.31, B), stage 3 (4.31, C) and stage 4 (4.31, D) of the 
estrous cycle. Nuclei are labelled with DAPI (Blue), TRPC1 with Alexa Four 647 FITC 
conjugated (Red) and TRPC6 with Alexa Flour 488 (Green). 
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Fig 4.32 Abundance of TRPC1 in non-permeabilized bovine ampulla epithelium throughout the 
estrous cycle on apical (4.32, A), basal (4.32, B) and the lateral (4.32, C) side of the tissue. On 
the apical and basal side of the non-permeabilized bovine ampulla epithelial tissue, no 
significant difference was observed in abundance of TRPC1 at stage 2, 3 and 4 of the estrous 
cycle compared to that of the stage 1. Furthermore, abundance of TRPC1 at stage 2 and 4 of 
the estrous cycle on lateral side of the tissue was equal to that of the stage 1. However, 
abundance of TRPC1 at stage 3 of the estrous cycle was lower than that of the stage 1.  All 
data are expressed as a mean of 3 replicates ± 1 standard deviation. (* = p<0.05; ** = p<0.01; 
*** = p<0.001). 
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Abundance of TRPC6 on the apical side of the non-permeabilized bovine 
ampulla epithelium at stage 2 (p= 0.1) was equal to that of stage 1 of the 
estrous cycle. However, abundance of TRPC6 channel was increased by 1.3 
(p= 0.01) and 1.62 (p= 0.02) fold at stage 3 and 4 respectively compared to 
stage 1 (Fig 4.33, A). On the basal side of the non-permeabilized bovine 
ampulla epithelial tissue, abundance of TRPC6 channel at stage 2 (p= 0.1), 3 
(p= 0.2), and 4 (p= 0.05) was not significantly different to that of stage 1 (Fig 
4.33, B). On the lateral side of the non-permeabilized bovine ampulla epithelial 
tissue, abundance of TRPC6 was increased by 1.57 fold (p= 0.04) at stage 2 of 
the estrous cycle compared to stage 1. However, at stage 3 and 4, abundance 
of TRPC6 was decreased by 0.5 (p= 0.0008) and 0.71 (p= 0.006) fold 
respectively relative to stage 1 (Fig 4.33, C). 
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Fig 4.33 Abundance of TRPC6 in non-permeabilized bovine ampulla epithelium throughout the 
estrous cycle on apical (4.33, A), basal (4.33, B) and the lateral (4.33, C) side of the tissue. On 
the apical side of the tissue, abundance of TRPC6 at stage 2 was not significantly different to 
that of the stage 1. However, abundance of TRPC1 was higher at both stage 3 and 4 on the 
apical side of the tissue compared to that of the stage 1. On the basal side of the non-
permeabilized bovine ampulla epithelium, there was no significant difference in abundance of 
TRPC1 at stage 2, 3 and 4 of the estrous cycle compared to that of the stage 1. However, on 
the lateral side of the tissue abundance of TRPC1 was increased at stage 2 and decreased at 
stage 3 and 4 compared to the stage 1 of the estrous cycle.  All data are expressed as a mean 
of 3 replicates ± 1 standard deviation. (* = p<0.05; ** = p<0.01; *** = p<0.001). 
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4.1.1.12 Changes in localization and abundance of TRPC1 and TRPC6 in 
permeabilized bovine ampulla epithelium throughout the estrous cycle 
Abundance of TRPC1 channels on the apical side of the permeabilized bovine 
ampulla epithelial tissue was decreased by 0.12 (p= 0.02) and 0.13 (p= 0.02) 
fold respectively at stage 2 and 4 compared to the stage 1 of the estrous cycle. 
However, abundance of TRPC1 was the same as that of stage 1 at stage 3 (p= 
0.8) of the estrous cycle (Fig 4.35, A). On the basal side of the permeabilized 
bovine ampulla epithelium, abundance of TRPC1 was reduced by 0.10 (p= 
0.02) and 0.14 (p= 0.03) fold respectively at stage 2 and 4 of the estrous cycle 
compared to that of stage 1. No significant changes in abundance of TRPC1 
were observed at stage 3 (p= 0.8) relative to stage 1 of the estrous cycle (Fig 
4.35, B). On the lateral side of the permeabilized bovine ampulla epithelial 
tissue, abundance of TRPC1 was reduced 0.09 (p= 0.01) and 0.16 (p= 0.02) 
fold at stage 2 and 4 of the estrous cycle respectively compared to stage 1. 
However, abundance of TRPC1 at stage 3 (p= 0.3) of the estrous cycle was the 
same as that of stage 1 (Fig 4.35, C). 
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Fig 4.34 Localization of TRPC1 and TRPC6 in permeabilized bovine ampulla epithelial tissue at 
stage 1 (4.34, A), stage 2 (4.34, B), stage 3 (4.34, C ) and stage 4 (4.34, D) of the estrous cycle. 
Nuclei are labelled with DAPI (Blue), TRPC1 with Alexa Four 647 FITC conjugated (Red) and 
TRPC6 with Alexa Flour 488 (Green). 
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Fig 4.35 Abundance of TRPC1 in permeabilized bovine ampulla epithelium throughout the 
estrous cycle on apical (4.35, A), Basal (4.35, B) and the lateral (4.35, C) side of the tissue.  
Abundance of TRPC1 on apical, basal and lateral side of the epithelial tissue of permeabilized 
bovine ampulla was lower at stage 2 and 4 compared to the stage 1 of the estrous cycle. 
However, abundance of TRPC1 at stage 3 of the estrous cycle was not significantly different to 
that of the stage 1. All data are expressed as a mean of 3 replicates ± 1 standard deviation. (* = 
p<0.05; ** = p<0.01; *** = p<0.001). 
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On the apical side of the permeabilized bovine ampulla epithelial tissue, 
abundance of TRPC6 channels was decreased by 0.03 (p= 0.02) and 0.04 (p= 
0.02) fold at stage 2 and 4 of the estrous cycle respectively compared to stage 
1. In contrast, abundance of TRPC6 was increased by 1.9 fold (p=  0.01) at 
stage 3 of the estrous cycle relative to stage 1 (Fig 4.36, A). Abundance of 
TRPC6 channel on the basal side of the permeabilized bovine ampulla epithelial 
tissue at stage 2 and 4 was decreased by 0.02 (p= 0.003) and 0.04 (p= 0.004) 
fold respectively compared to stage 1. However, abundance of TRPC6 on the 
basal side of the permeabilized bovine ampulla epithelial tissue at stage 3 (p= 
0.1) was not significantly different compared to stage 1(Fig 4.36, B). On the 
lateral side of the tissue, abundance of TRPC6 channel was decreased by 
0.017 (p= 0.01) and 0.03 (p= 0.01) fold respectively at stages 2 and 4 of the 
estrous cycle compared to that of stage 1. However, abundance of TRPC6 at 
stage 3 (p= 0.4) of the estrous cycle was equal to that of stage 1(Fig 4.36, C). 
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Fig 4.36 Abundance of TRPC6 in permeabilized bovine ampulla epithelium throughout the 
estrous cycle on apical (4.36, A), basal (4.36, B) and the lateral (4.36, C) side of the tissue. On 
the apical , basal and lateral side of the permeabilized bovine ampulla epithelial tissue, 
abundance of TRPC6 was lower at stage 2 and 4 compared to the stage 1 of the estrous cycle. 
However, abundance of TRPC6 at stage 3 was higher on apical side but not significantly 
different on none of the basal and lateral side of the tissue compared to the stage 1 of the 
estrous cycle. All data are expressed as a mean of 3 replicates ± 1 standard deviation. (* = 
p<0.05; ** = p<0.01; *** = p<0.001). 
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4.1.1.13 Changes in localization and abundance of TRPC1 and TRPC6 in 
non-permeabilized bovine isthmus epithelium throughout the estrous 
cycle 
On the apical side of the non-permeabilized bovine isthmus epithelium tissue, 
abundance of TRPC1 channel was decreased by 0.82 (p= 0.003) and 0.54 (p= 
2.95 x 10-6) fold at stage 2and 4 of the estrous cycle respectively compared to 
stage 1. However, abundance of TRPC1 on the apical side of the tissue at 
stage 3 (p= 0.06) was equal to that of stage 1 of the estrous cycle (Fig 4.38, A). 
On the basal side of the epithelium, abundance of TRPC1 channel was less at 
stage 2, 3 and 4 by 0.67 (p= 0.007), 0.39 (p= 5.98 x 10-5) and 0.21 (p= 0.001) 
fold respectively relative to  stage 1 (Fig 4.38, B). On the lateral side of the non-
permeabilized bovine isthmus epithelial tissue, abundance of TRPC1 channel 
was decreased by 0.28 (p= 3.14 x 10-5), 0.29 (p= 0.0002) and 0.19 (p= 0.0004) 
fold at stage 2, 3 and 4 of the estrous cycle compared to stage 1(Fig 4.38, C).  
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Fig 4.37 Localization of TRPC1 and TRPC6 in non-permeabilized bovine isthmus epithelial 
tissue at stage 1 (4.37, A), stage 2 (4.37, B), stage 3 (4.37, C) and stage 4 (4.37, D) of the 
estrous cycle. Nuclei are labelled with DAPI (Blue), TRPC1 with Alexa Four 647 FITC 
conjugated (Red) and TRPC6 with Alexa Flour 488 (Green). 
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Fig 4.38 Abundance of TRPC1 in non-permeabilized bovine isthmus epithelium throughout the 
estrous cycle in apical (4.38, A), Basal (4.38, B) and the lateral (4.38, C) side of the tissue. 
Abundance of TRPC1 on the apical side of the epithelium was the highest at stage 1 and lowest 
at stage 4. Abundance of TRPC1 at stage 3 was equal to that of the stage 1. A decrease in 
abundance of TRPC1 was observed at stage 2 compared to the stage 1 of the estrous cycle. 
On the basal side of the tissue, abundance of TRPC1 was the highest at stage 1 and gradually 
decreased throughout the estrous cycle and was the lowest at stage 4. On the lateral side of the 
tissue, abundance of TRPC1 was dramatically higher at stage 1 compared to stage 2, 3 and 4 
of the estrous cycle. Abundance of TRPC1 was equal at stage 2 and 3 where it was slightly 
higher than stage 4 of the estrous cycle. All data are expressed as a mean of 3 replicates ± 1 
standard deviation. (* = p<0.05; ** = p<0.01; *** = p<0.001). 
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On the apical side of the non-permeabilized bovine isthmus epithelial tissue, 
abundance of TRPC6 channel was highest  at stage 1 of the estrous cycle. At 
stage 2, abundance of TRPC6 was reduced to 0.09 fold (p= 0.04) compared to 
stage 1. Furthermore, at stages 3 and 4 of the estrous cycle abundance of 
TRPC6 channel was reduced by 0.19 (p= 0.04) and 0.15 (p= 0.04) fold 
respectively compared to stage 1 (Fig 4.39, A). On the basal side of the 
epithelium of the isthmus region, abundance of TRPC6 channel was lower by 
0.05 (p= 0.004), 0.12 (p= 0.005) and 0.15 (p= 0.005) fold respectively at stage 
2, 3 and 4 relative to stage 1 of the estrous cycle (Fig 4.39, B). Similar to the 
apical and basal side of the epithelium, abundance of TRPC6 on the lateral side 
of the epithelium was lower at stage 2, 3 and 4 by 0.025 (p= 0.02), 0.13 (p= 
0.03) and 0.058 (p= 0.02) fold respectively compared to stage 1 of the estrous 
cycle (Fig 4.39, C). 
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Fig 4.39 Abundance of TRPC6 in non-permeabilized bovine isthmus epithelium throughout the 
estrous cycle in apical (4.39, A), basal (4.39, B) and the lateral (4.39, C) side of the tissue. On 
all apical, basal and lateral side of the epithelial tissue, abundance of TRPC6 was highest at 
stage 1 and lowest at stage 2 of the estrous cycle. Abundance of TRPC6 at stage 3 and 4 was 
much lower than that of stage 1 on apical, basal and lateral side of the tissue. All data are 
expressed as a mean of 3 replicates ± 1 standard deviation. (* = p<0.05; ** = p<0.01; *** = 
p<0.001). 
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4.1.1.14 Changes in localization and abundance of TRPC1 and TRPC6 in 
permeabilized bovine isthmus epithelium throughout the estrous cycle 
Abundance of TRPC1 channel on the apical side of the permeabilized bovine 
isthmus epithelial tissue was highest at stage 1 throughout the estrous cycle. 
Abundance of TRPC1 channel was decreased by 0.16 (p= 5.71 x10-5), 0.30 (p= 
0.0001) and 0.24 (p= 0.0002) fold respectively at stage 2, 3 and 4 of the estrous 
cycle compared to stage 1 (Fig 4.41, A). On the basal side of the isthmus 
epithelium, abundance of TRPC1 was reduced by 0.32 fold at stage 2 (p= 
0.0006) and 3 (p= 0.0004) and 0.24 fold (p= 0.004) at stage 4 of the estrous 
cycle relative to stage 1 (Fig 4.41, B). On the lateral side of the permeabilized 
bovine isthmus epithelial tissue, abundance of TRPC6 was decreased by 0.21 
fold at stage 2 (p= 1.03 x10-5) and 3 (p= 5.07 x 10-6) and 0.16 fold (p= 0.0004) 
at stage 4 of the estrous cycle compared to stage 1 (Fig 4.41, C).  
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Fig 4.40 Localization of TRPC1 and TRPC6 in permeabilized bovine isthmus epithelial tissue at 
stage 1 (4.40, A), stage 2 (4.40, B), stage 3 (4.40, C) and stage 4 (4.40, D) of the estrous cycle. 
Nuclei are labelled with DAPI (Blue), TRPC1 with Alexa Four 647 FITC conjugated (Red) and 
TRPC6 with Alexa Flour 488 (Green). 
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Fig 4.41 Abundance of TRPC1 in permeabilized bovine isthmus epithelium throughout the 
estrous cycle in apical (4.41, A), basal (4.41, B) and lateral (4.41, C) of the tissue. On the apical 
side of the tissue  TRPC1 was most abundant at stage 1. Abundance of TRPC1 at stage 2, 3 
and 4 was much lower than that of stage 1 and the lowest abundance of TRPC1 was observed 
at stage 2 of the estrous cycle. On the basal and lateral side of the epithelium, abundance of 
TRPC1 was the highest at stage 1. On the basal and lateral side of the tissue, abundance of 
TRPC1 at stage 2 and 3 of the cycle was equal and slightly higher than that of stage 4.  All data 
are expressed as a mean of 3 replicates ± 1 standard deviation. (* = p<0.05; ** = p<0.01; *** = 
p<0.001). 
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On the apical side of the permeabilized bovine isthmus epithelium, abundance 
of the TRPC6 channel was reduced by 0.035 (p= 0.003), 0.092 (p= 0.004) and 
0.075 (p= 0.004) fold at stage 2, 3 and 4 respectively compared to stage 1 (Fig 
4.42, A). On the basal side of the isthmus epithelium, abundance of TRPC6 
channel was lower by 0.044 (p= 0.001), 0.064 (p= 0.001) and 0.052 (p= 0.001) 
fold at stage 2, 3 and 4 of the estrous cycle compared to stage 1 (Fig 4.42, B). 
On the lateral side of the bovine isthmus epithelium in the permeabilized tissue, 
abundance of TRPC6 channel was reduced by 0.033 (p= 0.001), 0.034 (p= 
0.001) and 0.019 (p= 0.001) fold respectively at stage 2, 3 and 4 of the estrous 
cycle relative to stage 1 (Fig 4.42, C). 
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Fig 4.42 Abundance of TRPC6 in permeabilized bovine isthmus epithelium throughout the 
estrous cycle in apical (4.42, A), basal (4.42, B) and the lateral (4.42, C) side of the tissue. On 
the apical, basal and lateral side of the tissue, abundance of TRPC6 was extremely higher at 
stage 1 compared to stage2, 3 and 4 of the estrous cycle. All data are expressed as a mean of 
3 replicates ± 1 standard deviation. (* = p<0.05; ** = p<0.01; *** = p<0.001). 
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4.1.2 Localization of TRPC1 and TRPC6 in bovine uterus throughout the 
estrous cycle 
Localization and abundance of TRPC1 and TRPC6 channels in bovine uterine 
epithelial tissue throughout the estrous cycle was studied using 
immunohistochemistry and confocal microscopy techniques. 
4.1.2.1 Localization of TRPC1 and TRPC6 in non-permeabilized bovine 
uterus throughout the estrous cycle 
On the apical side of the non-permeabilized bovine uterine epithelial tissue, 
abundance of TRPC1 channel was lower at stage 2 and 4 by 0.42 (p= 0.009) 
and 0.73 (p= 0.01) fold respectively compared to stage 1. However, abundance 
of TRPC1 on the apical side of the tissue at stage 3 was slightly increased, by 
1.37 fold, (p= 0.009) relative to stage 1 of the estrous cycle (Fig 4.44, A). On the 
basal side of the tissue, abundance of TRPC1 channel at stage 2 was 
decreased by 0.55 fold (p= 0.01) compared to stage 1. However, no significant 
difference was observed in abundance of the TRPC1 on the basal side of the 
tissue at stage 3 (p= 0.06) and 4 (p= 0.9) relative to stage 1 of the estrous cycle 
(Fig 4.44, B). On the lateral side of the non-permeabilized bovine uterine 
epithelial tissue, abundance of TRPC1 was decreased by 0.61fold (p= 0.02) at 
stage 2 compared to that of stage 1. However, abundance of TRPC1 on the 
lateral side of the tissue at stage 3 was increased by 1.53 fold (p= 0.009) 
relative to stage 1. Abundance of TRPC1 on the lateral side of the tissue at 
stage 4 (p= 0.1) of the estrous cycle was not significantly different to that of 
stage 1 (Fig 4.44, C). 
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Fig 4.43 Localization of TRPC1 and TRPC6 in non-permeabilized bovine uterine epithelial 
tissue at stage 1 (4.43, A), stage 2 (4.43, B), stage 3 (4.43, C) and stage 4 (4.43, D) of the 
estrous cycle. Nuclei are labelled with DAPI (Blue), TRPC1 with Alexa Four 647 FITC 
conjugated (Red) and TRPC6 with Alexa Flour 488 (Green). 
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Fig 4.44 Abundance of TRPC1 in non-permeabilized bovine uterine epithelium throughout the 
estrous cycle in apical (4.44, A), basal (4.44, B) and the lateral (4.44, C) side of the tissue. On 
the apical side of the non-permeabilized bovine uterine tissue, abundance of TRPC1 was lower 
at stage 2 and 4 compared to that of the stage 1. However, abundance of TRPC1 at stage 3 
was higher than that of the stage 1. On the basal side of the tissue, abundance of TRPC1 at 
stage 2 was lower than that of the stage 1. However, no significant difference in abundance of 
TRPC1 at stage 3 and 4 was observed compared to the stage 1 of the estrous cycle. On the 
lateral side of the tissue, abundance of TRPC1 was lower at stage 2 and higher at stage 3 
compared to the stage 1 of the estrous cycle. No significant difference was observed in 
abundance of TRPC1 at stage 4 relative to stage 1 of the estrous cycle on the lateral side of the 
tissue. All data are expressed as a mean of 3 replicates ± 1 standard deviation. (* = p<0.05; ** = 
p<0.01; *** = p<0.001). 
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Abundance of TRPC6 channel on the apical side of the non-permeabilized 
bovine uterine epithelial tissue was increased at stage 2, 3 by 1.3 (p= 0.02), 
2.99 (p= 0.04) fold respectively compared to stage 1. However, abundance of 
TRPC6 at stage 4 (p= 0.09) was equal to that of stage 1(Fig 4.45, A). On the 
basal side of the non-permeabilized bovine uterine epithelium, abundance of 
TRPC6 channel was increased by 2.41 fold (p= 0.01) at stage 2 compared to 
that of stage 1. However, abundance of TRPC6 on the basal side of the tissue 
at stage 3 (p= 0.07) and 4 (p= 0.5) of the estrous cycle was not significantly 
different to that of stage 1 (Fig 4.45, B). On the lateral side of the non-
permeabilized bovine uterine epithelium, abundance of TRPC6 at stage 2 was 
higher than that of stage 1 by 1.49 (p= 0.02). However, abundance of TRPC6 
on the lateral side of the tissue at stage 3 and 4 was not significantly different to 
that of stage 1 (Fig 4.45, C). 
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Fig 4.45 Abundance of TRPC6 in non-permeabilized bovine uterine epithelium throughout the 
estrous cycle in apical (4.45, A), basal (4.45, B) and the lateral (4.45, C) side of the tissue. On 
the apical side of the non-permeabilized bovine uterine epithelial tissue abundance of was 
higher at stage 2 and 3 compared of that of the stage 1. However, abundance of TRPC6 at 
stage 4 was not significantly different to that of the stage 1. On the basal and lateral side of the 
tissue, abundance of TRPC6 was higher at stage 2 compared to stage 1. However, on both 
basal and lateral side abundance of TRPC6 at stage 3 and 4 was not significantly different to 
that of the stage.  All data are expressed as a mean of 3 replicates ± 1 standard deviation. (* = 
p<0.05; ** = p<0.01; *** = p<0.001). 
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4.1.2.2 Localization and abundance of TRPC1 and TRPC6 in permeabilized 
bovine uterus throughout the estrous cycle 
On the apical side of the permeabilized bovine uterine epithelial tissue, 
abundance of the TRPC1 channel was increased at stage 2 and 3 by 1.82 (p= 
0.02) and 3.21 (p= 5.46 x 10-5) fold respectively compared to that of the stage 1 
However, abundance of TRPC1 at stage 4 (p= 0.2) was not significantly 
different to that of the stage 1 of the estrous cycle(Fig 4.47, A). On the basal 
side of the epithelium, there was no significant difference in abundance of 
TRPC1 at stage 2 (p= 0.1) and 4 (p= 0.4) compared to stage 1. However, at 
stage 3, abundance of TRPC1 was increased by 1.75 fold (p= 0.005) relative to 
stage 1 of the estrous cycle (Fig 4.47, B). On the lateral side of the tissue at 
stage 2 (p= 0.1) and 4 (p= 0.5) abundance of TRPC1 was not significantly 
different to that of the stage1. At stage 3, abundance of TRPC1 on the lateral 
side of the tissue was increased by 1.33 fold (p= 0.02) relative to stage 1 of the 
estrous cycle(Fig 4.47, C).  
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Fig 4.46 Localization of TRPC1 and TRPC6 in permeabilized bovine uterine epithelial tissue at 
stage 1 (4.43, A), stage 2 (4.43, B), stage 3 (4.43, C) and stage 4 (4.43, D) of the estrous cycle. 
Nuclei are labelled with DAPI (Blue), TRPC1 with Alexa Four 647 FITC conjugated (Red) and 
TRPC6 with Alexa Flour 488 (Green). 
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Fig 4.47 Abundance of TRPC1 in permeabilized bovine uterine epithelium throughout the 
estrous cycle in apical (4.47, A), basal (4.47, B) and the lateral (4.47, C) side of the tissue. On 
the apical side of the tissue, abundance of TRPC1 was higher at both stage 2 and 3 compared 
to stage 1 of the estrous cycle. On the basal and lateral side of the tissue, there was not any 
significant difference in abundance of TRPC1 at stage 2 and 4 compared to the stage 1 of the 
estrous cycle.  The same was the cause in permeabilized bovine uterine epithelium on the 
apical, basal and lateral side of the tissue. However, at stage 3 abundance of TRPC1 on both 
basal and lateral side of the tissue was higher than that of the stage 1. All data are expressed 
as a mean of 3 replicates ± 1 standard deviation. (* = p<0.05; ** = p<0.01; *** = p<0.001). 
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Abundance of TRPC6 channel on the apical side of the permeabilized bovine 
uterine epithelial tissue was increased at stage 2 and 3 of the estrous cycle by 
3.27 (p= 0.002) and 2.77 (p= 0.01) fold compared to stage 1. There was no 
significant difference in abundance of TRPC6 on the apical side of the tissue at 
stage 4 (p= 0.2) compared to stage 1(Fig 4.48, A). On the basal side of the 
permeabilized uterine epithelium, abundance of TRPC6 channel at stage 2 (p= 
0.1) and 4 (p= 0.4) was not significantly different to that of stage 1. However, 
abundance of TRPC6 on the basal side of the tissue at stage 3 was 1.75 fold 
(p= 0.005) higher than that of stage 1 (Fig 4.48, B). On the lateral side of the 
permeabilized bovine uterine epithelial tissue,abundance of TRPC6 at stage 2 
and 4 was not significantly different compared to that of stage 1. However, at 
TRPC6 was more abundant by 1.33 fold (p= 0.02) on the lateral side of the 
tissue at stage 3 compared to stage 1 of the estrous cycle (Fig 4.48, C).  
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 Fig 4.48 Abundance of TRPC6 in permeabilized bovine uterine epithelium throughout the 
estrous cycle in apical (4.48, A), basal (4.48, B) and the lateral (4.48, C) side of the tissue. On 
the apical side of the tissue, abundance of TRPC6 at stage 2 and 3 was higher than that of the 
stage 1. However,  abundance of TRPC6 at stage 4 was not significantly different to that of the 
stage 1. On both the basal and lateral side of the tissue, abundance of TRPC6 at stage 2 and 4 
was equal to that of stage 1. However, at stage 3 TRPC6 was more abundant on both basal 
and lateral side compared to the stage 1 of the estrous cycle. All data are expressed as a mean 
of 3 replicates ± 1 standard deviation. (* = p<0.05; ** = p<0.01; *** = p<0.001). 
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4.1.3 Effect of sex hormones on the abundance of TRPC1 and TRPC6 in 
cultured bovine oviduct epithelial cells throughout the estrous cycle 
It was shown in section 3.4 that sex hormones altered the gene expression of 
TRPCs in Bovine Oviduct Cultured Cells. Immunocytochemistry and confocal 
microscopy techniques were used to determine if sex hormones could also 
affect the abundance of TRPC1 and TRPC6 in BOEC. 
4.1.3.1 Effect of sex hormones on the distribution of TRPC1 and TRPC6 in 
non-permeabilized cultured bovine oviduct epithelial cells throughout the 
estrous cycle 
In non-permeabilized Bovine Oviduct Epithelial Cells (BOEC) at stage 1 of the 
estrous cycle, abundance of TRPC1 was not affected by Est (p= 0.6), FSH/LH 
(p= 0.9), Prog (p= 0.3) and a combination of Est, Prog, FSH and LH (p= 02)  
compared to that of the control group. At stage 2, Est (p= 0.2) and FSH/LH (p= 
0.5) did not induce any changes in abundance of TRPC1 in non-permeabilized 
BOEC. However, the Prog (p= 0.004) mixture of Est, Prog, FSH and LH 
increased the abundance of TRPC1 by 1.95 (p= 0.004) and 1.24 (p= 0.04) fold 
respectively compared to the control group. At stage 3 of the estrous cycle, 
abundance of TRPC1 in non-permeabilized BOEC was decreased by 0.65 (p= 
0.01) and 0.75 (p= 0.003) fold in cells treated with Est and FSH/LH respectively 
relative to that of the control group. Prog (p= 0.9) did not alter the abundance of 
TRPC1 channel in non-permeabilized BOEC compared to the untreated BOEC. 
However, a combination of Est, Prog, FSH and LH increased the abundance of 
TRPC1 in non-permeabilized BOEC by 1.4 fold (p= 0.0005) relative to that of 
the control group. In non-permeabilized BOEC at stage 4 of the estrous cycle,  
the abundance of TRPC1 channel was not affected byEst (p= 0.3), Prog (p= 
0.1), FSH/LH (p= 0.4) and the mixture of all these hormones (p= 0.6) compared 
to the untreated BOEC(Fig 4. 49, A). 
Sex hormones altered the abundance of TRPC6 channel in the non-
permeabilized BOEC. At stage 1 of the estrous cycle, Est decrease the 
abundance of TRPC6 by 0.38 fold (p= 0.002) relative to the untreated group. 
Furthermore, a 0.6 fold (p= 0.02) decreased in abundance of TRPC6 was 
observed in the non-permeabilized BOEC treated with FSH and LH. Abundance 
of TRPC6 in Prog-treated (p= 0.2) non-permeabilized BOEC was not 
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significantly different compared to the control group. There was no significant 
difference in abundance of TRPC6 in non-permeabilized BOEC treated with the  
mixture of Est, Prog, FSH and LH (p= 0.1) relative to the untreated group. At 
stage 2 of the estrous cycle, Est increased the abundance of TRPC6 channels 
by 3 fold (p= 0.003) in the non-permeabilized BOEC compared to the untreated 
group. In FSH/LH-treated BOEC a 1.8 fold (p= 0.01) increase was observed in 
abundance of TRPC6 channel relative to the control. Prog also increased the 
abundance of TRPC6 channel by 4.3 fold (p= 3.8 x 10-5) compared to the 
untreated BOEC. However, in BOEC treated with the mixture of Est, Prog, FSH 
and LH (p= 0.7) abundance of TRPC6 channels was not significantly different 
compared to the control group. At stage 3 of the estrous cycle, Est decreased 
the abundance of TRPC6 in non-permeabilized BOEC by 0.44 fold (p= 0.0006) 
relative to the control group. Abundance of TRPC6 in non-permeabilized BOEC 
treated with FSH/LH (p= 0.2) and Prog (p= 0.05) was not significantly different 
compared to the untreated cells. However, a mixture of Est, Prog, FSH and LH 
slightly decreased TRPC6 abundance by 0.53 fold (p= 0.001) compared to the 
untreated group. In non-permeabilized BOEC at stage 4 of the estrous cycle, 
abundance of TRPC6 channel was decreased by 0.70 fold (p= 0.04) in 
response to Est compared to the control group . In FSH/LH-treated BOEC (p= 
0.1) the abundance of TRPC6 was not significantly different relative to the 
untreated BOEC. Prog induced a 0.5 fold (p= 0.007) decrease in abundance of 
TRPC6 channel in non-permeabilized BOEC at stage 4 of the estrous cycle 
compared to the untreated BOEC. Furthermore, mixture of Est, Prog, FSH and 
LH reduced the abundance of TRPC6 channels by 0.66 fold (p= 0.04) 
compared to the control group (Fig 4.49, B).  
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Fig 4.49 Effect of sex hormones on abundance of TRPC1 and TRPC6 channels in non-
permeabilized Bovine Oviduct Cultured Cells (BOEC). Abundance of both TRPC1 
(4.49, A) and TRPC6 (4.49, B) channels was altered in BOEC treated with sex 
hormones throughout the estrous cycle. All data are expressed as a mean of 3 replicates ± 
1 standard deviation. (* = p<0.05; ** = p<0.01; *** = p<0.001). 
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4.1.3.2 Effect of sex hormones on the distribution of TRPC1 and TRPC6 in 
permeabilized cultured bovine oviduct epithelial cells throughout the 
estrous cycle 
In permeabilized Bovine Oviduct Epithelial Cultured Cells (BOEC) abundance of 
TRPC1 was altered by  the sex hormones throughout the estrous cycle. At 
stage 1 of the estrous cycle, Est reduced the abundance of TRPC1 channels by 
0.1 fold (p= 5.04 x 10-5) compared to the untreated group. However, FSH/LH 
induced a 1.89 fold (p= 0.01) increase in abundance of TRPC1 relative to that 
of the control group. Furthermore, in Prog-treated BOEC, abundance of TRPC1 
channels was increased by 1.4 fold (p= 0.004) compared to the untreated 
group. A mixture of Est, Prog, FSH and LH (p= 0.5) did not induce any 
significant changes in abundance of TRPC1 channels in permeabilized BOEC 
at stage 1 of the estrous cycle. At stage 2, no significant effect was observed in 
abundance of TRPC1 in BOEC treated with Est (p= 0.1) compared to the 
control group. However, FSH/LH and a combination of Est, FSH,LH and Prog 
reduced the abundance of TRPC1 in permeabilized BOEC by 0.82 (p= 0.02) 
and 0.81 (p= 0.008) fold respectively relative to the untreated BOEC. In BOEC 
treated with Prog, abundance of TRPC1 was slightly increased by 1.13 fold (p= 
0.04) compared to the control group. In permeabilized BOEC at stage 3 of the 
estrous cycle, abundance of TRPC1 channel was not significantly affected in 
Est (p= 0.2), FSH/LH (p= 0.1) and Prog (p= 0.3) treated BOEC compared to the 
untreated group. However, a mixture of Est, FSH, LH and Prog decreased the 
abundance of TRPC1 by 0.66 fold (p= 0.01) in permeabilized BOEC compared 
to the control group. At stage 4 of the estrous cycle, abundance of TRPC1 
channel in Est (p= 0.09) and FSH/LH (p= 0.1) treated BOEC was not 
significantly different relative to the untreated BOEC. However, Prog increased 
abundance of TRPC1 by 1.24 fold (p= 0.03) relative to the untreated BOEC. 
Furthermore, a mixture of Est, FSH, LH and Prog increased the abundance of 
TRPC1 channel by 1.4 fold (p= 0.008) in permeabilized BOEC at stage 4 of the 
estrous cycle compared to the control group (Fig 4.50, A). 
The abundance of TRPC6 in permeabilized BOEC at stage 1 of the estrous 
cycle was reduced by 0.04 fold (p= 0.008) compared to the control group under 
the effect of Est. However, FSH/LH (p= 0.9) and Prog (p= 0.4) did not induce 
any significant changes in abundance of TRPC6 relative to the untreated group. 
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A mixture of Est, FSH, LH and Prog decreased the abundance of TRPC6 
channel by 0.6 fold (p= 0.02) compared to the control group. At stage 2 of the 
estrous cycle, Est reduced the abundance of TRPC6 channel by 0.69 fold (p= 
0.01) relative to the control BOEC. In contrast, FSH and LH increased the 
abundance of TRPC6 by 1.38 fold (p= 0.009) compared to the untreated group. 
Prog significantly reduced the abundance of TRPC by 0.9 fold (p= 0.04) relative 
to the untreated group. A combination of Est, Prog, FSH and LH reduced the 
abundance of TRPC6 channel by 0.13 fold (p= 0.0008) compared to the control 
group.  At stage 3 of the estrous cycle in permeabilized  BOEC, Est (p= 0.9) did 
not induce a significant effect on abundance of TRPC6 channel compared to 
the untreated BOEC. However, both FSH/LH (p= 0.0003) and Prog (p= 0.002) 
reduced the abundance of TRPC6 channel by 0.56 and 0.77 fold respectively 
compared to the control group. Furthermore, a combination of Est, FSH, LH and 
Prog decreased the abundance of TRPC6 channel by 0.63 fold (p= 0.005) 
relative to that of the control group. At stage 4 of the estrous cycle, Est (p= 
0.05) and FSH/LH increased the abundance of TRPC6 in permeabilized BOEC 
slightly by 1.31 fold (p= 0.04) compared to the control group. However, Prog 
induced a decrease by 0.56 fold (p= 0.003) in abundance of TRPC6 compared 
to the control group. Furthermore, a combination of Est, FSH, LH and Prog 
decreased the abundance of TRPC6 channel by 0.79 fold (p= 0.04) in 
permeabilized compared to the untreated BOEC (Fig 4.50, B).  
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 Fig 4.50 Effect of sex hormones on abundance of TRPC1 and TRPC6 channels in 
permeabilized Bovine Oviduct Epithelial Cultured Cells (BOEC). Abundance of both 
TRPC1 (4.49, A) and TRPC6 (4.49, B) channels was altered in BOEC treated with sex 
hormones. All data are expressed as a mean of 3 replicates ± 1 standard deviation. (* = 
p<0.05; ** = p<0.01; *** = p<0.001). 
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4.2 Effect of sex hormones on protein expression of TRPC1 and TRPC6 in 
cultured bovine oviduct epithelial cells throughout the estrous cycle 
It was shown in section 3.4 and 4.1.3 that sex hormones are involved in TRPC 
gene expression regulation, and in the pattern of abundance of TRPC1 and 
TRPC6 channels in Bovine Oviduct Epithelial Cultured Cells (BOEC). The effect 
of sex hormones on TRPC1 and TRPC6 protein expression was studied using 
the western blot technique. As the amount of protein loaded on to each gel was 
equal (35 µg), the protein expression level of TRPC1 and TRPC6 in BOEC with 
different treatments could be compared to each other and the control. In BOEC 
treated with Est, TRPC1 protein expression was lower at stages 1, 2 and 3 
compared to the control (Fig 4.51, A and B). Protein expression of TRPC6 was 
strongly reduced in Est-treated BOEC at all stages of estrous cycle; more 
significantly at stage 3 and 4 compared to the untreated BOEC (Fig 4.51, A and 
B). In FSH/LH-treated BOEC, protein expression of TRPC1 was increased at 
stage 4 of the estrous cycle compared to the control group (Fig 4.51, A and C). 
In contrast, protein expression of TRPC6 was decreased at stage 1 and 
increased at stage 3 compared to the control group (Fig 4.51, A and C). In 
Prog-treated BOEC, protein expression of TRPC1 was slightly reduced at stage 
3 compared to the untreated BOEC. However, this decrease was significantly 
greater than at stage 4 of the estrous cycle compared to the control BOEC (Fig 
4.51, A and D). No significant difference was observed in TRPC6 protein 
expression in Prog-treated BOEC compared to the control group (Fig 4.51, A 
and D). Protein expression of TRPC1 at all 4 stages of the estrous cycle was 
significantly decreased in BOEC treated with the mixture of Est, FSH, LH and 
Prog (Fig 4.51, A and E). In contrast, protein expression of TRPC6 was slightly 
increased at stage 1 of the estrous cycle in BOEC treated with the mixture of 
Est, FSH, LH and Prog compared to that of the control BOEC (Fig 4.51, A and 
E). 
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Fig 4.51 Effect of sex hormones on TRPC1 and TRPC6 protein expression in Bovine Oviduct 
Epithelial Cultured Cells (BOEC). Protein expression level of TRPC1 and TRPC6 was altered by 
Est (4.51, B), FSH and LH (4.51, C), Prog (4.51, D) and the mixture of Est, FSH, LH and Prog 
(4.51, E) individually and combined compared to the untreated BOEC (4.51, A). n=1 
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4.3 Discussion 
The data presented in this chapter show that TRPC1 and TRPC6 are localized 
on the apical, basal and the lateral sides of the cells of the bovine oviduct and 
uterine epithelial tissue. Generally, TRPC6 is more abundant on the oviduct 
epithelium compared to TRPC1. In bovine oviduct epithelial tissue abundance 
of both TRPC1 and 6 on the apical, basal and lateral sides in the infundibulum, 
ampulla and isthmus regions of the oviduct changes throughout the estrous 
cycle. These changes in abundance of TRPC1 and TRPC6 follow the same  
pattern throughout the estrous cycle, however, some differences were observed 
in the pattern of  TRPC1 and 6 abundance on the apical, basal and lateral side 
of the tissue in the oviduct. For example, changes in membrane abundance of 
TRPC6 on the apical and basal sides of the infundibulum, ampulla and isthmus 
epithelium at stage 1 of the estrous cycle were different to that of the lateral 
side. The difference in abundance of TRPC1 on the apical, basal and the lateral 
sides of the epithelium might be due to its physiological role in association with 
STIM and the complex of STIM and Orai proteins (Hong et al., 2011). STIM1 
regulates TRPC1, 3, 4, 5 and 6 (Yuan et al., 2007). However, TRPC1, 4 and 5 
are gated directly by STIM1 whereas, the regulatory effect of STIM1 on TRPC3 
and TRPC6 is via the heteromultimerization of TRPC1-TRPC3 and TRPC4-
TRPC6 (Yuan et al., 2007). Therefore, TRPC channels are functional in STIM-
dependent and STIM -independent mode indicating their role as Store- 
Operated Channels (SOC) and Receptor- Operated Channels (ROC). The 
functional mode of TRPC channels could determine their localization either on 
the membrane (apical, basal and lateral) or intracellularly. 
Although TRPC6 was localized on all sides of the epithelial membrane, its 
abundance was highest on the apical membrane of both the oviduct and uterine 
epithelium throughout the estrous cycle. A similar pattern of TRPC6 distribution 
on both apical and basal membranes was described by  Bandyopadhyay et al., 
(2005) in polarized Madin-Darby canine kidney cells (MDCK) and salivary gland 
epithelial cells (Bandyopadhyay et al., 2005).  
Polarity is a key feature of epithelial tissues and intracellular calcium 
concentration plays a vital role in the maintenance of this (Schwab et al., 1997; 
Kimura et al., 2001). It has been clearly shown that TRPC1 is one of the key 
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players in determining the polarity of Madin–Darby canine kidney-focus 
epithelial cells (Fabian et al., 2008). Furthermore, in polarized rat podocyte cells 
the TRPC6 channel was localized on the apical membrane and co-localized 
with Na+-K+-ATPase (NKA) in the basolateral membrane (Goel et al., 2006). 
NKA is involved in maintaining the resting membrane potential (Lafaire & 
Schwarz, 1986), cellular ion transport, in particular across the epithelial cells 
(Sugi et al., 2001), controlling cell volume (Kerr et al., 1982) as well as being a 
signal transducer (Xie & Cai, 2003). Colocalization of TRPC6 with NKA in 
basolateral membrane of the rat podocytes suggests the presence of a similar 
functional unit in the bovine oviduct and uterine epithelial tissue (Goel et al., 
2006).  It would therefore be interesting in future work to investigate if such an 
interaction occurs in female reproductive tissue. 
Abundance of both TRPC1 and TRPC6 is variable from infundibulum to the 
isthmus end of the oviduct throughout the estrous cycle and this might indicate 
the involvement of these channels in various physiological functions of each of 
infundibulum (oocyte transport) (Talbot et al., 1999), ampulla (fertilization) 
(Shalgi & Phillips, 1988) and isthmus (spermatozoa reservoir and early embryo 
transport) (Lefebvre et al., 1995; Kölle et al., 2009) throughout the estrous 
cycle.     
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Chapter 5 
 
Physiological role of TRPC channels in 
calcium homeostasis of bovine oviduct 
epithelial cells 
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5.1 Functional role of Transient Receptor Potential (TRP) Channels in 
Bovine Oviduct Epithelial Cultured Cells (BOEC) throughout the estrous 
cycle 
These experiments were carried out to discover the physiological role of TRPC 
channels in Bovine Oviduct Epithelial Cultured Cells (BOEC). 
Fig 5.1 and 5.2 shows the data collected from experiments to discover whether 
uptake of calcium by BOEC varies throughout the oestrous cycle due to 
different expression level of TRPC channels at each stage of the cycle. BOEC 
of each stage of the estrous cycle were loaded with 10 µM Fura PE 3-AM in 
calcium free solution as described in section (2.21). Excess dye was removed 
and the basal intracellular calcium concentration of cells in calcium free solution 
was measured. Signal collected at 380 nm (F380) represents the amount of the 
free Fura PE 3-AM and signal collected at 340 nm (F340) emission represents 
the amount of Fura PE 3-AM bound to intracellular calcium. The ratio of 
F380/F340 gives the changes in intracellular calcium concentration. Addition of 
1.5 mM calcium to the extracellular solution resulted in a significant increase in 
calcium influx into the cell and consequently an increase in intracellular calcium 
concentration (Fig 5.1). The data from Fig 5.1 and 5.2 indicate that the calcium 
influx in stage 2 BOEC was modestly higher by 1.14 fold (p= 0.001) relative to 
that of the stage 1. There is no significant difference in basal calcium uptake in 
stage 3 BOEC (p= 0.1) compared to the stage 1. However in stage 4 BOEC 
calcium influx was higher by 1.20 fold (p= 0.0002) compared to that of stage 1.  
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 Fig 5.1 Basal calcium intake in Bovine Oviduct Epithelial Cultured Cells (BOEC) throughout the 
estrous cycle.  This figure is an example of data collected from the plate reader.  The figure 
indicates the changes in free Fura PE 3-AM  verses Fura PE 3-AM bound to the intracellular 
calcium when free calcium extracellular was replaced with solution containing 1.5 mM calcium. 
Changee in basal calcium uptake was measured in BOEC at stage 1 (5.1, A), Stage 2 (5.1, B), 
Stage 3 (5.1, C) and Stage 4 (5.1, D) of the estrous cycle. 
 
 
 
 
 
 
 
 
 
0 10 20 30 40 50 60 70
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
ACa
2+
R
a
ti
o
 o
f 
F
3
8
0
/F
3
4
0
Cycle
0 10 20 30 40 50 60 70
0.6
0.7
0.8
0.9
1.0
1.1
B
Ca
2+
R
a
ti
o
 o
f 
F
3
8
0
/3
4
0
Cycle
0 10 20 30 40 50 60 70
0.55
0.60
0.65
0.70
0.75
0.80
0.85
0.90
C
Ca
2+
R
a
ti
o
 F
3
8
0
/F
3
4
0
Cycle
0 10 20 30 40 50 60
0.50
0.55
0.60
0.65
0.70
0.75
0.80
0.85
D
Ca
2+
R
a
ti
o
 o
f 
F
3
8
0
/3
4
0
Cycle
193 
 
 
 
 
 
 
 
 
 
 
Fig 5.2 Basal calcium intake in Bovine Oviduct Epithelial Cultured Cells (BOEC) harvested from 
tracts at each stage of the oestrous cycle. This figure shows the mean of the data in Fig 5.1. 
Increase in [Ca
2+
]i occurred by replacing the extracellular Ca
2+
 free solution with solution 
containing 1.5 mM Ca
2+
 was higher at stage 2 and 4 relative to the stage 1. However, no 
significant difference was observed in calcium influx in stage 4 BOEC compared to that of the 
stage 1. All data are expressed as a mean of 6 experiments ± 1 standard deviation. (* = p<0.05; 
** = p<0.01; *** = p<0.001). 
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The data in Fig 5.3 and 5.4 indicate changes in intracellular calcium 
concentration induced by Hyperforin, a TRPC6 channel activator, and 
SKF96365, a general TRP channel blocker. Hyperforin did not induce an 
increase in calcium influx in BOEC at stage 1 of the estrous cycle. 
Unexpectedly, addition of SKF96365 which is a general TRP channel blocker 
slightly increased the calcium influx into BOEC by 1.16 fold (p= 0.01)  compared 
to the intracellular calcium ([Ca2+]i) level in BOEC treated with extracellular 
solution containing 1.5 mM Ca2+ and Hyperforin (Fig 5.3, A).  However, 
intracellular calcium concentration was increased by 1.15 fold (p= 0.001) after 
addition of Hyperforin to the extracellular solution at stage 2 of the estrous cycle 
compared to [Ca2+]i of BOEC incubated with extracellular solution containing 1.5 
mM Ca2+. The Hyperforin-induced increase in Ca2+ influx was abolished by 
addition of SKF96365 to extracellular solution in BOEC at stage 2 of the estrous 
cycle and [Ca2+]i was reduced by 0.89 fold (p= 0.008) compared to that before 
addition of SKF96365 (Fig 5.3, B). At stage 3 of the estrous cycle, treatment of 
BOEC with Hyperforin induced an increased in [Ca2+]i by 1.48 fold (p= 0.003) 
compared to that of the untreated BOEC. Treatment of stage 3 BOEC with 
SKF96365 while Hyperforin was still present in the extracellular solution 
promoted a 0.76 fold (p= 0.01) decrease in [Ca2+]i relative to that before addition 
of SKF96365 (Fig 5.3, C). Hyperforin increased the Ca2+ influx in BOEC at 
stage 4 of the estrous cycle by 1.30 fold (p= 2.78 x 10-7) compared to that 
before Hyperforin treatment. Treatment of stage 4 BOEC with SKF96365 
resulted in a decrease in [Ca2+]i by 0.34 fold (p= 4.64 x 10
-11) in comparison to 
that of the stage 4 BOEC before addition of SKF96365 (Fig 5.3, D). Changes in 
[Ca2+]i induced by Hyperforin in stage 2 BOEC was higher by 1.17 fold (p= 
0.0008) compared to that of the stage 1 BOEC. The increase in [Ca2+]i  induced 
by Hyperforin was higher by 1.29 (p= 0.01) and 1.12 (p= 0.0001) fold 
respectively at in stage 3 and 4 BOEC relative to the stage 1 BOEC. The 
intracellular calcium concentration in BOEC in response to SKF96365 at stage 
2 was lower by 0.76 (p= 0.001), 0.78 (p= 8.33 x 10-5) and 0.29 (p= 2.77 x 10-6) 
fold respectively at stage 2, 3 and 4 of the estrous cycle (Fig 5.4).  
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Fig 5.3 Changes in intracellular calcium concentration induced by Hyperforin and SKF96365 in 
Bovine Oviduct Epithelial Cultured Cells (BOEC) harvested from tracts at each stage of the 
oestrous cycle. This figure is an example of data collected from the plate reader. Hyperforin 
induced a small increase in calcium influx at stage 1 (5.3, A) of the estrous cycle. Calcium influx 
promoted by Hyperforin at stage 2 (5.3, B), stage3 (5.3, C) and stage 4 (5.4, D) of the estrous 
cycle was stronger than that of stage1 (5.3, A). SKF96365 slightly increased the calcium influx 
at stage1 (5.3, A) of the estrous cycle. However, intracellular calcium concentration was 
reduced by SKF96365 at stage 2 (5.3, B), 3 (5.3, C) and stage 4 (5.4, D) of the estrous cycle. 
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Fig 5.4 Changes intracellular calcium concentration induced by Hyperforin and SKF96365 in 
Bovine Oviduct Epithelial Cultured Cells (BOEC) throughout the estrous cycle. Hyperforin 
induced a calcium influx in stage 2, 3 and 4 BOEC but not in stage 1 BOEC. Preliminary 
activation TRPC6 channel by Hyperforin in BOEC at stage 1 of the estrous cycle resulted in 
unexpected increase in calcium influx by SKF96365 which is a general TRP channel blocker. 
However, at stage 2, 3 and 4 of the estrous cycle SKF96365 abolished the Hyperforin-induced 
increase in intracellular calcium concentration . All data are expressed as a mean of 6 
experiments ± 1 standard deviation. (* = p<0.05; ** = p<0.01; *** = p<0.001). * represents the P 
value, comparing the changes in calcium influx induced by Hyperforin  at different stage of the 
estrous cycle to the stage 1 in  BOEC. * represents the P value, comparing the changes in 
intracellular calcium concentration induced by SKF96365 at different stage of the estrous cycle 
to the stage 1 in  BOEC.  
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Fig 5.5 and 5.6 show that treatment of BOEC with SKF96365 without activation 
of TPC6 resulted in an inhibition in Ca2+ influx and decrease in [Ca2+]i by 0.90 
fold (p= 0.006), 0.76 fold (p= 2.93 x 10-7), 0.89 fold (p= 1.66 x 10-6)  and 0.63 
fold (p= 8.63 x 10-5) at stage 1 (Fig 5.5, A), 2 (Fig 5.5, B), 3 (Fig 5.5, C) and 4 
(Fig 5.5, D) of the estrous cycle respectively (Fig 5.6). Changes induced by 
SKF96365 in stage 2 BOEC was not significantly different (p= 0.2) to that of the 
stage 1. Furthermore, no significant difference were observed in effect induced 
by SKF96365 in stage 2 (P= 0.05) and 3 (p= 0.1) BOEC relative to that of stage 
1.  
Treatment of BOEC incubated in calcium solution containing SKF96365, with 
Hyperforin resulted in an increase in intracellular calcium concentration at all 
stages of the estrous cycle (Fig 5.5 and 5.6). Intracellular calcium concentration 
was increase by 1.46 (1.53 x 10-5), 1.53 (6.54 x 10-5), 1.57 (p= 0.001) and 1.53 
(p= 1.95 x 10-8) fold as a consequence of Hyperforin treatment of BOEC at 
stage 1, 2, 3 and 4 of the estrous cycle respectively (Fig 5.6). No significant 
difference was observed in BOEC response to Hyperforin at stage 2, 3 and 4 
relative to stage 1 of the estrous cycle (Fig 5.6).  
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Fig 5.5 Changes in intracellular calcium concentration induced by SKF96365 and Hyperforin in 
Bovine Oviduct Epithelial Cultured Cells (BOEC) throughout the estrous cycle. This figure is an 
example of data collected from the plate reader.  SKF96365 reduced the intracellular calcium 
concentration at stage 1 (5.5, A), 2 (5.5, B), 3 (5.5, C) and 4 (5.5, D) of the estrous cycle. 
Introducing Hyperforin to the extracellular solution led to an increase in intracellular calcium 
concentration at stage1 (5.5, A), 2 (5.5, B), 3 (5.5, C) and 4 (5.5, D) of the estrous cycle.  
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Fig 5.6 Changes in intracellular calcium concentration induced by SKF96365 and Hyperforin in 
Bovine Oviduct Epithelial Cultured Cells (BOEC) throughout the estrous cycle. SKF96365 
reduced the intracellular calcium concentration at all 4 stages of the estrous cycle. Treatment of 
BOEC with Hyperforin resulted in an increase in calcium influx at stage 1, 2, 3 and 4 of the 
estrous cycle. However, no significant difference was observed in effect of SKF96365 and 
Hyperforin at stage 2, 3 and 4 compared to stage 1 of the estrous cycle. All data are expressed 
as a mean of 6 experiments ± 1 standard deviation. (* = p<0.05; ** = p<0.01; *** = p<0.001). * 
represents the P value, comparing the changes in calcium influx induced by SKF96365  at 
different stage of the estrous cycle to the intracellular calcium level before the treatment in  
BOEC. * represents the P value, comparing the changes in intracellular calcium concentration 
induced by Hyperforin at different stage of the estrous cycle to the intracellular calcium 
concentration after SKF96365 in BOEC.  
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The data in Fig 5.7 and 5.8 indicate the effect of 2.5-Di-t-butylhydroquinone 
(DBQ) which is sarcoplasmic/endoplasmic reticulum Ca2+ -ATPase (SERCA) 
inhibitor on intracellular calcium.  DBQ induced a very small transient increase 
in intracellular calcium concentration at all stages of the estrous cycle (Fig 5.7). 
The DBQ-induced transient increase in intracellular calcium concentration at 
stage 2 was not significantly different (p= 0.6) to that of the stage 1. However, 
the DBQ-induced effect in BOEC was lower at stage 3 and 4 by 0.75 (p= 
0.0003) and 0.49 (p= 1.56 x 10-6) fold respectively relative to the stage 1. 
Replacing the Ca2+ free solution with extracellular solution containing 1.5 mM 
Ca2+ after depleting the intracellular store resulted in an increase in [Ca2+]i . This 
increase was not significantly different at stage 2 (P= 0.2), 3 (p= 0.05) and 4 (p= 
0.8) compared to the stage1 (Fig 5.7 and 5.8). Addition of SKF96365 to the 
extracellular solution led to a fall in [Ca2+]i in BOEC. Effect of SKF96365 was 
stronger at stage 4 compared to the other stages of the estrous cycle. Effect of 
SKF96365 was higher at stage 2, 3 and 4 by 1.18 (p= 0.04), 1.28 (p= 0.0002) 
and 2.09 (p= 6.69 x 10-8) fold respectively relative at stage 1 (Fig 5.7 and 5.8). 
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Fig 5.7 Depleting the intracellular calcium store by DBQ enhanced the inhibitory effect of 
SKF96365 on TRP channels present in Bovine Oviduct Epithelial Cultured Cells (BOEC) 
throughout the estrous cycle. This figure is an example of data collected from the plate reader. 
Treatment of BOEC with DBQ induced a small transient increase in intracellular calcium 
concentration due to the intracellular store depletion. SKF96365 inhibited the calcium influx at 
all 4 stages of the estrous cycle in BOEC. However, the effect of SKF96365 was much stronger 
at stage 4 (5.7, D) compared to stage 1 (5.7, A),  2 (5.7, B) and 3 (5.7, C) of the estrous cycle. 
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Fig 5.8 Depleting the intracellular calcium store by DBQ enhanced the inhibitory effect of 
SKF96365 on TRP channels present in Bovine Oviduct Epithelial Cultured Cells (BOEC) 
throughout the estrous cycle.SKF96365-induced decrease in intracellular concentration was 
stronger at stage 4 compared to the other stages of the estrous cycle. All data are expressed as 
a mean of 6 experiments ± 1 standard deviation. (* = p<0.05; ** = p<0.01; *** = p<0.001). * 
indicates the P value comparing the effect of SKF96365 on calcium influx at stage 2, 3 and 4 
relative to that of the stage 1 of the estrous cycle. 
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5.2 Discussion 
The data above indicate that basal calcium influx in stage 2 and 4 BOEC was 
significantly higher than in stage 1 and 3 (Fig 5.1 and 5.2). However, mRNA 
expression of all TRPC isoforms present in BOEC, other than TRPC2, were 
lower at stage 2 and 4 compared to that of stage 1 and 3 of the estrous cycle 
(Fig 3.3). However, it has been shown previously in chapter 3 and 4 that gene 
expression does not necessarily equate to functional protein levels. Higher 
mRNA level at 1 stage could be due to the requirement for a higher amount of 
functional protein for the next stage. The time gap between the high level of 
mRNA and high level functional protein could be due to the time required for 
translation and post-translational modification (PTM). In other work, mRNA of 
TRPC2 has been detected in bovine testis (Wissenbach et al., 1998). TRPC2 
mRNA was also detected in bovine spleen and liver (Wissenbach et al., 1998). 
Furthermore, TRPC2 is expressed in olfactory epithelium and is possibly 
involved in a pheromone signalling cascade (Liman et al., 1999). It has also 
been reported that Gαs-like G proteins are the G-protein coupled receptors 
involved in transduction in olfactory epithelium (Schild & Restrepo, 1998). 
Interestingly, the LH receptor induces it effects via Gαs-like G protein (Dufau, 
1998). This could indicate a possible role of TRPC2 channels in  bovine oviduct 
epithelium calcium homeostasis.  
 
In order to test functionality of the TRP channels, experiments were conducted 
where cells were exposed to a series of activators and inhibitors.  Hyperforin is 
a TRPC6 specific activator which induced an increase in calcium influx at stage 
2, 3 and 4 but not at stage 1 of the estrous cycle (Fig 5.4) indicating that TRPC6 
is physiologically active in the bovine oviduct epithelial cells. Hyperforin-induced 
calcium influx in BOEC was higher at stages 2, 3 and 4 of the estrous cycle 
compared to that of stage 1. However, the mRNA expression of TRPC6 in 
BOEC was lower at stages 2 and 4 compared to stages 1 and 3. The apparent 
discrepancy between the gene expression data and the findings relating to 
functional activity could be due to different ratios of homotetramer TRPC6 to 
heterotetramer TRPC3-TRPC6 in BOEC at each stage of the estrous cycle 
(Hirschler-Laszkiewicz et al., 2009). Furthermore, the association of TRPC6 
with STIM and the complex of STIM and Orai (Hong et al., 2011) could also 
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affect the activation of TRPC6 because of its distinct roles as Store-operated 
calcium channels (SOC) and Receptor-operated calcium channels (ROC).  
 
 SKF96365 is a general TRP channel blocker and surprisingly induced a 
modest increase in calcium influx in stage 1 BOEC after treatment with 
Hyperforin which did not induce any effect on intracellular calcium 
concentration. However, SKF96365 decreased the intracellular calcium 
concentration in stage 2, 3 and BOEC pre-treated with Hyperforin. Calcium 
entry into cells may act not only as a second messenger but can also induce 
membrane depolarization which consequently activates low voltage-activated 
calcium channels (Perez-Reyes, 2003). Besides blocking TRP channels, 
SKF96365 is a potent blocker of low voltage-activated t-type calcium channels 
which have been identified in bovine ciliary epithelial cells (Singh et al., 2010). A 
Hyperforin-induced increase in intracellular calcium concentration could lead to 
a membrane depolarization that could activate the low voltage-activated t-type 
calcium channels. Therefore, it may be concluded that SKF96365 blocks both 
the TRP isoforms present in BOEC and the low voltage-activated t-type calcium 
channels. At stage 1, Hyperforin did not affect the intracellular calcium 
concentration, suggesting that TRPC6 has limited involvement in the calcium 
homeostasis of stage 1 BOEC regardless to its interaction with other TRPC 
isoforms or other signalling proteins such as STIM. Therefore, stage 1 BOEC 
remained polarized after Hyperforin treatment and consequently low voltage-
activated t-type calcium channels were not activated. However, to determine the 
mechanism underlying the SKF96365-induced calcium influx into the stage 1 
BOEC after Hyperforin treatment further investigation is required. This could be 
done by using siRNA to knock-out each TRPC isoforms and study their role in 
this mechanism. Furthermore, SKF96365-induced activity of low voltage-
activated t-type calcium channels could be determined by depolarizing the cell 
membrane at this stage. 
 
SKF96365 alone induced a decrease in intracellular calcium concentration in 
BOEC at all 4 stages of the estrous cycle (Fig 5.6). This suggests that some or 
all TRPC isoforms present in BOEC are physiologically active throughout the 
estrous cycle. However, inhibition in calcium influx induced by SKF96365 in 
stage 4 BOEC pre-treated with Hyperforin was stronger than that of the BOEC 
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not treated with Hyperforin. This could be due to the activation of low voltage-
activated t-type calcium channels in BOEC pre-treated with Hyperforin (Singh et 
al., 2010). After blocking the TRP channels in BOEC with SKF96365, treatment 
of the cells with Hyperforin still induced an increase in intracellular calcium 
concentration with could be due to the reversible effect of the SKF96365 
(Cherednichenko et al., 2004).  
Depletion of the intracellular calcium store with 2.5-Di-t-butylhydroquinone 
(DBQ) increased the basal calcium intake in BOEC at all 4 stages of the estrous 
cycle compared to the control group indicating that intracellular store depletion 
which activates Store-Operated Calcium channels (SOC) is present and active 
in BOEC. Furthermore, this suggests the possible role of some TRPC isoforms 
present in BOEC as Store-Operated Calcium channels (SOC) (Chevesich et al., 
1997). The role of TRPC channels as SOC has been identified in other 
epithelial cells such as; TRPC1 in prostate epithelial cells (Vanden Abeele et al., 
2003) and TRPC4 in human corneal epithelial cells (Yang et al., 2005). In 
general, the data presented in this chapter indicate that some or all TRPC 
isoforms present in BOEC are functionally active, possibly as both Store-
operated calcium channels (SOC) and Receptor-operated calcium channels 
(ROC). 
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Chapter 6 
 
Role of TRPC channels in female fertility 
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According to the NHS website around 30% of infertility is related to problems 
with the woman. Causes of infertility in women are as below: 
1. Ovulation disorders which can  result in  number of conditions; 
 Polycystic ovary syndrome (PCOS) 
 Premature ovarian failure 
 Hyperthyroidism and hypothyroidism 
 Cushing's syndrome 
2. Damage or dysfunction of the womb and fallopian tubes which could be 
due to; 
 Pelvic surgery 
 Cervical surgery 
 Submucosal fibroids 
 Endometriosis 
 Pelvic inflammatroy disease 
3. Sterilisation 
4. Medicines and drugs 
 Non-steroidal anti-inflammatory drugs (NSAIDs) 
 Chemotherapy 
 Neuroleptic medicines 
 Spironolactone 
 Illegal drugs such as coaine 
5. Age 
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The polycystic ovary which is one of the causes of infertility in women was first 
described by Stein and Leventhal in 1935 (Stein & Leventhal, 1935) as an 
important cause of anovulation or irregular ovulation in infertile females. 
Polycystic ovarian syndrome (PCOS) is a common endocrine disorder with a 
spectrum of symptoms and signs among different individuals or in an individual 
over time (Balen et al., 1995). Different features of PCOS are classified into 
three categories; clinical, endocrine and metabolic. PCOS typically manifests as 
a combination of severe menstrual disturbance (amenorrhea or 
oligomenorrhea), hirsutism, acne, alopecia, and recurrent miscarriages (Sagle 
et al., 1988). The endocrine aspects of this syndrome include 
hyperandrogenism, elevated level of luteinizing hormone (LH), oestrogen and 
prolactin. Insulin resistance, obesity, lipid abnormalities and an increased risk of 
impaired glucose tolerance and type 2 diabetes mellitus are considered as the 
metabolic aspects of the syndrome (Tsilchorozidou et al., 2004). PCOS might 
be differentially inherited and its expression is affected by a number of 
interlinking factors. Genes that could be linked to PCOS are involved in the 
regulation of ovarian steroidogenesis and those which affect body mass index 
(BMI) and adiposity. Poor diet and reduced exercise are important 
environmental factors and PCOS frequently occurs in combination with obesity 
and insulin resistance. This could be an explanation of the correlation between 
obesity development and symptom severity in women with PCOS (Barber et al., 
2006).  
Ther pathogenesis of PCOS has been described by Tsilchorozidou, et al. 
(2004) as, "“A unique defect in insulin action and secretion that leads to 
hyperinsulinaemia and insulin resistance, a primary neuroendocrine defect 
leading to an exaggerated LH pulse frequency and amplitude, a defect of 
androgen synthesis that results in enhanced ovarian androgen production and 
an alteration in cortisol metabolism resulting in enhanced adrenal androgen 
production” (Tsilchorozidou et al., 2004). 
Insulin resistance occurs due to the low efficiency of insulin in lowering blood 
glucose level.  Insulin resistance is significantly higher in obese PCOS women 
compared to non-obese PCOS women. This observation indicates that insulin 
resistance in obese PCOS patients might result from a combination of dual 
factors; one unique to PCOS and the other obesity specific.  
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 The insulin receptor is a tyrosine kinase receptor (RTK class II). Its activity is 
increased by autophosphorylation of a tyrosine residue which consequently 
initiates signal transduction and subsequent actions of insulin. The action of 
RTK II is inhibited by serine phosphorylation. Excessive serine phosphorylation 
of insulin receptors leads to inhibit  insulin signalling; this represents a potential 
mechanism of insulin resistance in some PCOS women (Tsilchorozidou et al., 
2004). Serine phosphorylation also increases enzymatic activity of androgen 
biosynthesis, P450c17 (Zhang et al., 1995), which is a single defect and leads 
both to insulin resistance and hyperandrogenism (Tsilchorozidou et al., 2004). 
According to the World Health Organization (WHO) website, recent lifestyle 
changes have resulted in rising rates of obesity; 1.5 billion adults in 2008, and 
consequently hyperinsulinemia which in females is important in the 
pathogenesis of the PCOS. Secretion of androgen from the ovarian stroma is 
stimulated by insulin. Normal development of ovarian follicles is affected by 
androgen (Okutsu et al., 2010). Excessive androgens cause adverse effects on 
follicular growth as well as suppressing apoptosis which permits the survival of 
follicles which may ordinarily be lost by atresia.  
The correlation between hyperinsulinaemia and hyperandrogenism has been 
shown (Prelevic, 1997). However, most of the evidence suggests 
hyperinsulinaemia as a primary factor. Pathways leading to androgen 
production induced by hyperinsulinaemia (Fig. 6.1) include activation of Insulin-
like growth factor I receptors (IGF-1 R) of theca cells by insulin at high 
concentration and insulin-induced enhanced amplitude of LH pulses via 
stimulation of insulin receptors in pituitary tissue (Tsilchorozidou et al., 2004). 
Furthermore, circulating levels of IGF-1 are increased by insulin-induced 
inhibition of hepatic production of IGFBP-1. Hyperinsulinaemia also contributes 
to hyperandrogenism by inhibiting hepatic synthesis of serum sex hormone-
binding globulin (SHBG), which results in an elevation in levels of free androgen 
and estradiol in the blood stream. There is a striking inverse relation between 
peripheral insulin and SHBG levels such that SHBG concentration is considered 
a reliable marker for hyperinsulinaemic insulin resistance (Tsilchorozidou et al., 
2004). 
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Fig. 6.1 Scheme of proposed interactions leading to excessive androgen level in PCOS 
(Tsilchorozidou et al., 2004).  
 
 
 
 
 
 
 
 
 
 
 
 
211 
 
Consequently, PCOS is necessarily defined by a range of clinical and 
biochemical features including disturbed menstrual cycle, elevated serum 
concentration of LH, testosterone, androstenedione (Franks, 1995) and insulin, 
obesity, hirsutism, and acne. PCOS has various manifestations and one, all, or 
any combination of those mentioned could be present in association with 
polycystic ovaries.    
According to the Rotterdam polycystic syndrome consensus workshop group 
which is cosponsored by the European Society for Human Reproduction and 
Embryology (ESHRE) and the American Society for Reproductive Medicine 
(ASRM) diagnosis of PCOS should rely on the presence of at least two of the 
following 3 symptoms (Azziz, 2006):  
1) irregular or absent ovulation, elevated levels of androgenic hormones; 
2)  enlarged ovaries containing at least 12 follicles each  
3) polycystic ovaries (transvaginal ultrasound) 
These recommendations form the so-called “Rotterdam Criteria” the 
accepted standard for diagnosis of PCOS. (Rotterdam ESHRE/ASRM-
Sponsored PCOS Consensus Workshop Group., 2004)".  
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6.1 Expression of the TRPC family in human endometrium 
Analysis of TRPC expression in human samples was carried out on archived  
human endometrium biopsy tissues Hull Royal Infirmary Hospital Archives 
provided by Prof S.L. Atkin and used according to the REC reference number of 
07/Q1104/53. 
Expression of TRPC1 (Lane 2), 6 (Lane 6) and 7 (Lane 7) was detected in 
biopsies collected from human endometrium (fig 6.1). Positive expression of β 
actin acting as the endogenous control (Fig 6.1, Lane 1) confirmed the success 
of the PCR reaction. Furthermore, expression of Cytokeratin18 (Fig 6.2, Lane 
8), a marker specific to epithelial cells, confirmed that template cDNA was from 
epithelial cells. The expected size of the PCR products were  β actin 211 bp, 
TRPC1 242 bp, TRPC3 238bp, TRPC4 249bp, TRPC5 255bp, TRPC6 218 bp, 
TRPC7 240bp and Cytokeratin18  249 bp . 
 
 
   
  
  
  
  
  
Fig 6.2  Expression of TRPC genes in human endometrium. PCR product was loaded as 
following: Lane 1; β actin, Lane 2; TRPC1, Lane 3; TRPC3, Lane 4; TRPC4, Lane 5; TRPC5, 
Lane 6; TRPC6, Lane 7; TRPC7 and Lane 8; Cytokeratin18.  PCR Products were 
electrophoresed on a 2% agarose gel.  Band presence indicates positive expression of TRPC 1, 
6 and 7 in human endometrium tissue; expression of TRPC3, 4 and 7 was not detected. TRPC2 
is a pseudogene in the human.  All PCR products were of the predicted size.   of  β actin: 211 
bp, TRPC1: 242 bp, TRPC6: 218 bp, TRPC7: 240bp and Cytokeratin18 : 249 bp . 
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6.2 TRPC genes and fertility 
Expression of the TRPC channels were next examined in endometrial biopsies 
from women with Polycystic Ovary Syndrome and from women attending for 
assisted conception through In Vitro Fertilization (IVF). The biopsies from the 
endometria of women who were unable to conceive but not diagnosed with any 
physiological problem were used as the control. This group was named Male 
Factor since the cause of infertility was ascribed to pathology specific to the 
male, with the female not having compromised fertility.  These data are 
presented in Fig 6.3. 
 
6.2.1 Expression of TRPC genes in endometrium from Polycystic Ovary 
Syndrome (PCOS) patients 
The data in Fig 6.3, A indicate that expression of TRPC1 in the endometrium of 
PCOS patients was not significantly different (p= 0.1) relative to the male factor 
control. However, expression of both TRPC6 and TRPC7 was up-regulated by 
5.63 (p= 0.01) and 9.83 (0.04) fold respectively in the endometrium of PCOS 
patients compared to the male factor controls (Fig 6.3, B and C). 
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 Fig 6.3 Expression of TRPC genes in the endometrium of women with PCOS was different to 
that of the endometrium of normal women. Expression of TRPC1 in the endometrium of PCOS 
patients  was similar to that of the healthy women (6.3, A). However, TRPC6 and TRPC7 were 
both up-regulated compared to the control group (Fig 6.3 B and C respectively). All data are 
expressed as a mean of 3 replicates ± 1 standard deviation. (* = p<0.05; ** = p<0.01; *** = 
p<0.001). 
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6.2.2 Expression of TRPC genes in endometrium of IVF patients 
The human endometrium biopsies from IVF patients were provided by Dr E. 
Dickerson and used in accordance with REC approval reference number 
07/Q1104/53. 
The data from Fig 6.4, A indicate that in endometrium of women attending for In 
Vitro Fertilization (IVF) on day 21 of the menstrual cycle, expression of TRPC1 
was 6.78 fold (p= 0.009) higher than that of endometrium from women who 
were attending for treatment for ‘male factor’ infertility. Furthermore, expression 
of TRPC6 was 2.20 fold (p= 0.01) higher in endometrium of IVF patients relative 
to the male factor patients (Fig 6.4, B). However, TRPC7 was dramatically 
down-regulated to 10%  (p= 0.001) of its value in the control group (Fig 6.4, C). 
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Fig 6.4 Expression of TRPC genes in endometrium of IVF patients was different to that of the 
endometrium of normal women. Expression level of TRPC1 (Fig 6.4 A) and TRPC6 (Fig 6.4 B) 
was up regulated in endometrium of IVF patients relative to the male factor. However TRPC7 
expression was reduced compared to the control group (Fig 6.4 C). All data are expressed as a 
mean of 3 replicates ± 1 standard deviation. (* = p<0.05; ** = p<0.01; *** = p<0.001). 
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6.3 Localization of TRPC channels in human endometrium throughout the 
menstrual cycle 
Semi-quantitative measurements of TRPC1 and TRPC6 throughout the 
menstrual cycle were carried out in relation to the proliferative phase of the 
cycle. In non-permeabilized human endometrium tissue, the expression level of 
TRPC1 channels on cytoplasmic membranes was similar at the proliferative, 
early secretory (p= 0.05) and late secretory (p= 0.1) phases of the menstrual 
cycle. However, at the mid secretory phase, abundance of TRPC1 was lower by 
0.41 fold (p= 0.003) compared to that of the proliferative phase (Fig 6.5).  
Membrane abundance of TRPC6 protein in human endometrium was higher in 
glandular epithelium at the proliferative phase compared to the rest of the tissue 
(Fig 6.5, A). However, at early (p= 0.8) and mid (p= 0.1) secretory phase, 
abundance of TRPC6 was similar throughout the tissue (Fig 6.5, B and C). At 
the late secretory phase abundance of TRPC6 was lower by 0.50 fold (p= 0.04) 
relative to that of the proliferative phase (Fig 6.5, D).  
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Fig 6.5 Localization of TRPC1 and TRPC6 in non-permeabilized human endometrium 
throughout the menstrual cycle. Abundance of  TRPC1 was similar at proliferative (6.5, A),  
early secretory (6.5, B) and late secretory (6.5, D) phase. Abundance of TRPC1 was lower at 
mid secretory phase (6.5, C) compared to other stages of the menstrual cycle. TRPC6 was 
more abundant in the glandular compartment (shown by arrows) compared to the rest of the 
tissue in the proliferative phase (6.5, A). At the early secretory (6.5, B), mid secretory (6.5, C) 
and late secretory (6.5, D) phase, TRPC6 was localized evenly throughout the non-
permeabilized human endometrium tissue. Abundance of TRPC6 was equal at proliferative (6.5, 
A), early (6.5, B) and mid (6.5, C) secretory phase. Abundance of TRPC6 was lowest at late 
proliferative phase (6.5, D). Nuclei are labeled with DAPI (Blue), TRPC1 with Alexa Four 647 
FITC conjugated (Red) and TRPC6 with Alexa Flour 488 (Green). 
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Fig 6.6 Abundance of TRPC1 and TRPC6 in non-permeabilized human endometrium 
throughout the menstrual cycle. Abundance of TRPC1 was similar at proliferative and early and 
late secretory phases. However, abundance of TRPC1 was reduced by to half of that 
proliferative phase at the mid secretory phase of the menstrual cycle (6.6, A). Abundance of 
TRPC6 was similar at the proliferative, early and mid secretory phases of the menstrual cycle. 
However, abundance of TRPC6 was reduced to half at the late secretory phase compared to 
the proliferative phase of the menstrual cycle (6.6, B). All data are expressed as a mean of 3 
replicates ± 1 standard deviation. (* = p<0.05; ** = p<0.01; *** = p<0.001). 
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In the permeabilized human endometrium tissue, abundance of TRPC1 was 
higher in columnar epithelium compared to the glandular part of the tissue at the 
proliferative phase of the menstrual cycle (Fig 6.7, A). Abundance of TRPC1 in 
permeabilized tissue was lower by 0.62 (p= 0.002) and 0.69 (p= 0.008) fold at 
the early proliferative and late proliferative phases respectively relative to that of 
the proliferative phase. However, no significant difference was observed in 
abundance of TRPC1 in permeabilized tissue at mid secretory phase relative to 
the proliferative phase (Fig 6.8, A). 
Abundance of TRPC6 in permeabilized human endometrium was higher in 
glandular epithelium compared to the columnar epithelium at the proliferative 
phase as shown by the arrow in Fig 6.7, A.  At early and late secretory phase 
TRPC6 was present at even amounts (Fig 6.7, A, B and D) relative to the 
proliferative phase. However, abundance of TRPC6 at mid secretory phase in 
permeabilized human endometrium was even higher by 1.67 fold (p= 0.03) 
compared to that of the proliferative phase of the menstrual cycle (Fig 6.8, B).  
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Fig 6.7  Localization and abundance of TRPC1 and TRPC6 in permeabilized human 
endometrium throughout the menstrual cycle. TRPC1 tended to be more abundant in columnar 
epithelium compared to glandular cells in permeabilized human endometrium at the proliferative 
phase of the estrous cycle (6.7 A). However, at  the early secretory stage (6.7 B), mid secretory 
(6.7 C) and late secretory phase (6.7 D) of the menstrual cycle, abundance of TRPC1 was even 
throughout the tissue. TRPC6 appeared more abundant in the glandular part compared to the 
rest of the tissue at proliferative phase, shown by an arrow (6.7 A). At early secretory (6.7 B), 
mid secretory (6.7 C), and late secretory phases (6.7 D) intracellular TRPC6 was localized 
evenly throughout the permeabilized human endometrium tissue. Nuclei are labelled with DAPI 
(Blue), TRPC1 with Alexa Four 647 FITC conjugated (Red) and TRPC6 with Alexa Flour 488 
(Green). 
 
 
 
 
 
222 
 
 
  
 
 
 
 
  
  
  
 
 
 
 
 
 
 
 
 
 
Fig 6.8 Abundance of TRPC1 and TRPC6 in permeabilized human endometrium throughout the 
menstrual cycle. Abundance of TRPC1 was similar at the proliferative and mid secretory 
phases. However, lower of TRPC1 was observed at early and late secretory phases (6.8, A). 
Abundance of  TRPC6 was similar in proliferative, early and late secretory phase but higher at 
mid secretory phase compared to other stages of the menstrual cycle (6.8, B). All data are 
expressed as a mean of 3 replicates ± 1 standard deviation. (* = p<0.05; ** = p<0.01; *** = 
p<0.001). 
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6.4 Discussion 
The data presented in this chapter may have significant clinical relevance. The 
results collected from normal human endometrium indicate that TRPC1, 6 and 7 
are expressed (Fig 6.2). Changes in the mRNA expression level of these TRPC 
isoforms and their physiological role in human endometrium throughout the 
menstrual cycle could not be studied due to the lack of biopsies.  However, 
changes in mRNA expression of TRPC1, 6 and 7 in the endometrium of 
patients with Polycystic Ovarian Syndrome as well as endometrium of women 
attending In Vitro Fertilization (IVF) at day 21 of the menstrual cycle strongly 
suggest an important role for TRPC channels in human fertility as well as that of 
the bovine.  
Expression of TRPC1 mRNA in endometrium of PCOS patients was not 
significantly different to that of control tissue. However, mRNA expression level 
of both TRPC6 and TRPC7 was dramatically increased in endometrium of 
PCOS patients (Fig 6.3). Between 6-8% percent of women of reproductive age 
suffer from PCOS (Diamanti-Kandarakis et al., 1999; Asunción et al., 2000; 
Azziz et al., 2004). Variable clinical presentations are observed in this 
heterogeneous disorder. However, increased levels of LH and a normal level of 
FSH are observed in more than 60% of PCOS patients (Blank et al., 2006). 
Furthermore, the post-ovulatory increase in progesterone secretion is not 
present in women with PCOS (Blank et al., 2006). In Chapter 3, it was 
demonstrated that FSH and LH up-regulate the gene expression of TRPC 
isoforms in BOEC at different stages of the estrous cycle and that progesterone 
prevents this up-regulatory effect (Fig 3.4-3.8). Furthermore, the mRNA 
expression level of TRPC isoforms in bovine uterine epithelium was highest at 
stage 4 of the estrous cycle where progesterone is absent and FSH and LH are 
at their highest concentration (Fig 3.10). These data suggest a possible up-
regulatory role of FSH and LH on mRNA expression of TRPC isoforms in 
bovine uterine epithelial tissue and endometrium of PCOS patients and the 
antagonistic activity of progesterone in this process. Examination of TRPC1, 6 
and 7 protein expression levels in endometrium of PCOS patients is necessary 
for further confirmation of these findings.  
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Expression of TRPC1 and 6 was up-regulated in endometrium of patients 
attending for IVF compared to that of women without a physiological problem 
who could not conceive as a result of male partner pathological specification. 
However, expression of TRPC7 was down-regulated in endometrium of these 
patients (Fig 6.4). Discovering the mechanism underlying the changes in 
expression of TRPC1, TRPC6 and TRPC7 in the endometrium of subfertile 
women who attended for IVF is difficult due to lack of background information 
about the patients, however, these data do indicate a role for TRPC channels in 
the epithelial cells of the female reproductive tract.  
The examination of changes in TRPC1, 6 and 7 mRNA expression throughout 
the menstrual cycle was not possible due to difficulties in obtaining human 
biopsies. However, the protein localization and abundance of TRPC1 and 6 was 
studied in endometrium of normal women throughout the menstrual cycle. In the 
glandular epithelium of endometrium, localization of TRPC6 was greater on the 
apical side. Human endometrium acts as a secretory tissue in the early, mid 
and late secretory phase (Kabir-Salmani et al., 2005). Evidence for a possible 
role in this tissue for TRPC channels is provided by the report that G-coupling 
receptors which are the mediators of TRPC channels are localized on the apical 
membrane of  rat salivary glands and kidney ductal cells (Bandyopadhyay et al., 
2005b).  
In conclusion, data presented in this chapter indicate an important role of TRPC 
channels in female reproductive tract, particularly in the epithelium lining the 
endometrium and fallopian tubes. Furthermore, data collected from human 
samples confirmed the possibility of a regulatory role of sex hormones on TRPC 
channel activity.   
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7. Discussion 
The objective of this research was to determine the role of Transient Receptor 
Potential Canonical channels in female reproductive tract; specifically in the 
oviduct and uterus. The focus was on  epithelial tissue due to its direct 
interaction with the gametes and embryo (Croxatto, 2002a) as well as its  role in 
providing an optimal environment (Leese et al., 2001) for reproductive 
processes such as capacitation (Kervancioglu et al., 2000) and fertilization 
(Kano et al., 1994; Kervancioglu et al., 1997). Intracellular calcium 
concentration plays a vital role in the physiological function of epithelial cells 
(Friedman & Gesek, 1995; van de Graaf et al., 2004; Nijenhuis et al., 2005). A 
variety of channels are involved in calcium homeostasis in epithelial cells, one 
of which is TRP channels (van de Graaf et al., 2004; Nijenhuis et al., 2005; 
Menè, 2006; Harteneck & Reiter, 2007; van de Graaf et al., 2007). However, the 
role of TRP channels as an important superfamily of cation channels has been 
neglected in the epithelia of female reproductive tract. The focus of the project 
was on TRPC channels due to their diverse activation pathways as Receptor-
Operated Channels (ROC) and Store-Operated Channels (SOC) and 
physiological function (Xu & Beech, 2001; Clapham, 2003b; Albert et al., 2007). 
The bovine was used a model for the human due to difficulties in obtaining 
human biopsies, and the physiological similarities in female reproductive tract 
and cyclic changes between human and bovine (Navara et al., 1995; Anderiesz 
et al., 2000; Malhi et al., 2005). 
There are several reproductive events after ovulation that are highly calcium 
dependent.  These include: increase in the secretory activity of the epithelial 
cells lining the oviduct in order to provide an optimal microenvironment for the 
gametes and the early embryo; increase in the number of ciliated epithelial cells 
to facilitate the transport of the gametes to the site of the fertilization in the 
ampullary-isthmus junction (AIJ) as well as helping the movement of the early 
embryo to the uterus (Hunter, 1994; Croxatto, 2002a). Changes in the 
intracellular calcium concentration is key in the processes of both secretion 
(Richardson et al., 1985; Sharma & Rao, 1992; Dickens et al., 1996) and 
beating frequency of ciliated cells (Salathe, 2006) and TRP channels have been 
reported to play a role in each process.  For example (Uchida & Tominaga, 
2011), insulin secretion is mediated by TRPM2 via Cyclic adenosine 
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diphosphate ribose (cADPR) (Takasawa et al., 1993) and Protein Kinase A 
(PKA), (Togashi et al., 2006) whereas localization of TRPV4 the base of the 
cilia in the hamster oviductal epithelial cells (Fernandes et al., 2008) and 
localization of TRPV4 at the base of cilia in tracheal epithelial cells (Lorenzo et 
al., 2008) implies a role for these proteins in regulating and stimulating beating 
frequency of the cilia (Lorenzo et al., 2008) 
7.1 TRPC genes expression in epithelial tissue lining female reproductive 
tract 
It was shown in chapter 3 that from seven isoforoms of the TRPC family, 
TRPC1, 2, 3, 4 and 6 are expressed in both bovine oviduct and uterine 
epithelial tissue (Fig 3.1 and 3.9). Quantitative measurements of mRNA of 
TRPC isoforms obtained from each stage of the estrous cycle indicate that the 
expression level of these isoforms changes throughout the estrous cycle in both 
the oviduct and uterus (Fig 3.2 and 3.10). 
Changes in mRNA expression of TRPC isoforms in bovine oviduct epithelium 
was different to that of the bovine uterine epithelium throughout the estrous 
cycle (Fig 3.2 and 3.10).  Expression of TRPC1, 2, 3, 4 and 6 in bovine oviduct 
epithelial tissue was highest at stage 1 where progesterone is the dominant 
hormone and the concentrations of 17β- estradiol, FSH and LH are very low 
(Kaneko et al., 1992). However, in uterine epithelial tissue, expression of all the  
t TRPC isoforms present was  highest at stage 4 of the estrous cycle where the 
concentration of progesterone is very low or absent and 17β- estradiol, FSH 
and LH are the dominant hormones (Kaneko et al., 1992). Stage 1 (day 1-4) 
starts immediately after ovulation, when the oocyte is transported into the 
oviduct. Transport of the oocyte is dependent on the ciliary beat frequency 
which is calcium-dependant (Schmid & Salathe, 2011). Furthermore, plasma 
concentration of 17β- estradiol dramatically drops via  a reduction in 17β- 
estradiol production due to the regression of the corpus luteum (CL).  
Gene expression of both TRPV5 and TRPV6 is up-regulated by 17β-estradiol in 
epithelial cells of duodenum. However, the mechanism underlying this up-
regulation is not understood (van Abel et al., 2003). The regulatory effect of 
17β-estradiol on gene expression of other TRP channel has not been reported. 
One possible link between 17-estradiol and regulation of TRPC expression is 
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the signalling factor nuclear factor-kappa B (NF-КB).  It has been reported by 
Valdez and colleagues (2005) that 17β- estradiol stimulates the NF-КB 
activation in bovine granolusa cells (Valdez & Turzillo, 2005). Moreover, It has 
been reported that FSH triggers the NF-КB activity in rat granolusa cells leading 
to expression of the X-linked inhibitor of apoptosis (XIAP) and inhibition of 
apoptosis (Valdez & Turzillo, 2005). Furthermore, inhibition of  NF-КB activation 
suppresses the FSH-stimulated follicle growth in vitro (Wang et al., 2002a). By 
contrast, progesterone reduces the activation of toll-like receptor 4 (TLR4) and 
NF-κB signalling pathway in the brain of male rats after subarachnoid 
hemorrhage (Wang et al., 2011). The promoter region of TRPC1 contains an 
NF-КB binding site (Paria et al., 2004). Furthermore, expression of TRPC1 in 
human vascular endothelial cells (Paria et al., 2004) and TRPC3 in human 
airway smooth muscle cells (White et al., 2006) is up-regulated in response to 
TNF-alpha; which is an activator of NF-КB pathway (Findlay et al., 2000). The I 
kappa B Kinase (IKK) which phosphorylates the NF-КB inhibitor (IКB) is 
activated by TNF-α. Phosphorylation of IКB at serine 32 and 36 leads its 
ubiquitination and degradation by 26S proteasome. This in turn results in the 
release of the nuclear localization signal of NF-КB and translocation of NF-КB to 
the nucleus. Consequently, binding of NF-КB to its binding sites on DNA is likely 
to result in transcription of NF-КB-linked proteins such as TRPC1 and TRPC3. 
However, FSH-induced activation of NF-КB is independent of IКB 
phosphorylation (Wang et al., 2002b).   
At stage 2 and 3 of the estrous cycle, the concentrations of 17β- estradiol and 
LH are at their lowest level. Several slight increases in FSH concentration (FSH 
waves) occur throughout stage 2 and 3 of the estrous cycle. An increase in the 
concentration of Progesterone begins  between the end of stage 1 and the 
beginning of stage 2, reaching a plateau at the end of stage 2 (Gordon, 2003). 
Progesterone levels drop at the end of stage 3 as the result of regression of the 
corpus luteum, which is induced by secretion of PGF2α by the endometrium 
(Schramm et al., 1983). At stage 4 of the estrous cycle, uterine epithelial tissue 
undergoes proliferation and secretes PGF2α (LaVoie et al., 1975), which is 
induced by binding of oxytocin to its specific receptor in the endometrium. 
Oxytocin signalling elicits a rise in inositol phosphates (IPs), key players in the 
activation pathway for TRPC channels (Clapham, 2003b). Upon activation of 
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Gq-coupled receptors (Okada et al., 1998; Schaefer et al., 2000) and receptor 
tyrosine kinases which activate phospholipases C (PLCs), TRP channels might 
be activated via three pathways; production of diacyglycerol (DAG), hydrolysis 
of phosphatidylinositol (4,5) bisphosphate and production of inositol (1,4,5) 
trisphosphate (IP3) (Ramsey et al., 2006). Activation of α subunit of Gq-coupled 
receptors family leads to stimulation of PLCβ, which in turn results in formation 
of IP3 and DAG. IP3 binds to the IP3 receptor on the endoplasmic reticulum 
membrane and promotes calcium release from internal stores. Furthermore, IPs 
can act as an intracellular calcium concentration regulator (Asselin et al., 1997). 
DAG is an activator of PKCs (Birnbaumer et al., 1996).  Interleukin-1β (IL-1β) is 
a cytokine that regulates protein synthesis and PGF2α secretion in 
endometrium (Davidson et al., 1995). Also, IL-1β regulates the expression of 
TRPC genes in human myometrium (Dalrymple et al., 2004). Furthermore, the 
role of TRPC isoforms in proliferation such as; TRPC6 (Thebault et al., 2006) 
and TRPC1 (Fiorio Pla et al., 2005) has already been  established. Therefore, 
IL-1β could have a regulatory effect on endometrium proliferation through TRPC 
signalling pathways. IL-1β and TNF-α mediate activation of NF-kB in fibroblast-
like synoviocytes via IKK-β (Aupperle et al., 1999). The increase in mRNA of the 
TRPC isoforms present in bovine uterine epithelium at stage 4 of the estrous 
cycle could be partially related to the effect of IL-1β by a similar mechanism, 
due to presence of NF-kB binding site in the promoter region of TRPCs such as 
TRPC1(Paria et al., 2003).  
It was interesting to note that the expression pattern of TRPC isoforms in bovine 
oviduct and uterine epithelial cells maintained in cell culture was different to that 
of the native tissue. This suggests that a key regulatory factor present in vivo is 
absent in conventional in vitro culture medium.  Given the level of endocrine 
control of the reproductive cycle, I hypothesised that the sex hormones may 
play a role in regulating expression of TRP channels.  This was based on the 
observations that sex hormones are the main variable throughout the estrous 
cycle and were absent in the epithelial culture medium. Further investigation 
confirmed the hypothesis that sex hormones regulate the gene expression of 
TRPC isoforms in bovine oviduct and uterine epithelium. 
To examine this possibility, BOEC harvested from different stages of the 
estrous cycle were acutely treated with physiological concentration of sex 
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hormones (Ginther et al., 2010). A combination of FSH and LH resulted in an up 
regulation in expression of all TRPC isoforms throughout the estrous cycle. 
Addition of 17β-estradiol to the mixture of FSH and LH increased the up 
regulatory effect of FSH and LH for each TRPC isoform throughout the estrous 
cycle. Each of these have been shown to have a regulatory role on gene 
expression, for example the regulatory role of 17β- estradiol in gene expression 
in breast cancer (Charpentier et al., 2000), progesterone-induced gene 
expression regulation in the endometrium of rhesus moneky (Okulicz & Ace, 
1999), role of LH in gene expression regulation in mouse granulosa cells 
(Carletti & Christenson, 2009) and the regulatory role of FSH in gene 
expression in pig granulosa primary cells (Bonnet et al., 2006). Furthermore, 
FSH and LH receptors are expressed in the ovary (Camp et al., 1991), human 
ovarian surface epithelium and fallopian tube (Zheng et al., 1996), pig fallopian 
tube (Gawronska et al., 1999) and bovine uterine vein where the LH receptor 
mRNA and protein level are highest during proestrous and estrous cycle 
(Shemesh, 2001). It has been reported that 17β-estradiol increases the 
expression of LH receptors in the epithelium and smooth muscle cells of pig 
oviduct (Gawronska et al., 1999). The promoter region of LH receptor gene 
contains three sites for the transcription factor Specificity Protein 1 (SP1) sites 
(Tsai-Morris et al., 1993). It has been reported that estrogen receptor α (ERα) 
can interact with SP1 in the promoter of low density lipoprotein receptor (LDLR) 
gene which leads to activation of LDLR gene transcription by 17b-estradiol in 
liver hepatoma cells (HepG2) (Li et al., 2001) A similar mechanism might 
explain the increased up regulatory effect of FSH and LH on TRPC gene 
expression in BOEC following  addition of  17β-estradiol  
When Prog was added to the mixture of either FSH and LH or FSH/LH and Est, 
the up regulatory effect of these combinations on expression of TRPC genes 
was lost. In cultured murine leydig cells, Prog reduces the mRNA level and 
function of the LH receptor (El-Hefnawy & Huhtaniemi, 1998). Furthermore, 
progesterone has an inhibitory effect on activation of toll-like receptor 4 (TLR4) 
and nuclear factor-kappa B (NF-κB) signalling pathway (Wang et al., 2011). As 
mentioned above, NF-κB binding site is one of the elements in the promoter of 
some of TRPC channels such as TRPC1 (Paria et al., 2004) . Enhanced 
activation of NF-κB by FSH (Wang et al., 2002b)and 17β-estradiol (Valdez & 
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Turzillo, 2005) and the inhibitory effect of progesterone (Wang et al., 2011) on 
NF-κB activation could explain the up-regulatory effect of FSH, LH and 17β-
estradiol and down-regulatory effect of progesterone on TRPC gene expression 
in BOEC.  
Furthermore, the difference in expression level of some of the TRPC isoforms 
reported in chapter 3 could be due to expression of their splice variants and 
possible different regulation pathway; for instance, TRPC1 (Dedman et al., 
2004; Dedman et al., 2005) and TRPC4 (Schaefer et al., 2002) with both have 
several splice variants.   
To summarise, TRPC1, 2, 3, 4 and 6 are expressed in both bovine oviduct and 
uterine epithelium. Expression of these TRPC isoforms changes throughout the 
estrous cycle. These changes are most likely induced by endocrine changes 
throughout the estrous cycle as the treatment of BOEC with physiological 
concentration of Est, FSH, LH and progesterone individually and in combination 
altered the TRPCs gene expression level in various pattern. Sex hormone 
possibly induced their effect on TRPC gene expression via TNF-α and NF-κB 
pathways. To confirm these hypothesis, inhibitors of NF-κB such as SN50 which 
inhibits the translocation of NF-κB into the nucleus (Wang et al., 2002a) could 
be used. Expression of TRPC genes could be studied in BOEC treated with 
NS50 in combination with sex hormones.  
7.2 Localization and abundance of TRPC1 and 6 proteins in epithelial 
tissue lining female reproductive tract 
Measuring the Fluorescent intensity of TRPC1 and TRPC6, which are the 
common TRPC isoforms expressed in both human and bovine endometrium, 
indicates that TRPC1 and 6 were expressed at the apical, basal and lateral 
membranes of bovine oviduct epithelium. However, abundance of TRPC6 was 
generally higher than that of TRPC1. Furthermore, TRPC6 was more abundant 
on the apical membrane compared to the basal and lateral membranes. This 
could be due to the direct or indirect physiological role of this TRPC isoforms in 
secretion in altering the intracellular calcium concentration (Berridge et al., 
1998b; Li et al., 2003).  
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In general, changes in abundance of TRPC1 and TRPC6 were detected in the 
ampulla and isthmus throughout the estrous cycle, especially their intracellular 
abundance.  The changes in abundance of protein were generally similar to the 
mRNA level changes detected for these two genes. However, changes in 
abundance of TRPC1 and TRPC6 in infundibulum did not follow the same 
pattern as their gene expression throughout the estrous cycle. The infundibulum 
is a small section of oviduct compared to ampulla and isthmus and the 
difference observed between the abundance of TRPC1 and TRPC6 channels in 
infundibulum and their mRNA level in bovine oviduct epithelium could be due to 
the small amount of mRNA extracted from the infundibulum compared to the 
ampulla and isthmus. Therefore, the changes in mRNA levels of TRPC1 and 
TRPC6 in oviduct throughout the estrous cycle mainly reflect those of the 
ampulla and isthmus but not infundibulum. To re-examine the changes in 
mRNA level of TRPC1 and TRPC6 in infundibulum, ampulla and isthmus it 
would be necessary to confirm the difference in abundance of TRPC1 and 
TRPC6 in different sections of the oviduct throughout the estrous cycle. Due to 
the lack of research on the role of TRPC channels in epithelia in general and 
the epithelia lining the female reproductive tract in particular, no literature was 
found to support or contradict these findings. However, it has been reported that 
localization of TRPC6 was detected on both the apical and basal sides of 
epithelial cells, whereas localization of TRPC1 was limited to the basal side of 
Madin-Darby canine kidney cells (MDCK) and salivary gland epithelial cells. 
(Bandyopadhyay et al., 2005a). In agreement with the data presented in 
Chapter 4, TRPC6 was localized on both the apical and basal sides of the 
epithelial tissue as well as the lateral face of the tissue. In contrast with the 
report by Bandyopadhyay (2005), localization of TRPC1 in polarized Madin-
Darby canine kidney cells (MDCK) and salivary gland epithelial cells was not 
limited to the basal side of the bovine oviduct/uterine epithelial tissue but was 
observed on all apical, basal and lateral sides of the tissue. In polarized cells 
such as epithelial cells, cellular functions which are regulated by calcium are 
limited to specific microdomains (Muallem & Wilkie, 1999; Petersen, 2000; 
Bootman et al., 2001; Kiselyov et al., 2002; Kiselyov et al., 2003; Petersen, 
2003). These domain-restricted calcium changes have been shown to occur 
close to the IP3 receptor sites (Sun et al., 1998; Thomas et al., 1998). The 
apical side of the secretory cells is well-known for local calcium signals 
233 
 
(Petersen et al., 1999) and the oviductal epithelium secrets specific proteins into 
the oviductal lumen. A group of these proteins are expressed throughout the 
estrous cycle while secretion of the other group of the proteins by oviductal 
epithelium is cyclical (Gandolfi et al., 1989). Furthermore, secretion is a well-
known feature of the uterine epithelium (Jacobs & Carson, 1993). Apical 
localization of TRPC6 could be due to its involvement in secretory function of 
either oviduct or uterine epithelium. Specially, high abundance of TRPC6 on the 
apical side of the uterine glandular epithelium could confirm this hypothesis.      
The epithelial cells in infundibulum are more ciliated compared to the ampulla. 
The number of ciliated epithelial cells in the isthmus is very low or absent. In the 
rabbit, secretion of oviductal fluid is greater from the ampulla than the isthmus 
due to the greater surface area of the epithelial cells in ampulla (Leese, 1983).  
In the bovine, secretion of oviductal fluid is 10 times greater at estrous where 
the 17β- estradiol is at its highest concentration throughout the estrous cycle 
(Roberts et al., 1975). Similarly, in ewes (McDonald & Bellvé, 1969) estradiol 
triggers the secretion of oviductal fluid, however, progesterone abolishes the 
estradiol-induced secretion. Non-secretory ciliated epithelial cells undergo 
hypertrophy, maturation and elongation under the effect of oestrogen (Comer et 
al., 1998). In contrast, two studies have reported that progesterone induces 
secretion (Gregoraszczuk et al., 2001), for instance, secretion of dipeptidyl 
peptidase-IV by endometrium of ewe and cow  (Liu & Hansen, 1995). It has 
been reported that TRP channels are involved in secretion (Uchida & 
Tominaga, 2011), and Liu et al., (2007) reported that TRPC1 play an important 
role in the secretion of fluid from salivary gland acinar cells (Liu et al., 2007). 
Membrane and intracellular abundance of TRPC1 and 6 in different sections of 
the bovine oviduct was higher in ampulla and isthmus compared to the 
infundibulum. This could be due to a higher number of non-ciliated secretory 
epithelial cells in ampulla and isthmus and related to the physiological role of 
ampulla and isthmus in fertilization (Ellington, 1991) and spermatozoa 
capacitation (Suarez, 2002). 
The difference in abundance of TRPC1 and TRPC6 protein in bovine uterine 
epithelial tissue at different stages of the estrous cycle was not as dramatic as 
that of their mRNA level. This difference could be due to post-transcriptional 
modifications (PTM). However, further investigation is required to clarify the role 
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of PTM and this could be done by using fluorescent staining of two dimensional 
gels (Jacob & Turck, 2008).Furthermore, the antibodies used in this research 
might not be capable of binding to the possible splice variants of TRPC1 and 
TRPC6 proteins while the mRNA of the possible splice variants could have 
been detected by the primers used. This could be another reason for 
differences in the mRNA and protein expression level of TRPC1 and TRPC6 
detected in bovine oviduct epithelial cells. 
The physiological role of TRPC1 in association with Stromal Interaction 
Molecule (STIM) and Orai proteins involved in Store-Operated Channels (SOC) 
complex (Hong et al., 2011) could explain the difference in abundance of these 
channels on the apical, basal and lateral sides of the oviduct and uterine 
epithelia. Furthermore, heteromultimerization of TRPC isoforms with each other, 
which is partially regulated by STIM1 protein, could also affect the localization of 
these channels (Yuan et al., 2007). Differences in abundance of both TRPC1 
and TRPC6 in the bovine oviduct and uterine epithelia throughout the estrous 
cycle and within the tissue might be due to their various physiological roles 
which could be a result of the interaction of TRPC channels with other proteins. 
 7.3 Physiological function of TRPC isoforms in bovine oviduct epithelial 
cultured cells 
Measuring the changes in intracellular calcium concentration using Fura PE 3-
AM (calcium dye) indicated that TRPC6 is physiologically active in bovine 
oviduct epithelial cultured cells. The unexpected response of BOEC to 
Hyperforin at stage 1 of the estrous cycle, which begins just after ovulation, 
could be related to the different ratio of homotetramer TRPC6 and 
heterotetramer TRPC3-TRPC6 in BOEC at this stage of the estrous cycle and 
the possible difference in the activation pathways of these two protein 
complexes (Hirschler-Laszkiewicz et al., 2009). Moreover, the physiological 
association of TRPC6 to STIM and the complex of Orai and STIM (Hong et al., 
2011) might affect the channel response to Hyperforin due to the distinct 
physiological function of  TRPC6 channel  in the form of  Store-operated 
calcium channels (SOC) or Receptor-operated calcium channels (ROC). 
However, the role of other TRPC isoforms could not be studied individually due 
to lack of a specific agonist and antagonist for each TRPC isoforms. Further 
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investigation is required to address the physiological role of each TRPC 
isoforms by using siRNA technique to knock out individual isoforms prior to 
measuring the changes in the intracellular calcium concentration. Furthermore,  
and as shown in chapter 3, expression level of TRPC isoforms in BOEC is 
different to that of the intact tissue. Therefore, to provide a better in vitro model, 
changes in intracellular calcium concentration should be measured in cells 
treated with physiological concentrations of sex hormones. In addition, as 
polarity of the epithelial cells is pivotal to their function, measuring the changes 
in intracellular calcium concentration in polarized cells treated with and without 
hormones is required to expand our understanding of the physiological role of 
TRPC channels in the oviduct and uterine epithelia (Chandra et al., 2007). This 
could be done using transwell permeable supports (Fig 7.1) which permit the 
cells to take up and secrete molecules on both their apical and basal sides and 
thereby carry out metabolic activities under more natural conditions, with  the 
cells as a polarized monolayer.  
 
 
 
 
 
 
 
Fig 7.1  Snapwell transwell permeable supports (adapted from Corning, Transwell-guide) 
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7.4 TRPC channels in human endometrium 
To determine the clinical relevance of the data about the role of TRPC channels 
in epithelial tissue lining the bovine oviduct and uterus, gene expression of 
TRPC isoforms was studied in endometrium of normal women and women   
with Polycystic Ovarian Syndrome as well as in endometrium of women at day 
21 of the menstrual cycle attending for In Vitro Fertilization (IVF).  
Of 7 isoforms of TRPC family, TRPC1, 6 and 7 were expressed in human 
endometrium. Changes in the expression of TRPC6 and 7 in endometrium of 
women with PCOS support the idea that FSH and LH, which are elevated in 
PCOS patients, (Blank et al., 2006) up-regulate the expression of TRPC 
isoforms, and that progesterone which is absent or present at a very low levels 
in PCOS patients inhibits the up-regulatory effect of FSH and LH (Blank et al., 
2006).  This general pattern was observed in in vitro studies in Chapter 3. 
Furthermore, changes in expression level of TRPC1, 6 and 7 in endometrium of 
women attending for IVF point tantalisingly to a role of TRPC channels in this 
tissue .  
Due to the lack of biopsies of endometrium at different stages of the menstrual 
cycle, the changes in expression level of TRPC isofoms throughout the 
menstrual cycle could not be examined.  However, localization and abundance 
of TRPC1 and 6 were studied throughout the menstrual cycle. TRPC1 was 
more abundant in the epithelium, while TRPC6 was more abundant at the apical 
membrane of glandular epithelium indicating the possible role of this TRPC 
isoform in secretion (Li et al., 2003).  
7.5 Conclusion and future work 
TRPC1, 2, 3, 4 and 6 are expressed in both bovine oviduct and uterine 
epithelia. The mRNA level of expressed TRPC isoforms in these tissues 
changes throughout the estrous cycle. Cyclic changes in plasma concentration 
of sex hormones throughout the estrous cycle may regulate the expression level 
of TRPC channels. Further investigation is required to determine the 
mechanisms underlying the regulatory pathways of sex hormones on TRPC 
channels.  TRPC channels are possibly involved in oocyte pick up, sperm 
capacitation, fertilization and early embryo transport in oviduct and secretion as 
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they are present throughout the oviduct and uterine epithelia at all 4 stages of 
the estrous cycle. The TRPC6 channel is physiologically active in bovine 
oviduct epithelial cultured cells.  
Studying the mRNA expression of each of TRPC isoforms and their splice 
variants in infundibulum, ampulla and isthmus is necessary to determine the 
relation between the gene and protein expression of each of these isoforms at 
different stages of the estrous cycle. Furthermore, finding the possible changes 
in the gene and protein expression level of FSH, LH, Est and Prog receptors 
would be critical for understanding the regulatory effect of these hormones on 
gene and protein expression of TRPCs in the epithelial tissues lining the female 
reproductive tract.    Hence, to determine the physiological activation of other 
TRPC isoforms in oviduct and uterine epithelium, the siRNA technique to 
knockout individual TRPC isoforms would be useful. Moreover, activity of these 
channels in polarized epithelial monolayers and in the presence of physiological 
concentration of sex hormones needs to be studied. More importantly, creating 
TRPC isoform-deficient mice and studying oocyte maturation, fertilization, early 
embryo transport, implantation and any other reproductive events would provide 
a great opportunity for understanding the role of these important calcium 
channels in mammalian female reproduction.    
The expression level of TRPC channels in women attending for IVF was 
significantly different compared to the control. Further investigation is therefore 
required to determine the changes in expression level of TRPC isofoms 
throughout the menstrual cycle. Moreover, determining the association between 
the mRNA and protein expression of TRPC isoforms in human endometrium 
and fallopian epithelium throughout the menstrual cycle is important. Finally, the 
physiological role of TRPC channels in the endometrium needs to be 
determined using calcium imaging and electrophysiological, including patch 
clamp, techniques. 
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